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ABSTRACT 
Peripheral nerve damage affects thousands of people every year. While less severe 
injuries usually heal over time, surgery is the only option to attempt restoration of 
sensation and function in severely damaged peripheral nerves. Autologous nerve 
grafting is currently the most successful and commonly used treatment for injuries 
of the peripheral nervous system. The functional outcomes of autografting are still 
far from ideal and further limitations result from the need to sacrifice a nerve from 
elsewhere in the body. To overcome these limitations research has focussed on the 
development of artificial nerve conduits which are designed to support the 
damaged nerve to reconnect.  
The list of requirements for artificial nerve conduit design is long and includes a 
biocompatible and biodegradable material resembling a 3D channel, which 
provides appropriate guidance cues. Other desirable factors are the ability to 
contain and deliver bioactive factors and incorporation of supportive cells. The 
effect of electrical stimulation on peripheral nerve regeneration is still discussed 
controversially, however it is routinely named as a desirable component of a nerve 
conduit. Comparison between results of different groups is very difficult, which 
results from the lack of standardization of stimulation set-ups and parameters 
used. Very little data is available on the effect of electrical stimulation on cells in 
3D even though the desired application presents a 3D environment. This work 
focussed on the development of a 3D structure which incorporates electrically 
conducting components to facilitate electrical stimulation of cells within the 
construct.  
To introduce electrical conductivity into alginate hydrogels, blends of polypyrrole 
nanoparticles (PPy) and alginate were prepared and the resistivity of the system 
analysed in wet-state using electrochemical impedance spectroscopy. It was 
determined that the introduction of spherical nanoparticles into alginate gel does 
not reduce, but rather slightly increases resistivity of the hydrogel in the wet-state. 
These findings resulted in a change of focus away from conducting bulk materials 
towards conducting fibres which would be incorporated into hydrogels in order to 
deliver electrical stimulation to cells within the hydrogel structure. To achieve this, 
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the PPy nanodispersion was optimised for conductivity and processability by 
decreasing the quantity of stabilizing polyvinylalcohol (PVA) before and after 
synthesis. As-synthesised and PVA-reduced PPy particles were spun into all-
nanoparticle fibres. While fibres made from PVA-reduced PPy showed higher 
electroactivity and improved mechanical properties compared to fibres composed 
of the dispersion with a high PVA content, they were still found to be insufficient 
for the proposed application.  
To improve the properties of the PPy fibres, composite fibres composed of PPy 
nanoparticles and reduced graphene oxide (rGO) were produced using a wet-
spinning approach. The electrical conductivity of the composite fibres increased 
significantly with the addition of rGO while the mechanical properties of the 
composite fibres also improved. The biological compatibility of the fibres was 
investigated using L929 fibroblasts seeded onto fibres as well as exposed to media 
that had been used to extract leachates from fibres. Cells were affected by the 
fibres when exposed to 10-100 mg ml-1, depending on the rGO-PPy ratio. Overall, 
these composite fibres showed promising mechanical and electrical properties 
while not significantly impeding cell growth, making them a good candidate for 
delivering electrical stimulation to cells within hydrogels. 
An innovative method combining pultrusion and wet-spinning techniques and 
facilitating incorporation of pre-formed filaments into ionically crosslinkable 
hydrogels was developed and tested. This biofabrication technique allows the 
incorporation of filaments, controlled guidance channels and living cells into 
alginate hydrogels. The rGO-PPy composite fibres were successfully incorporated 
into 3D alginate structures and did not show any negative effects on PC12 cell 
viability. 
The ability of PC12 cells to differentiate within the 3D alginate was analysed and 
found to be limited by the encapsulation of the gel. To support cell differentiation a 
separate channel was introduced into the alginate gel containing cells dispersed in 
a weakly crosslinked gellan gum microink. A proof of concept of electrical 
stimulation of the cells within the 3D hydrogel was prototyped and performed 
using stainless steel filaments. Cells were shown to be differentiating with and 
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without the application of electrical stimulation however quantitative data on the 
cell differentiation was not obtained.  
A novel system has been developed and demonstrated to allow the systematic 
analysis of the effects of electrical stimulation of cells within a 3D environment. 
The flexibility of the system facilitates the application of a range of stimulation 
regimes, making it an extremely useful tool to help better understand the effects of 
electric and magnetic fields on cells in a 3D biomimetic environment. 
 
Bulk hydrogels and blends of hydrogels and conducting nanoparticles appear to be 
insufficient to provide the necessary features for a cell supportive and electrically 
conductive material, therefore the introduction of conducting filaments is 
necessary. Here it has been shown that the development of conducting fibres from 
PPy nanoparticles is possible but not ideal, and composite or metallic fibres have 
been found to be more suitable. Lastly, the development of a robust and 
reproducible system for the formation of multicomponent conducting and cell 
supportive conduits is achievable. These structures can also provide electrical cues 
to cells embedded within the structure to determine the efficacy of this 
stimulation. The work presented here introduces a method which allows future 
studies to analyse the specific stimulation regimes required to trigger specific 
desired outcomes. 
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Chapter 1 
Chapter 1: INTRODUCTION 
The work undertaken in this project is interdisciplinary in nature. As a result this 
introductory chapter encompasses biological, material and fabrication aspects 
relevant to peripheral nerve regeneration and the fabrication of artificial nerve 
conduits. Section 1.1 introduces the biological aspects related to peripheral nerve 
injury, regeneration and recovery, before introducing current treatments. In 
Section 1.2, materials for regenerative nerve applications are introduced, with a 
particular focus on hydrogels and organic conducting materials. In Section 1.3, 
potential fabrication methods are presented with a focus on cell compatible fibre 
spinning and printing methods. In the final section of the introduction, the aims 
and goals of this project are outlined. 
 
1.1 The Peripheral Nervous System 
The nervous system of vertebrates is a very complex network of connections, 
which is divided into two main parts. The central nervous system (CNS) includes 
the brain and the spinal cord, which are responsible for the integration of 
information received from sensory organs, and the coordination of activities of the 
body. The peripheral nervous system (PNS) consists of all nerves and ganglia 
outside of the brain and spinal cord. It is divided into the somatic and autonomic 
nervous system. The somatic system controls voluntary muscle movement, while 
the autonomic system operates mostly unconsciously to control body functions 
like heart rate, breathing and digestion. 
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1.1.1 Structure of the Peripheral Nerve 
Peripheral nerves (PN) are not protected by bony structures, such as the skull or 
vertebrae, which protect the brain and spinal cord in the CNS. Mechanical 
protection for peripheral nerves is provided by a hierarchical structure of tough 
and fibrous connective tissue with high compressive and tensile strength (Figure 
1.1). The axons are the information conducting elements of the nerve and are 
concentrically enclosed in three layers of tissue, which comprise the axonal sheath. 
A single layer of Schwann cells enclose peripheral motor and sensory nerve axons 
with an insulating myelin sheath (or act as part of mesaxonal complexes for non-
myelinated axons), providing chemical, homeostatic and neuroregenerative 
functions to the PN. This layer is followed by two layers of connective tissue: the 
fine neurilemma and the slightly more dense endoneurium. Both the axon and its 
sheath comprise the nerve fibre. A varying number of nerve fibres combine to 
make up the PN fascicles. The fascicles are enclosed by perineurium and bundles 
thereof are surrounded by the epineurium, which forms a tough, fibrous sheath 
around the entire nerve structure. The epineurium is clearly demarcated from the 
surrounding tissue, allowing it to move freely with movement of the body. 
 
 
Figure 1.1: Hieracrchical structure of peripheral nerves. Illustration adapted from Grinsell and 
Keating1 
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1.1.2 Injuries to the Peripheral Nerve and their Classification  
Injuries of the PN are often the result of physical impact occurring through acute 
injury and trauma (accidents), disease, as well as iatrogenic side effects of 
surgery2. Exposure to conditions including high or low temperatures, high doses of 
radiation or electrical shocks can also result in some form of nerve injury3. The 
most commonly obtained injuries to the PNS are stretch-related and result in 
partial or, in rare cases, complete disconnection of the nerve. Lacerations are the 
next most observed cause of damage to the PNS4. Nerves can be fully transected, 
however in most cases some element of the nerve remains in contact above and 
below the site of injury. Compression is the third most common type of injury and 
least severe in its outcome. Compression injuries usually heal within a few hours, 
even after motor and sensory function was lost temporarily. 
In 1942, Seddon proposed a system to classify and group injuries to the PNS, which 
was then added to by Sunderland in 19515, 6. The classifications are still used to 
classify injuries to the PNS. Seddon originally introduced three categories of 
injuries: neurotmesis, axonotmesis and neurapaxia (Figure 1.2). If a nerve is fully 
severed it is classified as neurotmesis. A lesion that causes full axonal 
degeneration, but leaves the supporting structures at least partly connected, is 
referred to as axonotmesis. A neurapraxia is described as an injury that results in 
short term paralysis, which recovers fully in a short amount of time. These 
categories were refined by Sunderland (Figure 1.2), roughly 10 years after Seddon 
first introduced them. The refined classification comprises of 5 classes of injuries, 
based on the changes that have been induced by the injury, compared to the 
normal structure of the nerve4, 5.  
 
Figure 1.2: Schematic illustration of nerve injuries and their classifications according to Sunderland 
and Seddon. Illustration adapted from Netter’s Orthopaedics7.  
4 | Introduction 
 
The first and least severe form of damage describes the interruption of conduction 
along the axon, without any break in continuity or to the structure of the nerve 
trunk. A lack of Wallerian degeneration is typically observed in this injury group, 
with full recovery of the nerve after a short period of time. This first degree injury 
is equivalent to the neurapraxia described by Seddon (Figure 1.2).  
Second degree injury is characterised by a break in the continuity of the axon and 
resultant Wallerian degeneration (described in section 1.1.3) below the site of 
injury. The axonal sheath and endoneurial tube are not compromised structurally 
and integrity of the nerve is preserved. The regenerating axon is confined to the 
original endoneurial tube, insuring that the axon reconnects appropriately, 
resulting in fully restored function a few days after the injury (Figure 1.2). 
A third degree injury shows not only the disintegration of the axon, but also 
disorganisation of the internal nerve structures and discontinuity of the 
endoneurial tube. Fascicles are disorganised, but continuity is preserved (Figure 
1.2). Since the axon’s original path through the endoneurium has been destroyed, 
regrowth can be obstructed and misdirected into other tubes, resulting in largely 
modified patterns of reinnervation. In an attempt to bridge the tissue gap, 
Schwann cells proliferate and migrate from both sites of the damaged nerve. 
Forth degree injuries are characterised by a fully disorganised inner structure of 
the nerve, including fascicles and internal epineurium. The continuity of the overall 
structure is preserved, however the lack of internal structure causes undirected 
regrowth of axons, rarely resulting in reconnection (Figure 1.2). Formation of 
neuroma is likely as well as development of a fibrous tissue reaction.  
A fifth degree injury is sustained if the nerve trunk is discontinued (Figure 1.2), 
which results in complete loss of motor, sensory and sympathetic function. 
Wallerian degeneration can be observed at the distal side of the injury. Some 
regenerating axons may reach across the gap between the nerve ends, however the 
chance of restoring functionality is extremely limited4-6.  
1.1.3 Natural Response to a Nerve Injury 
The first step in the regeneration of a damaged nerve is degeneration. Wallerian 
degeneration occurs in all types of injury except class one nerve damage, which 
only requires unblocking of the interrupted connection. Wallerian degeneration 
takes place at the distal end of a nerve injury. Macrophages enter the site and 
remove debris from degenerating myelin and axons (Figure 1.3). Schwann cells, 
which play a critical role in axonal regrowth, start proliferating when they lose 
contact with the peripheral nerve. While doing so, they synthesise growth factors 
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that attract the sprouting nerve end from the proximal side of the injury, 
encouraging the axon to extend up to a several millimetres every day3, 8, 9. If the 
endoneurial tubes have not been damaged (class 2), they can still provide guidance 
for the regrowing axons, therefore appropriate re-innervation is likely to occur. If 
the endoneurial tubes have been damaged, the regenerating axons lack guidance as 
they are no longer confined to their original sheath. This usually results in axonal 
sprouting to neighbouring endoneurial tubes and a greatly reduced chance of 
reconnection to appropriate targets3, 4. 
 
Figure 1.3: Schematic of processes occurring in the peripheral nerve after an injury, resulting in the 
regeneration of the nerve. Illustration adapted from Netter’s Orthopaedics7. 
 
1.1.4 Existing and Emerging Approaches for Repair of Damaged Peripheral Nerve 
As described above, minor injuries to the PNS generally regenerate on their own. If 
the injury is larger or more severe, the nerve generally fails to reconnect by itself 
and surgical intervention is required. If the nerves are fully separated, but no gap 
has formed, the nerve ends can be sutured together. The nerve cannot be 
connected under too much tension, so if the gap is too large, other surgical 
approaches have to be considered10. 
1.1.4.1 Nerve Grafts 
Autologous nerve grafting (autografting) is currently considered the most 
successful strategy to treat major injuries to the PNS and as a result is the most 
common method of nerve repair. Nerve autografting involves the removal of a 
nerve segment, usually a sensory nerve, from another part of the body and re-
implantation into a site of nerve damage. The implanted nerve provides 
endoneurial tubes for the regenerating axons to follow. The disadvantages in this 
technique include limitations in the supply of available nerve graft material, 
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permanent loss of function at the harvest site and limited capacity to restore motor 
function.3, 11, 12 
Other alternatives to autografts are allografts and xenografts, where the tissue is 
taken from a human donor or a donor from another species, respectively. This is 
usually performed to overcome a lack of autologous material, however the 
functional outcomes do not match those of autografts in most cases2, 13-15. The 
disadvantages of allografts and xenografts are the same as those of autografts, with 
the additional complication of potential immune responses as well as the risk of 
introducing diseases11, 12, 16, 17. 
1.1.4.2 Synthetic Nerve Conduits 
In terms of synthetic alternatives to biologically derived autografts, allografts and 
xenografts, the main clinically approved alternatives are currently hollow nerve 
guidance conduits18. These nerve conduits are made of different materials such as 
polyvinyl-alcohol (PVA) for non-degradable conduits and usually polyglycolide 
and polylactide-based materials or collagen for degradable nerve conduits and 
wraps. An overview of the nerve conduits approved by the American Food and 
Drug Administration (FDA) is given in Table 1.1. The components of all these 
conduits are not functionalized with proteins, drugs or growth factors and present 
a simple, hollow tube format, thus fulfilling only the most basic physical guidance 
criteria for nerve guides3, 16, 19.  
 
Table 1.1: Overview of nerve guidance conduits approved by the US Food and Drug Administration 
(FDA) 
Product Name Manufacturer Material Attributes 
GEM Neurotube 
Synovis Micro Companies 
Alliances, US 
Polyglicolic acid 
absorbable, woven mesh tube 
 
Neurolac Polyganics, Netherlands 
Poly(D,L-lactide-co-ε-
caprolactone) 
transparent, semi-permeable, biodegradable tube 
Salutunnel Salumedica, US Polyvinyl alcohol non-biodegradable tube 
Salubridge Salumedica, US Polyvinyl alcohol non-biodegradable wrap 
NeuraGen Integra Life Sciences, US Collagen Type I semi-permeable, degradable tube 
NeuraWrap Integra Life Sciences, US Collagen Type I 
semi-permeable, degradable tube with longitudinal 
slit 
NeuroMatrix Stryker, US Collagen Type I absorbable, semi-permeable tube 
NeuroFlex Stryker, US Collagen Type I absorbable, semi-permeable, kink-resistant tube 
NeuroMend Stryker, US Collagen Type I absorbable, semi-permeable, self-curling wrap 
AxoGuard Connector Cook Biotech Products 
Porcine small intestinal 
submucosa 
absorbable tube 
AxoGuard Protector Cook Biotech Products 
Porcine small intestinal 
submucosa 
absorbable wrap 
 
 
  
Introduction | 7  
 
The major limitations of the non-degradable nerve guides are creation of tension at 
the suture and nerve compression after the nerve has regenerated16. Furthermore, 
the efficacy of some of the non-degradable FDA approved conduits has not been 
fully tested16. Some of the degradable polymers take too long to degrade in the 
body and as a result pose the same risk of nerve compression as the non-
degradable materials. Other limitations include induction of immune responses 
and performance variation between fabrication batches12, 16, 19. 
To overcome the limitations of autologous nerve grafting and the challenges 
associated with current FDA approved nerve guidance channels, improved conduit 
design and attempts to match the biological requirements of the regenerating 
nerve with material properties has been the focus of research over the last decade. 
As a result of this, a number of important design and material criteria have been 
identified to address those challenges. In principle, this involves a biocompatible 
and biodegradable soft material, which does not provoke any immune response 
and prevents compression of the nerve, while having sufficient structural integrity 
to mimic the endoneurial tubes during the period of nerve regeneration. The 
design should resemble a 3D channel, which provides appropriate guidance cues, 
with the right porosity (between 10-20 µm16) to allow diffusion and influx of 
oxygen and nutrients, while preventing the infiltration of inflammatory cells into 
the structure and site of injury12, 16. Other desirable factors are the ability to 
contain and deliver bioactive factors and incorporation of supportive cells, as well 
as a matrix that guides cell migration and axonal regeneration, such as 
intraluminal channels that mimic the structure of nerve fascicles (Figure 1.4). 
Some level of electrical activity is also considered to be beneficial for nerve repair 
applications1. The choice of materials is vital to allow addressing of these desirable 
properties. 
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Figure 1.4: Schematic illustration of characteristics and properties important in artificial nerve 
conduits. Modified from de Ruiter, et al. 20. 
 
1.1.4.3 Growth Factors and Supportive Cells  
Apart from the appropriate choice of materials, the incorporation and delivery of 
supportive cells and growth factors is an important factor when aiming to achieve 
the best possible regeneration of an injured nerve. After an injury of the peripheral 
nerve, nerve growth factor (NGF) is upregulated in the distal nerve stump. NGF 
plays an important role in the survival of neurons and outgrowth of new neurites1, 
4. A large number of studies incorporate NGF in fibres, implants or conduit 
structures, which are implanted mostly into rat models, and show improved 
regeneration outcomes compared to the same structures lacking NGF21-24. Other 
important factors for nerve regeneration include, but are not limited to, 
extracellular matrix proteins including fibronectin, tenascin and laminin as well as 
cell adhesion molecules (CAM) such as neural cadherin (NCAD) or neurofascin, 
neurotrophin 3 (NT-3) and brain-derived neurotrophic factor (BDNF)9, 25. In 
recent years, the application of gradients of growth factors has gained interest, as 
it has shown to not only deliver necessary factors to stimulate the regeneration of 
the nerve, but also provide directional guidance for regenerating neurons26-28. 
Not only has the incorporation of growth factors been increasingly studied, but 
also the use of supportive cells. Schwann cells have especially been shown to have 
positive effects on a regenerating nerve, when delivered to the site of injury29-32. 
Furthermore Schwann cells can be modified genetically to overexpress 
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neurotrophins. Incorporation of these Schwann cells into nerve conduits combines 
the positive effects from the presence of Schwann cells with increased levels of 
neurotrophins33.  
1.1.4.4 Electrical Stimulation 
Electrical fields, currents and potentials naturally occur within the body and are 
known to be responsible for a variety of functions and signalling processes. Cells 
themselves create potentials by pumping differently charged ions across their 
membranes. The resulting electrical gradient across the cell membrane is typically 
15-100 mV. These membrane potentials can be found in electrically excitable cells 
including muscle cells and neurons34. Electrical fields and signals have been shown 
to have a significant influence on cell behaviour, and as a result influence intra- and 
extra- cellular communication, wound healing and different regeneration 
processes as well as muscle contractions35, 36. 
In both the central and peripheral nervous systems electricity plays an essential 
role, especially in communication and signal transmission37. An action potential is 
the mode by which the electric membrane potential rapidly rises and falls in an 
axon. After its initiation at the axon hillock, the action potential travels down the 
axon to the nerve terminal, where the action potential triggers a cascade of events 
that lead to release of neurotransmitter molecules37. An action potential is an 
active response to an external signal by the axon, during which the base membrane 
potential increases in a discrete area from its naturally negative state to positive 
before the potential returns to its resting value, with the membrane flux 
propagating along the axon. This change in charge happens very fast and in 
neurons only lasts around 1 ms34. Action potentials can be triggered artificially by 
applying electrical stimulation to the cell to change the membrane potential. Not all 
electrical stimulation will trigger action potentials while still affecting cell 
behaviour38.  
Electrical stimulation is a well-established tool in some clinical applications. A 
variety of different electrical therapies have been developed to treat or assist in 
bone growth, wound healing, muscle restoration and chronic pain35. The simplest 
method of applying electrical stimulation is achieved by applying a direct current 
(DC) to one or more tissues using a battery. More advanced stimulation can be 
generated by applying monophasic, biphasic or pulsating wave functions of various 
shapes, including square, rectangular, triangular, sinusoidal or more complicated 
waves (Figure 1.5).  
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Figure 1.5: Electrical stimulation terminology (A), wave forms (B) and modes (C, D). 
Electrical stimulation can be delivered to cells and tissues directly or indirectly. 
Direct stimulation requires the electrodes to be in contact with the cells. This is 
achieved by culturing cells or tissue slices in intimate contact with the electrode or 
implanting the electrodes into the tissues of an animal or patient35. Even though 
direct stimulation provides stimulation to the target tissues, with less spread to 
other parts of the body39, the majority of therapeutic devices use a less invasive 
indirect stimulation method, where stimulation is delivered from electric, 
magnetic or electromagnetic fields external to the target tissue. The main incentive 
for use of indirect methods is the advantage of bypassing issues of implant toxicity 
and insufficient biocompatibility resulting from the electrodes and the chemical 
processes occurring on the electrode surfaces that may take place during 
stimulation35.   
Different cell types react differently to various forms of electrical stimulation 
including, the wave form, amplitude, frequency, duration and type of stimulation 
(direct, indirect and field) applied. The effects of electrical stimulation on the 
morphological and functional outcome in nerve regeneration have been discussed 
widely in literature over the past decades, however there is little or no consensus 
on effects of various stimulation types, and no easily observed behaviour patterns 
to cell responses. It is challenging to compare research results with each other, as 
stimulation parameters, cell types and sources, electrode materials and protocols 
are not standardized and vary greatly within and between research groups. The 
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consensus of review articles published between 2010 and 2015 on the topic is that 
electrical stimulation of nerves, when using the appropriate stimulation 
parameters, can increase the number of regenerating axons, accelerate the 
regeneration process and guide regeneration and re-innervation1, 35, 36, 39, 40 (Table 
1.2). The choice of stimulation parameters is drastically influenced by the 
conducting materials and cell types used in in vitro studies, the materials and 
configurations applied in vivo, as well as the stimulation set up. Table 1.2 
summarizes publications relevant to electrical stimulation in nerve regeneration, 
published between 2010 and 2015.  
Even though nerve regeneration occurs in three dimensions (3D), very few in vitro 
studies have been performed where electrical stimulation was applied to cells 
within a 3D construct41. Consequently, the effects of stimulation in 3D as well as 
the required configurations and parameters are largely unknown. In 3D 
application of constant or monophasic stimulation is considered more suitable as 
resulting electric and magnetic fields will not be affected by changes in direction. 
Studies applying constant or monophasic stimulation in 2D have been performed 
several times42-44. Koppes, et al. 44 applied constant DC stimulation of 1mA for a 
period of 8 hrs to dissociated dorsal root ganglia poly-lactic acid films, reporting 
greater neurite outgrowth compared to unstimulated samples. Similar results 
were reported by Durgam, et al. 42 where primary sensory neurons seeded on 
polypyrrole- polycaprolactone films received stimulation for 2 hrs with 0.1 mA 
direct current, resulting in an increase in neurite length and number of cells with 
long neurites compared to unstimulated samples. These examples indicate that 
monophasic direct stimulation of neural cells in 2D has positive effects on the cells 
differentiation. 
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1.2 Materials for Nerve Regeneration 
A variety of different materials have been investigated and used for nerve 
regeneration applications. The material requirements within nerve conduits are 
dictated by their function. While the outside of the conduit needs to provide 
mechanical protection and allow suturing to the nerve, the inside needs to be soft 
and promote cell adhesion, proliferation and differentiation. Synthetic 
biodegradable polymers including lactide and glycolide based polymers3, 62, 63 have 
shown potential to provide a supportive framework as well as topographical 
guidance in conduits. Protein-based biopolymers such as collagen and gelatin64, 65 
as well as biological-derived polysaccharides including gellan gum and alginate66-70 
are promising soft filling materials. Additional properties such as inherent 
electrical conductivity or the ability to controllably release drugs or growth factors 
are necessary to create a conduit fulfilling the requirements listed in section 
1.1.4.2. 
The following section focuses on hydrogels, with a particular emphasis on alginate 
materials, as well as different conducting materials to evaluate their potential to 
facilitate electrically-mediated improved nerve regeneration.  
1.2.1 Hydrogels as Scaffold Materials 
Hydrogels are three-dimensional polymeric networks containing large quantities 
of water (water content ≥30% by weight)71. These networks are mostly made of 
hydrophilic polymers of natural or synthetic origin, crosslinked to water-insoluble 
matrices. Synthetic hydrogel polymers used in tissue engineering applications 
include poly(ethylene glycol) (PEG), poly(vinyl alcohol) (PVA) or polyacrylates 72-
75. Natural hydrogels have been typically formed of proteins and extracellular 
matrix components such as collagen and fibrin, as well as materials derived from 
other biological sources such as chitosan and alginate amongst others 76-80. Over 
the last decade both natural and synthetic hydrogels have been extensively studied 
and engineered as extracellular matrix mimics81. This is due to their high tissue-
like water content, efficient mass transfer, easily manipulated physical properties 
and their biomechanical and structural similarity to native extracellular matrix82, 
83. Since they are derived from natural sources, most natural hydrogel polymers 
show excellent biocompatibility in vitro and in vivo77. They have also shown to 
promote many cellular functions due to the numerous endogenous factors present, 
which can be advantageous for cell viability, proliferation, and development of 
many cell types83. 
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The crosslinked structure of hydrogels is determined by the nature of polymer 
junctions, which are the connecting points of several chains. At these connecting 
points, strong chemical linkages such as covalent or ionic bonds, permanent or 
temporary physical entanglements, microcrystallite formation or weaker 
interactions like hydrogen bonds hold polymer chains together. The hydrogel 
network morphology can be amorphous, semi-crystalline, hydrogen-bonded, 
supramolecular or made of hydrocolloidal aggregates80. The polymer chains 
forming the hydrogel may be of natural or synthetic origin or a hybrid combination 
of both. In terms of charge, hydrogels can be neutral, cationic, anionic or 
ampholytic, depending on groups incorporated in the backbone. The overall 
characteristics and structure of the hydrogels depend on the starting material, 
synthesis and fabrication methods, solvent conditions, degradation and mechanical 
loading history78. 
Parameters that are frequently used to quantify hydrogel structure include the 
amount of polymer within the swollen gel (polymer volume fraction), the average 
molecular weight between crosslinks and the mesh size (measured distance 
between crosslinks). These factors all have a significant influence on the physical 
characteristics of the resulting hydrogel, which in turn influence cellular behaviour 
for cells growing on or within the hydrogel matrix77, 78, 80. 
Factors critical for tissue engineering such as matrix stiffness and elasticity, pore 
size, and degradation rate can be specifically tailored in some hydrogels77, 78, 84, 85. 
The incorporation of living cells within the hydrogel is also possible as well as 
incorporation and delivery of growth factors and drugs84-88. As mentioned before, 
the biocompatibility of hydrogels is generally suitable for tissue applications, as 
their major component is water. Natural hydrogels are frequently regarded as 
having superior biocompatibility over synthetic hydrogels, however the presence 
of synthetic crosslinkers and polymerization initiators and their effect on the 
biocompatibility need to be considered in both natural and synthetic hydrogels. It 
must be noted that the chosen method of sterilization, a critical factor particularly 
for in vivo applications, needs to be compatible with hydrogel structures80.  
A wide range of different hydrogels of natural, synthetic or semi-synthetic origin 
have been used in tissue engineering applications. Hyaluronic acid hydrogels have 
been used in eye, bone, cartilage, facial, skin and vascular tissue applications, 
amongst others, with functions ranging from cell encapsulation to use as barriers 
for chemical and biological substances in drug delivery and scaffolds for bone 
regeneration, wound healing as well as nerve and muscle regeneration78, 89-92. 
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Poly(ethylene glycol) and poly(vinyl alcohol) have found applications in cartilage, 
pancreatic and vascular tissue engineering93-95. Dextran sulphate96, 97, chitosan98-
100, collagen64, 65, 101, chitin68, fibrin102-105 and agarose106 have also been 
investigated for engineering of various tissue types with purposes ranging from 
drug delivery, barrier encapsulation and scaffold applications78. Gellan gum, a 
polysaccharide and common food additive produced by bacteria, has been 
investigated in recent years, especially with a focus on bone and cartilage tissue 
engineering applications69, 107, 108. Another naturally derived polysaccharide, 
alginate, has been used in different studies focussing on nerve66, 92 regeneration 
applications amongst others. This is due to its high biocompatibility in vitro and in 
vivo109, the possibility of functionalising the alginate matrix to include biological 
factors85, 92 and it’s drug delivery characteristics110. Furthermore, alginate shows 
structural similarity to the extracellular matrices in tissues and can be 
manipulated to meet a range of different requirements with regard to mechanical 
properties and porosity111. 
  
1.2.1.1 Alginate Hydrogels for Applications in Nerve regeneration 
Alginates are a group of materials comprising naturally-occurring polysaccharides 
extracted from brown seaweed. This hydrogel provides the strength and flexibility 
essential for algal growth in the ocean. The gum, which is generally produced from 
brown algae as sodium alginate, is water soluble and used as a viscosity agent in 
the food industry76, 112. Alginate is found in algae as a mixed 
calcium/sodium/potassium salt of alginic acid within intercellular spaces and cell 
walls113. Alginic acid is a copolymer of β-D-mannuronic acid (M) and α-L-guluronic 
acid (G) units (Figure 1.6). Regions can be made of M blocks, G blocks or 
heteropolymeric MG blocks.  
 
Figure 1.6: Chemical structure of sodium alginate, consisting of guluronic acid (G blocks) and 
mannuronic acid (M blocks). 
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Sodium alginate can form gels in the presence of calcium and other multivalent 
metal ions, which ionically crosslink the polymer114. A number of divalent cations 
interact with alginate to form gels. Calcium is particularly suitable as a crosslinker 
for applications in tissue engineering, due to its non-toxicity at low 
concentrations115. When sodium alginate is added to a solution containing calcium 
salt, sodium ions (Na+) are exchanged with calcium ions (Ca2+), and the polymer 
becomes crosslinked to form a gel (Figure 1.7). The properties of an alginate gel 
depend on the molecular weight (chain length), the ratio and arrangement of M 
and G units, the method of preparation, the degree of transformation to calcium 
alginate and the source of calcium ions76, 109.  
 
Figure 1.7: Schematic illustration of crosslinking of sodium alginate to calcium alginate. 
 
To be suitable for use as an implant for neuroregenerative applications, the 
mechanical properties of the alginate scaffold must be sufficient to maintain 
physical integrity until the newly-formed nerve or muscle tissue replaces them, or 
until the gel has completed its function76. Mechanical properties, such as stiffness 
and swelling, can be controlled by physical factors such as the crosslinking density, 
the type of crosslinking and the molecular weight distribution of the alginate 
polymers71. The most obvious way to vary the properties of the resulting alginate 
is to increase or decrease the concentration of the gel. A lower concentration of 
alginate leads to the formation of a softer gel, while an increase in alginate 
concentration results in stiffer gels with smaller pore sizes116. A further increase in 
compressive modulus was achieved by Kuo and Ma 117 when alginate was 
crosslinked with calcium carbonate compared to calcium sulphate, this effect was 
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found to increase with the amount of calcium present117. They further found an 
improvement in mechanical properties with increasing alginate concentration 
which was attributed to the increase in polymer chain density and 
entanglement117. In another example it has been observed that the gelation time, 
which varies with the crosslinker used (calcium carbonate and calcium sulphate 
verses calcium chloride), has an influence on the gels homogeneity and mechanical 
integrity109. However, these factors also influence cellular behaviour, thus a 
compromise between facilitation of gel properties, fabrication processes and 
ultimate gel structure effect on cell behaviour is necessary109, 116. The 
biocompatibility of alginate has been evaluated extensively in vitro and in vivo, 
however there are still debates regarding the impact of alginate composition. This 
likely relates to the varying levels of purity used in different reports. Since alginate 
is produced from natural sources, various impurities such as heavy metals, 
endotoxins, proteins, and polyphenolic compounds could potentially be present. 
Highly purified alginate did not induce any significant foreign body reaction when 
implanted in animals 109. 
Ionically cross-linked alginate gels become de-gelled and dissolve at neutral pH 
upon loss of the divalent crosslinking cations, which results in uncontrolled and 
typically slow degradation in vivo. Again, the degradation can be tailored to meet 
the requirements of a specific application by changing the physical characteristics 
of the gel. The structure and properties of alginate have an impact on the 
compatibility with and within organisms. The molecular weight, composition of M 
and G-blocks, degree of crosslinking, pore size, purity and source of alginate have 
an impact on the biocompatibility of alginate gels76. Alginate in many forms has 
been used in a wide range of clinical applications and pre-clinical experiments. 
Specific tissue engineering systems based on alginates include bioartificial 
pancreas, bone and liver76, 85, 114, 118, 119. A list of alginate-based biomaterials have 
been approved as health care products and for clinical trial (PROGENIX, K081950, 
in vivo; FOREseal GLP-I CellBeads, NCT01298830, in vivo; DIABECELL(R), 
NCT00940173, in vivo). Furthermore alginate has been in use (in vitro and in vivo) 
as a bulking agent, for drug delivery devices and as scaffolds for cell 
transplantation85, 112, 120, 121.  
Alginate can easily be fabricated into films122, 123, coatings124, 125, a range of 
particles in different sizes126, fibres127, 128 and other three-dimensional 
structures129, 130. Selected fabrication methods suitable for alginate will be 
introduced in Section 1.3. 
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1.2.2 Conducting Materials for Cell Stimulation 
As mentioned in section1.1.4.4, electrical stimulation of cells and tissues for tissue 
engineering applications in vitro and in vivo has gained interest in the research 
community over the past decade, as it is thought to support regeneration of nerve 
tissue39. As materials used for tissue engineering applications are typically not 
electrically conductive, different approaches, including blends and coatings of 
conductive materials with biocompatible, non-conductive materials, have been 
recently investigated to impart electrical conductivity into biomaterials36, 131-133.  In 
the following section, selected examples of two groups of conductive materials, 
namely metals and organic conductors will be discussed.  
1.2.2.1 Metals 
Metallic materials have been used in a wide range of medical applications, usually 
because of their superior mechanical and conductive properties. Due to their good 
biocompatibility, strength and high wear resistance the most frequently used 
metals for implantation into the human body are stainless steels (such as 316L), 
titanium and its alloys, as well as cobalt-chrome alloys134. Since most metals 
conduct electricity, a variety have found application as in vitro and in vivo 
stimulation electrodes, including stainless steel43, 46, 48, titanium32, platinum60 and 
tungsten53. Usually these electrodes are fibres, needles, films or coatings as 
summarized in Table 1.2. The most significant limitation for the use of metals in 
nerve regenerative applications is the lack of degradability in the human body.  
Electron band theory gives reasonable explanations of electronic structure and the 
resulting electrical properties of metals. When the atoms of a material are closely 
spaced the energy levels of the electrons form bands. The valence band is the 
highest occupied electronic level and the lowest unoccupied band is the 
conduction band. The electrical properties depend on the way the bands are filled 
and can be summarised as follows. When bands are completely filled or empty, no 
conduction can be observed (Figure 1.8). If the distance between the valence and 
conduction band is narrow, excitation of the electrons from the valence band to the 
conduction band leads to rising conductivity. This phenomenon is found in 
classical semiconductors. In cases where the gap is too wide to excite electrons 
across it, the material acts as an insulator. In conductors, there is no gap between 
the bands and the valence bands overlaps the conduction band, which leads to high 
conductivity (Figure 1.8). 
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Figure 1.8: Schematic of the band theory of conductivity, showing electron energy configurations of 
insulators, semi-conductors or conductors. 
 
1.2.2.2 Organic Conductors 
Non-metallic, carbon-based conducting materials such as organic conducting 
polymers, carbon nanotubes and graphene have been extensively used to add a 
conductive layer or phase to non-conducting materials.  
First produced several decades ago, today there are over 25 conductive polymer 
systems including polypyrroles, polyanilines and poly(3,4-
ethylenedioxythiophene)135. They merge the positive properties of metals and 
conventional polymers, such as the ability to conduct charge, great electrical and 
optical properties, with flexibility in processing and ease of synthesis. The early 
work on conductive polymers was triggered by the observation that the 
conductivity of polyacetylene, a polymer that is normally only semiconducting, 
increases by 10 million-fold when polyacetylene is oxidized using iodine vapour. 
The underlying phenomenon was named “doping” and is essential for the 
conductivity of polymers136. Even though these polymers share many structural 
features (conjugated backbone, planarity and large anisotropy ratio), they show a 
wide range of different properties in terms of their conductivity, mechanical and 
optical properties, which can usually be tuned137. Inherently conducting polymers 
are relatively new to the tissue engineering field and appear to be alternative 
candidates for use as bioactive materials. Recent research in the biomedical field 
has demonstrated many potential medical applications for the conductive polymer 
materials, including electrical stimulation133.  
Another organic conductor that has gained interest in recent year is graphene. 
Ideal, pristine graphene is a single-layered two-dimensional sheet of atomic 
honeycomb carbon lattices that can be isolated from the multi-layed structures of 
graphene, called graphite. This isolation of single layers of graphene was first 
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achieved in 2004138 resulting in a Nobel prize in 2010. Due to its great mechanical 
properties, high thermal conductivity and close to ballistic electrical conductivity, 
it has been the interest of a large number of research groups all around the world, 
finding use and improving applications in virtually all scientific disciplines.  
Another example of organic conductors are carbon nanotubes. Structurally, carbon 
nanotubes can be viewed as tubes formed from graphene sheets and like graphene 
can be synthesised in a number of ways, including chemical vapour deposition, 
laser ablation of graphite, or arc discharge. Single-walled carbon nanotubes have 
one layer of graphene sheet, whereas, the multi-walled carbon nanotubes contain 
multi layers of graphene sheets. The well-ordered molecular structure brings 
carbon nanotubes many remarkable physical properties, including excellent 
mechanic strength, ultrahigh surface area, high aspect ratio, distinct optical 
properties, and excellent electrical conductivity 139, however concerns about their 
biocompatibility have led to a decrease in the research on biological/tissue 
engineering applications using  carbon nanotubes140.  
The following sections will focus on polypyrrole as a conducting polymer and 
graphene and their potential applications as conducting elements in nerve 
regenerative applications. 
1.2.2.2.1 Polypyrrole 
Amongst the range of conductive polymers available, polypyrrole (PPy, Figure 1.9) 
is extensively studied and widely used because of its versatility, as it is easy to 
polymerize chemically or electrochemically, and available in a variety of forms 
such as powders, coatings, films or dispersions, increasing its range of 
applications141. PPy, as other conducting polymers, is considered a semiconductor 
and consists of repeating units of pyrrole monomers (Figure 1.9). It can be 
polymerized chemically or electrochemically by oxidation of the pyrrole monomer. 
The polymerization of PPy results in insoluble coarse powers or brittle thin films, 
respectively. By addition of a soluble polymer during oxidative polymerization, 
PPy powders can also be synthesized in solution, forming nanometre-sized 
dispersions142. These dispersions have interesting characteristics such as a large 
internal interface area, thermodynamic stability and ability to be stably dispersed 
in aqueous solutions143. The size of PPy particles polymerized in solution typically 
ranges between 20 nm and 200 nm144, 145. 
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Figure 1.9: Chemical structure of undoped polypyrrole, showing the configuration of two units of 
pyrrole monomer. 
In the case of conducting polymers, electron band theory is insufficient to explain 
the electrical conduction mechanisms. The processes leading to conductivity in 
these organic materials are not yet fully understood, however conduction by 
polarons and bipolarons is thought to be the dominant mechanism of charge 
transport in organic materials146, 147. A polaron is defined as a radical cation that is 
partially delocalized over several monomer units in a polymer segment, which is 
produced by low doping levels148. High doping levels produce radical dications 
called bipolarons. Polarons and bipolarons are mobile and can move along the 
chain of the polymers (Figure 1.10), allowing conduction in the conjugated 
polymer systems.  
 
Figure 1.10: Oxidative doping of polypyrrole and resulting polarons and biopolarons. Top: neutral 
undoped chain. Middle: Oxidization of the chain leads to the formation of radical cations partially 
delocalized over several monomers forming a polaron. Bottom: High level doping leads to the 
formation of radical dications called bipolarons. 
In the doping process, insulating polymers can be transformed to conductors by 
formation of charge-transfer complexes using electron donors such as sodium or 
potassium, which reduce the polymer or electron acceptors (often iodine, AsF5 or 
FeCl3). This results in oxidation of the polymer and production of a doped polymer 
backbone that is locally charged. The dopant itself stays within the oxidized 
polymer, with the negative charge balancing the positive charge on the polymer 
backbone143. 
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This process creates a localized electronic state in the band gap. Increasing the 
level of doping results in the formation of continuous bipolaron bands. The band 
gap increases as newly formed bipolarons have a higher energy level. For a very 
heavily doped polymer the upper and the lower bipolaron bands merge with the 
conduction and the valence bands respectively to produce partially filled bands 
and metal-like conductivity143.  
The material properties largely depend on the synthesis and the dopant anion. In 
general the mechanical properties are higher when PPy is doped with organic 
anions compared to inorganic anions. Depending on the dopant the tensile 
strength of films ranges between 8 to 100 MPa with an elongation at break 
between 2% - 8%. The elastic modulus can range between 0.4 – 4 GPa. The overall 
structure of the polymer is amorphous148, 149. Conductivity in the bulk material can 
reach 100 S cm-1 depending on the dopant and the degree of doping141, 150. The 
choice of dopant not only affects the polymers material properties, but also its 
biocompatibility. Some of the most frequently used dopants for PPy include, but 
are not limited to para-toluene sulfonate, dodecylbenzene sulfonate, poly(4-
styrenesulfonate) and hyaluronic acid151-153. 
PPy has found application in different niches within the field of tissue engineering. 
This is due to its high conductivity as well as good general biocompatibility154, 
which both depend on the pathway of synthesis155, selected dopant153 and physical 
shape and size132, 156-160. PPy has been used successfully in a large number of 
electrical stimulation applications in vitro and in vivo, demonstrating its 
biocompatibility as well as the effects of different stimulation carriers on cell and 
tissue behaviour42, 45, 47, 51, 55, 161-164. 
1.2.2.2.2 Graphene 
Initially, single-layer graphene was isolated from graphite by mechanical 
exfoliation achieved using sticky tape138.  More recent approaches to produce 
graphene include chemical vapour deposition in which graphene is made directly 
as well as the functionalization of graphite to graphite oxide and following 
exfoliation of single layer graphene. Graphite oxide is highly oxidized and has 
oxygenated functionalities within its structure, which result in an increased 
distance between the layers (Figure 1.11). This functionalization also increases the 
hydrophilicity which allows an increased dispersability in water compared to 
unfunctionalized graphite165. This property enables graphite oxide to be exfoliated 
in water, using sonication amongst other techniques, ultimately producing single 
or few layer graphene oxide (GO)165-167. GO is classified as an electrical insulator, 
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as oxidization causes a disruption of the sp2 bonding networks. To regain electrical 
conductivity, the sp2 bonds need to be restored, which requires reduction of the 
GO165-170 (Figure 1.11). GO can be reduced using thermal, chemical and 
electrochemical processes, leading to the removal of oxygen-containing functional 
groups and restoring most of the sp2 bonds166, 170. Reduced GO (rGO) can conduct 
electricity171, but is more difficult to disperse in aqueous solutions and has a 
tendency to re-aggregate as a result of the removal of oxygen groups169, 172. 
 
Figure 1.11: Schematic illustration of the relation between multi-layer graphite, graphite oxide, 
single-layer graphene and graphene oxide. Modified from Chua and Pumera173. 
The mechanical, physical and optical properties of graphene vary widely due to 
large differences on a molecular level resulting from synthesis or functionalization. 
The elastic modulus of single-layer rGO ranges in the 10 – 100s GPa, while the  
conductivity has been reported with values between 1 – 100 S cm-1 166, 168, 174. 
The dispersibility of GO and rGO in both aqueous and organic solvents is a 
desirable property for fabrication of composites, as mixing with other materials 
can easily be achieved with the conducting particles stably in solution175. rGO has 
been used frequently to improve the electrical and mechanical properties of both 
insulating176 and conducting polymers, including PPy.176-178. Composites 
containing both graphene and PPy have found applications as capacitors179-184, 
sensors185-187 or electrodes188, 189. An increase in biocompatibility of composites 
containing graphene has been reported190, however the biocompatibility of the 
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different forms of graphene and their effects on cells are still being investigated by 
the scientific community190. Graphene by itself has shown to have some adverse 
effects in vitro and in vivo. Some in vitro studies report reduced cell viability191, 
oxidative stress as well as apoptosis192 when cells are exposed in various manners 
to a variety of types of graphene or graphene oxide174, 191. For example A 
comparative study measuring mitochondrial toxicity and cell membrane integrity 
in neuronal PC12 cells which suggested that the biological activities of graphene 
andsingle-wall carbon nanotubes (SWCNT) were shape-dependent. After a 24-
hour exposure, the metabolic activity of PC12 cells decreased in a dose-dependent 
manner, with graphene producing higher toxicity at low concentrations and lower 
toxicity at high concentrations than SWCNT. Another comprehensive study on the 
toxicity of GO observed neither obvious cellular uptake nor obvious effects on the 
morphology, viability, mortality, and membrane integrity in adenocarcinomic 
human alveolar basal epithelial cells, but GO exposure was able to induce oxidative 
stress at a concentration as low as 10 mg ml-1 191, 192. Furthermore mechanical 
damage to cells as well as tissues can arise from the sharp edges present in 
graphene. Studies performed in vivo have reported accumulation of the material 
and local inflammatory responses190, 193. Similar to PPy, the synthesis, size and 
structure of the material, as well as chemical functionalization will alter the 
biocompatibility of graphene and GO193-195. 
1.3 Fabrication of 3D Structures for Nerve Regeneration 
For nerve regeneration, fabrication of purposefully designed three-dimensional 
(3D) structures is necessary in order to mimic the natural hierarchical assembly of 
a nerve (Figure 1.1) and achieve the best possible regeneration results and 
functional outcomes. Depending on the selected material, the shape and 
complexity of the design to be fabricated and the desired spatial resolution, 
different fabrication approaches including various 3D printing techniques, plotting, 
casting and spinning can be utilized. In the following section, spinning and additive 
manufacturing techniques suitable for alginate are introduced.   
1.3.1 Wet-Spinning of Hydrogels 
Wet spinning is a process that occurs in solution phase, where one or more 
materials are formed into fibres or tubes. A polymer solution is injected into a 
coagulation bath through a spinneret. The solidification of the fibre in the 
coagulation bath is based on one of three physicochemical principles196. The 
formation of a solid crystalline region is the result of a lyotropic liquid-crystalline 
polymer solution injected into non-solvent solution. A well-known example of this 
approach is wet spinning of Kevlar. Another approach is based on the principles of 
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phase separation where two different phases are formed in solution, one 
containing no or little polymer and one rich in polymer forming the fibre. In the 
third method gelation/solidification of the polymer solution is achieved through 
intermolecular bonds formed on exposure of the polymer to the coagulation 
solution. This can be a result of changes in temperature, concentration changes in 
solution or the formation of ionic or covalent bonds196. Initially solidification takes 
place at the polymer-coagulant interface, but continues throughout the fibre197. 
The spinneret, from which the fibre or tube-forming polymer is extruded, is critical 
in determination of fibre shape and diameter, as well as the rate that the polymer 
solution flows through the spinneret and the viscosities of the spinning solution 
and the coagulation bath. A typical wet spinning setup is shown in Figure 1.12. A 
syringe containing the spinning solution, usually controlled by a syringe pump is 
attached to a spinneret. The spinneret is placed in a bath of coagulant, which leads 
to solidification of the fibre as it emerges from the aperture. When using differently 
designed and shaped spinnerets, solid, coaxial or triaxial fibres of different 
diameters and shapes and containing different materials can be produced. A 
drawing zone can be incorporated into the fabrication line to reduce the filaments 
diameter, also leading to increased mechanical properties in some fibres, as a 
result from internal alignment. The continuous filaments are collected on a 
collector. 
 
Figure 1.12: Schematic of wet spinning setup. 
Alginate is well suited for the use in wet-spinning approaches, as it can be 
crosslinked ionically when exposed to divalent cations such as calcium. No extreme 
temperatures, harsh chemicals or pH changes are required in the process114, which 
allows for the encapsulation of living cells and other chemically sensitive 
biologically-relevant substances (such as growth factors or cell nutrients). 
Furthermore, the setup required to reliably produce wet-spun alginate fibres is 
relatively simple, which allows for an easy translation into sterile conditions. 
Alginate fibres containing living cells have been fabricated in previous research, 
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showing good viability of the cells after the spinning process, as well as after 
extended periods of being cultured within the gel198, 199.  
1.3.2 Additive Manufacturing of 3D gels 
Additive fabrication, rapid prototyping or 3D-printing are all terminologies used 
for a group of techniques which create three-dimensional (3D) objects by 
accurately depositing materials, layer by layer, to build up large structures. 
Additive manufacturing (AM) is the term that has been adopted to describe the 
underlying principles of the above-named application-based technologies200. More 
and more technologies are emerging in the area of AM, and as a result it is not 
surprising that 3D scaffolds for tissue engineering applications are being created 
utilizing AM201-203. AM is not only used to produce 3D scaffold templates, which are 
then functionalized with biologically relevant substances204 (growth factors, cell 
adhesion sites, drugs, surface coatings, cells, etc.) but also finds application for 
creation of 3D scaffolds from materials which already contain biologically relevant 
substances205. The advantage of incorporating cells, growth factors, adhesion 
molecules and cells directly into the scaffold is the ability to create an even 
distribution of biological factors in a 3D fashion, throughout the whole structure206, 
207. Alternatively, there is the ability to create non-homogenous structures, with 
patterning of protein or material gradients and discrete populations of cells208. The 
possibility of printing cells and tissues into whole organs is gaining interest209, 
which is a result of the advances in creation of inhomogeneous 3D structures 
containing multiple materials and cell210, 211. Additive fabrication using sensitive 
biological entities requires development of inks that can support cell or protein 
survival, while facilitating the transition from a printable ink to a material strong 
enough to retain a shape, without impacting on biological components212. 
Frequently used corsslinking mechanisms for solidification of bioinks include 
exposure to ions210, different temperatures206, 207, UV or other light sources212 and 
sonication213, 214. Hydrogels, including alginate are utilized frequently as bioinks 
for the creation of 3D scaffolds containing living cells212, 215-218.   
 
1.4 Thesis Aims and Outline 
To overcome the limitations of autologous nerve grafting and provide a realistic 
alternative to allografts for peripheral nerve injuries, improvements to current 
commercial artificial nerve conduits need to be made. Improvement to conduits 
can be made at a number of levels including the introduction of softer and more 
compliable hydrogels and the introduction of conducting elements. This thesis 
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presents research focussed on the fabrication of artificial nerve conduits for 
alginate hydrogel containing electrically conducting elements. The application of 
electrical stimulation has shown to be beneficial to regenerating nerve cells, 
however materials usually used for fabrication of artificial nerve conduits are not 
conductive and as a result facilitation of electrical stimulation is not possible.  
Therefore, the focus of this project is to develop fabrication strategies and 
techniques to fabricate fibrous structures composed of alginate hydrogels, living 
cells and inherently conducting materials (such as metals and organic conductors). 
Overall, the aim is to create a 3D structure that facilitates the electrical stimulation 
of cells and tissues for nerve regenerative applications. 
In summary the aims of the project are: 
 Incorporation of inherently conducting materials into alginate gels to 
introduce electrical conductivity and facilitate electrical stimulation of cells 
within the gel. 
 Fabrication of the alginate – conductor composite into a 3D construct which 
mimics the structure of a nerve and facilitates electrical stimulation. 
 Validation of biocompatibility of the created 3D structure and the 
facilitation of electrical stimulation in vitro. 
The general experimental procedures and techniques used for the work described 
in the following chapters are summarized in Chapter 2.  
Chapter 3 focuses on the blending of alginate gel and polypyrrole nanoparticles 
and the analysis of the electrochemical properties of the blend. This chapter aims 
to investigate if spherical conducting nanoparticles can introduce sufficient 
electrical conductivity into alginate hydrogels for cell stimulation. 
Chapter 4 explores the possibility of producing solid fibres from the optimized 
polypyrrole nanodispersions. The optimization of dispersions with regards to their 
electrical conductivity is also presented. 
The aim of the work presented in Chapter 5 is to explore the possibility of 
improving the mechanical properties and electrical conductivity of polypyrrole 
fibres by incorporation of graphene. 
An innovative fabrication approach to encapsulate electrically conducting wires or 
fibres into 3D alginate gels is introduced in Chapter 6. The controllability, 
reliability and versatility of the developed system are showcased and the 
biocompatibility of the method analysed. 
  
Introduction | 31  
 
Chapter 7 describes the engineering and design of a multi-layer cell stimulation 
mould, which reliably accommodates the 3D structures described in Chapter 6 and 
furthermore facilitates electrical stimulation of cells within this structure. 
The aim of Chapter 8 is to place all the results within the context of peripheral 
nerve regeneration and discuss them critically. An outlook on future work and 
directions is presented.  
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Chapter 2 
Chapter 2: GENERAL METHODOLOGY 
This section describes the fundamental instrumentation and procedures used as 
part of the work presented in this thesis. Where indicated exact experimental 
conditions and details are given within the experimental section of each relevant 
chapter. 
2.1 Chemical and Electrochemical Characterization of 
Nanoparticles and Fibres 
2.1.1 Elemental Analysis 
Elemental analysis was used to analyse the amount of polyvinyl alcohol (PVA) and 
polypyrrole (PPy) in a PVA stabilized PPy nanodispersions. The analysis was 
carried out by the Microanalytical Unit at the Australian National University in 
Canberra. A Carlo Erba 1106 elemental analyser (quantifying C, H, N), flame atomic 
absorption spectrophotometer (quantifying S) and iron chromatography 
(quantifying Fe) were used to determine the respective amounts of carbon, 
hydrogen, nitrogen, sulphur and iron present in polypyrrole (PPy) 
nanodispersions. 
The results of elemental analysis were given in percentage of weight of the overall 
sample weight analysed. Components present in the PPy nanodispersion are PPy, 
PVA, para-toluenesulfonate (pTS) and potentially iron. Utilizing the known atomic 
mass of each element (C: 12.01, H:1.01, N:14.01, S: 32.06, Fe: 55.86) and the atom 
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rations of each component present (PPy: C4 H2 NH, PVA: C2 H4 O, pTS: CH3 C6 H4 SO3 
H), the amount of each component was calculated based on the assumption that all 
N is associated with PPy and all S is associated with pTS. Taking the known atom 
ratios of the present components into consideration, the percentage of each 
component present in the PPy nanodispersion was calculated.  
2.1.2 Dynamic Light Scattering 
Dynamic light scattering (DLS) was utilized to investigate the average 
hydrodynamic diameter and the polydispersity of PPy and silver nanoparticle 
dispersions respectively. In this study, a Malvern Zetasizer (Nano-ZS, UK) with 
corresponding Zetasizer software 6.01 was used. 
2.1.3 Four Point Probe Resistivity Measurement 
A Jandel RM3 (UK) four point probe was used to measure the sheet resistance (Rs) 
of PPy nanoparticle films. Since the film thickness was much smaller than the 
distance between the probes of the four point probe, a correction factor for thin 
films was used as follows: 
Equation 2.1: Sheet resistance of thin films 
𝑅𝑠 = 4.53
𝑉
𝐼
 
where Rs is the sheet resistance, V is the voltage measured between the inner probes when a current 
I is passed through the outer probes.  
From the sheet resistance (Ω/sq) the resistivity in ohm centimetre (Ω cm) of a 
sample, with a known thickness (cm) can be calculated from: 
Equation 2.2: The relationship between sheet resistance, resistivity and thickness of the sample 
𝑅𝑠 =
𝑅
𝑡
 
where Rs is the sheet resistance, R the resistivity of the material and t the thickness of the sample 
film. 
The conductivity of PPy nanoparticle films is reported in Siemen per cm (S cm-1), 
which is the inverse of the resistivity in ohm cm (Ω cm). 
A custom made four point probe was utilized to analyse the resistivity of different 
organic fibres, which were attached to the custom four point probe using silver 
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paint. The same underlying principles for thin film analysis apply, as the fibre 
diameter was smaller than 40% of the distance between the probes. 
2.1.4 Electrochemical Analysis 
2.1.4.1 Cyclic Voltammetry of Polypyrrole Dispersions 
Cyclic Voltammetry (CV) was performed on PPy nanodispersions in a 3 electrode 
setup using a CHI660D electrochemical workstation (USA), with gold or glassy 
carbon electrodes as the working electrode, saturated Ag|AgCl as the reference 
electrode and platinum mesh as the counter electrode (Figure 2.1). CVs were 
performed on particles dispersed either in water, DMEM or 1M sodium nitrate at 
concentrations between 1 to 10 wt%. The potential was scanned between -0.8 – 
0.8 V or less, at scan rates between 10 and 100 mV sec-1. The exact experimental 
conditions used are outlined in the experimental sections of the relevant chapters. 
2.1.4.2 Cyclic Voltammetry on Fibres 
A CHI660D electrochemical workstation was used to determine the CVs of fibres 
made from PPy as well as fibres made from graphene and PPy. All fibres were used 
as the working electrode in a 3 electrode setup, with platinum mesh as the counter 
electrode and saturated Ag|AgCl as the reference electrode (Figure 2.1). CVs were 
performed in 1M sodium nitrate or phosphate buffered saline (PBS). The potential 
was scanned between -0.6 – 0.6 V at scan rates between 5 and 100 mV sec-1. The 
current was normalized to the weight of the fibre or the weight of PPy present in 
the fibre. The experimental sections of the relevant chapters contain the exact 
conditions applied for each sample. 
 
Figure 2.1: Schematic of standard 3-electrode setup (WE: working electrode, RE: reference electrode, 
CE: counted electrode) of electrochemical analyses. 
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2.1.4.3 EIS 
Electrochemical Impedance Spectroscopy (EIS) was used to investigate the 
impedance and resistance of alginate and the changes associated with the 
introduction of conducting PPy or silver nanoparticles into the gel.  
In Ohm’s law the resistance R is described as a ratio between voltage E and current 
I. 
Equation 2.3: Ohm’s Law 
𝑅 =
𝐸
𝐼
  
where R is the resistance in ohm (Ω), E is the potential difference across the resistor (V) and I is the 
current passing through the resistor in amperes (A). 
 
This relationship is true only for an ideal resistor. In reality, electrical circuit 
elements show much more complex behaviour. For more complex systems, 
impedance is used to describe the events associated with the ability of a circuit to 
resist the flow of electrical current. During EIS a small sinusoidal alternating 
current (AC) is applied to the electrochemical cell and the current that passes 
through the circuit is measured. The potential applied to the system is described in 
a complex function (Equation 2.4), resulting in a complex current response 
(Equation 2.5), both containing an imaginary component. 
Equation 2.4: Complex Function of Electrical Potential 
𝐸𝑡 = 𝐸0exp (𝑗𝜔𝑡) 
where Et is the potential at any time t, E0 is the amplitude of the potential, j is the imaginary 
component and ω is the radial frequency. 
 
Equation 2.5: Complex Function of Current response to Electrical Potential Applied 
𝐼𝑡 = 𝐼0exp (𝑗𝜔𝑡) 
where It is the current response at any time t, I0 is the amplitude of the current, j is the imaginary 
component and ω is the radial frequency. 
The impedance of a system can be calculated using the resulting equivalent to 
Ohm’s Law. 
  
General Methodology | 45  
 
Equation 2.6: Complex Function of Impedance 
𝑍𝜔 =
𝐸
𝐼
=
𝐸0exp (𝑗𝜔𝑡)
𝐼0 exp(𝑗𝜔𝑡)
= 𝑍0(𝑐𝑜𝑠∅ + 𝑗𝑠𝑖𝑛∅) 
where Z(ω) is the impedance, E is the potential, I is the current, j is the imaginary component, ω is the 
radial frequency, t is the time, Z0 is the magnitude of the impedance and ϕ is the shift of the phases. 
One way to present the data obtained via EIS is the Nyquist plot, which shows the 
real part of the impedance on its x-axis and the imaginary part on the y-axis 
(Figure 2.2). Each point on the plot represents the impedance analysed at a specific 
frequency. Usually the separate points are represented as a line. The sweeps of 
high frequencies are typically plotted at the left end of the graph, with frequencies 
decreasing toward the right. 
 
Figure 2.2: Schematic of a typical Nyquist plot. 
R1 in Figure 2.2, where the graph intersects with the axis, is typically 
representative for the solution resistance Rsol of the system. The second 
intersection between graph and x-axis is indicative of the charge transfer 
resistance Rct, which can be calculated as the difference of the values at which the 
graph intersects with the x-axis (Rct = R2 – R1). The line rising from point R2 is 
indicative of the impedance at low frequencies. If this line has a slope of 0.5, or the 
phase angle is 45°, ideal Warburg impedance is present. The Warburg impedance 
is a measure of the impedance created by diffusion in the system. At high 
frequencies the Warburg impedance is negligible as the reactants travel only short 
distances. At lower frequencies the effect becomes more predominant as reactants 
have to diffuse further. The ideal or “infinitive” Warburg impedance can only be 
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found in systems with an infinitively thick diffusion layer. For most systems this is 
not the case and the slope of the diagonal line in the Nyquist plot will differ from 
0.5.  
To accurately draw the resistivity from each analysed sample measured via EIS, 
the obtained data was fitted to a model of an electric circuit consisting of resistor 
in series with two parallel circuits, the first being a resistor parallel with a 
standard RC-circuit, the second consisting of a capacitor and Warburg element 
(Figure 2.3). 
 
Figure 2.3: Electric circuit used to model Nyquist plots obtained via EIS analysis of alginate gels and 
alginate gels blended with conducting spherical nanoparticles1. 
EIS was used to analyse the resistance of alginate gel and alginate gels blended 
with spherical conducting particles made from PPy or silver. The resistivity of the 
gel will be affected by the size of the gel analysed or more accurately, the distance 
between the working and counter electrode. The resistivity of a gel tested at a 
certain length is proportional to the length. As a result of that, an increase in 
distance between the electrodes will result in an increased resistivity. To analyse 
the resistance of the system, as opposed to the resistivity of each individual 
sample, the sample length was varied and the resulting resistivites plotted as a 
function of the distance. The slope of the linear regression of the resistivities was 
then used as an indication of the length independent resistance of the material. 
EIS was performed on 2 %(w/v) and 4 %(w/v) alginate, 2 %(w/v) alginate 
blended with 5 %(w/v) PPy nanoparticle, 2 %(w/v) alginate gel blended with 
2.5 %(w/v) silver nanoparticles and 2 %(w/v) alginate supplemented with 0.71M 
sodium nitrate. Using a CHI660D electrochemical workstation, EIS was performed 
in a custom designed three-electrode setup (Figure 2.4), allowing the exact 
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positioning of glassy carbon working electrode, platinum mesh (counter electrode) 
and saturated Ag|AgCl reference electrodes. Potential was applied between -0.5 – 
0.5 V in 0.1 V steps, staring from 0 V with an increasing potential amplitude, each 
scanned between 0.1 Hz and 106 Hz, with an amplitude of 0.01 V. To ensure no 
electroplating of the working electrode was occurring, CV measurements were 
performed before and after each set of EIS measurements. 
 
Figure 2.4:Custom made electrochemical cell setup accommodation three standard electrodes for EIS 
measurements of gels over different distances1. 
This procedure was repeated for at least three different distances between 
working and counter electrode, per material. 
2.2 Morphological Characterization of Nanoparticles, Films, 
Fibres and Cells 
2.2.1 Profilometry 
A stylus profilometer (Dektak 150 by Veeco Instruments (USA), with the 
corresponding software Dektak 9.2.0.8) was utilized to investigate the film 
thickness of thin PPy nanoparticle films. 1 ml of PPy dispersion was cast into films 
1.5 x 1.5 cm in size on glass slides and film thickness analysed over 5 mm at 
different points along the edges of the film as illustrated in Figure 2.5. 
 
Figure 2.5: Schematic illustration of stylus profilometry and topography output. 
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2.2.2 Optical Microscopy  
Bright field microscopy was used throughout this study to investigate and monitor 
cells, fibres and particles. Fluorescently labelled cells were imaged using 
fluorescence microscopy to investigate cell number, viability, morphology and 
distribution. A confocal microscope (Leica TSC SP5 II) and two standard 
fluorescence microscopes, Axio Vert from Carl Zeiss (Germany), with 
corresponding software and the Leica DM IL LED (Germany) with LAS software, 
were used to image cells and obtain digital micrographs. A Leica M205A 
microscope with LAS 4.0 was used for imaging of fibres without cells. 
The Leica TSC SP5 II confocal microscope and its corresponding software were 
used to obtain z-stacked and tiled images of fluorescently labelled cells, cultured in 
3-dimensional gels. Procedures to fluorescently label cells and cell components are 
described in section 2.4.2. 
Polarized Optical Microscopy (POM, Leica CTR600 with corresponding software 
LAS 4.4.0) was used to analyse the crystallinity of samples containing liquid crystal 
graphene oxide by placing the polarizer and analyser perpendicular to each other, 
with the microscope operated at transmission mode. The samples were drop cast 
onto glass slides and air dried before analysis. 
2.2.3 Scanning Electron Microscopy 
In this study a JEOL JSM 7500 Cold Field Emission Gun scanning electron 
microscope (SEM, Japan) was used for all dehydrated, non-biological samples, 
including dried films of PPy nanoparticles and fibres fabricated from graphene and 
PPy. If required, samples were sputter coated with a thin layer of gold (Edwards 
Sputter Coater). Imaging of biological samples and hydrogels was performed using 
a low-vacuum JEOL JSM 6490LV after freezing the samples in liquid nitrogen. 
Information on specific sample preparation and operational settings of the SEM 
are outlined in the relevant experimental sections of the following chapters. 
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2.3 Mechanical Characterization of Spinning Solutions and 
Fibres 
2.3.1 Tensile Testing 
As part of this work a Shimadzu EZ-S tensile tester (Japan) was used to investigate 
the tensile properties of fibres. Typically a 10 N load cell and a sample rate of 
1 mm min-1 was used to test 1 cm of fibre. To allow for easier and secure clamping 
of fibres, samples were glued into a paper frame laser cut from copy paper, using 
glue and sticky tape as illustrated in Figure 2.6. The framed fibres were then 
clamped into the tensile tester and the paper frames cut with scissors, before the 
test was started. Specific experimental parameters are specified in the 
experimental sections of relevant chapters. 
 
Figure 2.6: Paper frame assembly for tensile testing on fibres. 
2.3.2 Rheology Analysis 
Rheometry was performed to investigate the viscosity of PPy nanoparticle 
spinning solutions at known shear rates, to determine their suitability of wet-
spinning. Used was a TA instruments ARG2 rheometer (USA) with a 50 mm cone 
and an angle of 2%. The shear rates were applied increasingly over 5 min between 
1 and 100-s.  All experiments were performed at room temperature.  
2.4 Biological Methodology 
2.4.1 Cell Models and Routine Cell Culturing 
The following sections introduce the cell types used in this study. All cell culturing 
procedures were performed in biosafety cabinets (BSC) under sterile conditions. 
All cell types were cultured under standard conditions in 5 % CO2 at 37°C. 
2.4.1.1 PC12 Cells 
The PC12 cell line was clonally derived from a rat adrenal medullary tumour in 
19762. PC12 cells respond to continued exposure of nerve growth factor (NGF) by 
ceasing cell division and extending neurites (i.e. differentiation). Neurotrophin 
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based signalling, which is critical for the survival, development and function of 
neurons, was identified in PC12 cells2. As a result, PC12 cells have been widely 
used as a model cell line for studies investigating neuronal and endocrine cell 
physiology. In this study, PC12 cells are used to investigate the ability of cells to 
survive, proliferate and differentiate in and on structures targeting nerve 
regenerative applications. This includes studies of cell response to 3D structures, 
which is especially critical for the present work.  
All PC12 cells used in this study were used at passage 11 to 32. Cells were split 
routinely (every 2 to 3 days) when semi confluent using 0.05% Trypsin (Life 
Technologies, Australia) following the protocols from the American Type Culture 
Collection (ATCC)3. PC12 cell density was determined by staining cells with 0.4% 
trypan blue solution (Sigma, Australia) and estimation of viable cell number using 
a hemocytometer. Cells were maintained in proliferation medium and induced to 
differentiate by serum starvation and the addition of NGF (differentiation 
medium). Media compositions were used as follows: 
Proliferation medium: 
 Dulbecco’s Modified Eagle’s Medium (DMEM, Invitrogen, Australia) 
 10% Horse serum (Sigma) 
 5% Fetal bovine serum (FBS, Bovogen, Australia) 
 2 mM Glutamine (Life Technologies) 
Differentiation medium: 
 DMEM 
 1% Horse serum 
 50 ng ml-1 Nerve Growth Factor (NGF, Bioscientific) 
 2 mM Glutamine 
2.4.1.2 L929 Cells 
The L929 fibroblast cell line was derived from normal subcutaneous areolar and 
adipose tissue of a male mouse. L929 cells are routinely used for toxicity testing of 
materials4. L929 cells were split routinely (every 2 to 3 days) when semi confluent 
using 0.25% Trypsin (Life Technologies) following the protocols from the ATCC4. 
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L929 cell density was determined by staining cells with 0.4% trypan blue solution 
before counting using a hemocytometer. L929 cell proliferation medium 
composition was used as follows: 
 DMEM 
 10% FBS 
 2 mM L-glutamine 
In this study, L929 fibroblasts were used to investigate the toxicity of leachates 
from fibres. The exact culture conditions are outlined in the experimental section 
of Chapter 5. 
2.4.2 Cell Staining 
2.4.2.1 Live and Dead Cell Staining 
Calcein acetoxymethyl ester (Calcein AM, Life Technologies) and propidium iodide 
(PI, Life Technologies) were used to fluorescently label live and dead cells 
respectively. Staining solutions were made separately by diluting Calcein 1:500 
and PI 1:1000 in PBS or DPBS (Dulbecco’s phosphate buffered saline, Life 
Technologies), for staining cells within hydrogels. Cells were incubated with 
Calcein staining solution for 15 min at 37°C, followed by 5 min of incubation with 
PI staining solution at room temperature. Staining solution was then replaced with 
PBS or DPBS and cells imaged immediately. 
2.4.2.2 Immunofluorescence Staining of Differentiated PC12 cells 
To stain differentiated PC12 cells, cells were fixed with 4% paraformaldehyde 
(PFA, Fluka, Germany) in PBS for 15-20 min at 4°C, before permeabilization and 
blocking with 0.3% Triton X-100 (Sigma) for 60 min at 4°C. Cells were then 
washed in PBS or DPBS three times for 20 min. The primary antibodies rabbit anti-
growth associated protein 43 (GAP43, Millipore, Australia) and mouse anti beta-III-
tubulin (BIIIT, Covance, Australia) were diluted 1:1000 from original stock in 10% 
donkey serum and incubated with cells at 4°C for 8 - 12 h. Cells were washed again 
in PBS before incubation with donkey anti mouse alexa fluor 594 (red, Life 
Technologies) and donkey anti rabbit alexa fluor 488 (green, Life Technologies), 
diluted 1:1000 in 10% donkey serum. Samples were incubated with the secondary 
antibodies at 4°C or room temperature for 2 - 8 h. 
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Cell nuclei were stained with 0.1 g ml-1 4,6-Diamidin-2-phenylindol (DAPI, Life 
Technologies) in PBS for 20 – 60 min. Staining solution was replaced with PBS or 
DPBS and cells imaged or stored at 4°C, protected from light. 
Incubation times vary depending on the cell arrangement in 2D or 3D and the 
thickness of the 3D structure. Information on incubation times are given in the 
experimental section of the relevant chapters.  
2.5 Materials Synthesis and Fabrication 
2.5.1 Synthesis of Conducting Dispersions 
2.5.1.1 Polypyrrole Nanoparticle Dispersion 
To synthesize PPy nanodispersions, PVA (Sigma, molecular weight 31 – 50 kDa) 
was stirred in MilliQ water at 80°C until fully dissolved at concentrations of 0.5 – 
1.2 wt%. The solution was cooled to 4°C before 0.05 M of iron (III) para-
toulenesulfate (FepTS, Sigma) was added to the PVA solution and stirred until 
dissolved. 0.1 M of pyrrole monomer (Merck, Australia distilled) was slowly added 
to the cooled PVA solution under continuous stirring and left to polymerize and 
oxidize for 8 to 12 h before the solution was dialysed against deionized water 
using dialysis tubing (Sigma, 12 kDa molecular weight cut off). Dialysis was carried 
out for 48 h with three water changes. As described in chapter 4, particle 
dispersions were optimized by the addition of a filtration step to reduce the 
amount of PVA present in the dispersion. Detailed information on this procedure 
can be found in the experimental section of chapter 4. Particle size and distribution 
was analysed using DLS and SEM. Electrochemical characterization was carried out 
by CV. The conductivity of dried particle films was analysed in using four point 
probe resistivity measurements and profilometry to analyse the thickness of the 
films 
Particles were freeze dried using a Christ Alpha 24LD plus freeze dryer. To 
disperse particles in solution, freeze dried powder was added to the desired 
weight to volume ratio of dispersant (0.5 – 10 wt%) and stirred using a magnetic 
stirrer until the dispersion was homogenous. 
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2.5.1.2 Silver Particle Synthesis 
Citrate-decorated silver nanoparticles were synthesized based on an adapted 
method from Lee and Meisel5. Briefly, 500 ml of a 2.1 mM solution of silver nitrate 
(Sigma) was brought to a boil before 20 ml of 1% sodium citrate were added. The 
mixture was stirred at room temperature until a colour change was observed. This 
reaction was repeated three times and the three reactions combined. The overall 
volume of 1.5 l was reduced to 12 ml via freeze-drying (Christ Alpha 2 4 LD plus 
freeze dryer, Germany) to achieve a particle concentration of 2.5 wt% in water. 
Particle size and size distribution was then analysed using DLS.  
2.5.1.3 Synthesis of Graphene Oxide Dispersions 
Dry expandable graphite flakes (3772, Asbury Graphite Mills, USA) were treated 
thermally for 15 s at 1050°C before use as a precursor for (GO) synthesis, as  
previously described6, 7. Briefly, expanded graphite and sulphuric acid were mixed 
and stirred, before potassium permanganate (KMnO4, Sigma) was slowly added to 
the mixture. The mixture was transferred into an ice bath, before MilliQ water and 
hydrogen peroxide (H2O2, Sigma) were slowly added to the mixture, resulting in a 
colour change of the suspension to light brown. After stirring for another 30 min, 
the GO particles were washed and centrifuged in hydrochloric acid (HCl, 
ChemSupply) before further centrifugation and washing with MilliQ water, until 
the solution pH reached 5. The resulting GO sheets were dispersed at 8.7 % in 
deionized water by gentle shaking to form a liquid crystalline graphene oxide 
dispersion (LCGO)8, 9. 
2.5.2 Alginate and Alginate-blends 
Alginate solutions were prepared at desired concentrations by adding dried 
alginate power to MilliQ water or calcium free DMEM (Gibco, Austalia) and mixing 
until fully dissolved. The alginates used as part of this study are listed in Table 2.1.  
For investigations involving cells, ultrapure alginate or alginate RGD were utilized. 
The experimental sections of the relevant chapters specify which alginate was 
used. Alginates were sterilized by filtration through a 0.2 µm sterile filter (Merck). 
Alginate powders as well as prepared and sterilized solutions were stored at 4°C. 
Alginate solutions were used within two months of preparation. 
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Table 2.1: Types of alginate used as part of this work 
Description Viscosity Specification Supplier 
Alginate medium - Sigma-Aldrich 
Ultrapure Alginate low < 60% G units Pronova, USA 
Alginate RGD low Modified with Arg-Gly-Asp 
< 60% M units 
Novatech, USA 
 
Blends with alginate and PPy nanoparticles were prepared by adding freeze dried 
PPy particles to the alginate gel solution and magnetically stirring the solution 
until the particles were homogenously dispersed in the alginate solution. 
To blend silver nanoparticles with alginate, alginate powder was added to the 
dispersion of silver particles as the silver particles could not be fully dried and 
redispersed in solution. The blend was stirred until the alginate was fully dissolved 
and the blend homogenous.  
2.5.3 Gellan Gum Microgel 
A gellan gum (GG) microgel (GGink) was made by modification of a protocol for the 
preparation of a GG based bio-ink10. 0.5 ml of sterile 1% GG solution (Gelzan CM, 
Sigma-Aldrich) in MilliQ water (resistivity 18.2 MΩ cm) and 9.5 ml DMEM were 
separately heated to 80°C. Both solutions were mixed together in a 50 ml 
centrifuge tube (Greiner) and immediately vortexed at medium intensity until the 
solution cooled to room temperature. The GG microgel was then stored at 4°C. 
2.5.4 Production of Fibres 
2.5.4.1 Wet-Spinning of Alginate Gel Fibres 
Fibres were spun from alginate and ultrapure alginate by pumping the prepared 
spinning solution through spinnerets at defined flow rates controlled by a syringe 
pump (Gemini 88, Walker Scientific, Australia). The spinnerets were submerged 
into a bath containing 0.5 – 2 wt% CaCl2 (calcium chloride dihydrate, ChemSupply, 
Australia), which leads to the coagulation of the alginate solution into an alginate 
gel fibre based on principles described in section 1.2.1. Formed fibres were 
collected and drawn by a collector rotating at constant speed or manually collected 
using tweezers.  
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Fibres with cells encapsulated throughout were prepared from a spinning solution 
containing sterile ultrapure alginate with a known concentration of cells. All 
required equipment was sterilized using 70% Ethanol (ChemSupply, in deionized 
water) (syringe pump, collector, etc.), or autoclaved (scissors, tweezers, bath, 
spinnerets, etc., 121°C for 20 min) where possible and moved into a BSC to 
maintain sterility. All solutions were filter sterilized or autoclaved. Spun fibres 
were passed through a water bath to remove excess calcium before being 
transferred to appropriate cell culture media. No extra supplements were added to 
the culture media, as fibre integrity was maintained due to enough Ca2+ ions 
present in DMEM. Exact spinning conditions, cell types and concentrations are 
outlined in the experimental sections of the relevant chapters.  
2.5.4.2 Extrusion of  3D Gels Containing Wires 
An in house designed extrusion method was used to extrude alginate gel around 
wires or fibres, resulting in their encapsulation. This process was applied with and 
without the incorporation of cells. The schematic setup for this extrusion method 
is shown in Figure 2.7. A 50 mm extruded aluminium frame and a perforated, 
threated plate built the foundation of the setup. The Gemini 88 dual syringe pump 
(KD Scientific) was installed vertically, secured by holders at the front and the 
back of the pump. Perpendicular to the syringe pump a Cool Muscle RCM1 moving 
stage (Muscle Corporation) was installed equipped with a holder to accommodate 
the coagulation bath. The Cool Muscle stage was power by a Jaytech MP 3082 DC 
power supply and driven by the corresponding software Cool Works Lite 4.1.4.  
The filaments were threated through the spinneret, before being aligned and 
secured within the coagulation bath. The spinneret was then connected to the 
syringe containing the hydrogel solution and placed in the first position in the 
syringe pump. If a second spinning solution was required, it was placed into the 
second position in the syringe pump and connected to the spinneret via a piece of 
tubing (Figure 2.7 B & C). 
The hydrogel was extruded through the spinneret as the syringe pump applies 
pressure. While the hydrogel flows out of the spinneret and crosslinks immediately 
in the coagulation bath, the Cool Muscle started moving the bath and the hydrogel 
was drawn along the filaments, encapsulating them into the gel (Figure 2.7). 
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Extrusion rates and stage speeds depend on the spinneret used and the desired 
diameter of the extruded hydrogel structure, more information is presented in 
chapter 6. 
To allow the incorporation of cells, the setup was moved into a Class II biosafety 
cabinet. Instrumentation not suitable for autoclaving (syringe pump, power 
supply, stage, tubing, etc.) was sterilized using 70% ethanol. All other parts 
(coagulation bath, spinneret, holders, etc.) were autoclaved at 121°C for 20 min. 
 
Figure 2.7: Schematic setup used to encapsulate filaments into hydrogels. Zoom sections show 
extrusion using one (B) and two (C) gels. Arrows indicate moving direction of coagulation bath.  
Exact settings and parameters used are presented in the experimental part of each 
relevant section. Chapter 6 gives a detailed description of design, assembly and 
operation of the system. All spinnerets used as part of this work are custom 
designed to accommodate the requirements for filament arrangements and fibre 
diameters. Single lumen spinnerets of different diameters were fabricated in 
house. All coaxial and multi-lumen spinnerets were designed and manufactured by 
Ramé-Hart Instruments Co. (USA). 
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2.5.4.3 Extrusion of Polypyrrole Fibres 
PPy nanoparticles spinning solution was prepared by adding freeze dried 
nanoparticles into dichloroacetic acid (DCAA, Fluka). A 3D-Bioplotter (Envisiontec, 
Manufacturer Series, Germany) was used to extrude the spinning solutions into a 
deionised water bath (18.2 MΩ cm-1) cooled to 10°C, using a 21-gauge tip. After 
extrusion the fibres were left in the water bath until solidified, before washing in a 
series of ethanol/water solutions. After washing, fibres were dried under vacuum 
at 60°C11. A more detailed description of parameters is presented in chapters 4 and 
5. 
2.5.4.4 Extrusion of Graphene-Polypyrrole Composite 
Wet-spinning of graphene-PPy composite fibres (at different ratios) was carried 
out using a rotational wet-spinning setup. The spinning solutions were prepared 
by adding different amounts of PPy nanoparticles to graphene oxide dispersed in 
water. Fibres were extruded through a 20 gauge single lumen metal spinneret at a 
rate of 25 ml h-1. The coagulation bath was a mixture of ethanol, acidic reducing 
agent and calcium chloride. Fibres remained in the coagulation bath at 90° for 4 h, 
before they were collected and dried under vacuum at 60°C. Detailed information 
is presented in chapter 5.  
2.5.5 Designing and Manufacturing of Parts 
2.5.5.1 3D - Printing 
An Objet Connex 350 Multi-material 3D printer (Stratasys, USA) was used to print 
biocompatible, transparent parts from MED610 (Tested to standard DIN EN ISO 
10993-1:2009, Stratasys, polyjet process 16 µm per layer) as well as structurally 
stronger white RGD5160-DM (Statasys, polyjet process, 30 µm per layer) material. 
All designs were created using the 3D computer aided design (CAD) software 
Solidworks. Materials printed from RGD5160-DM were not post-treated after the 
removal of support material. Parts printed from MED610 were freed from all 
support material before incubation in a 2% sodium hydroxide bath for 2 h and 
rinsing in water. As a last step, parts were soaked in isopropanol for 30 min and 
allowed to dry for at least 24 h before coating with a thin layer of parylene to 
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increase the resistance to ethanol used for sterilization purposes and reduce the 
absorption of soluble cell media components into the material.  
A SLM-50 (Realizer, Germany) metal printing system was used to print custom 
designed parts from titanium (titanium 6-4, power of spherical particles 20 - 60µm 
distribution in 25 µm layers) for applications which required high structural 
stability or electrical conductivity. The post-treatment of the printed parts 
involved the removal of support material and bath sonication in water to remove 
loose material. If a smooth surface finish was required the parts were sand blasted 
and sonicated again.  
An Up Plus 2 (3D Printing Systems, Australia) printer was used for parts where 
low resolution was sufficient. Acrylonitrile butadiene styrene (ABS) was used as a 
material with a layer thickness of 250 µm in a fused deposition modeling (FDM) 
approach.  
A more comprehensive description of designs and utilized printing technique is 
part of the applicable section of each relevant chapter.  
2.5.5.2 Laser Cutting 
A Universal Laser Systems PLS6MW (USA) laser cutter was used to cut or engrave 
different materials as required. Outlines or drawings were designed using 
CorelDraw X6 and transferred to the systems corresponding control panel 
software. Routinely cut materials include different thickness of plexiglass acrylic as 
well as polydimethylsiloxane (PDMS). Specific settings and parameters are given in 
the experimental section of each relevant chapter. 
2.5.5.3 Parylene Coating 
A PDS 2010 coater (Specialty Coating Systems) was used to apply thin coatings of 
parylene (Specialty Coating Systems) to different surfaces. This was performed to 
achieve electrical isolation, chemical inertness, increased hydrophobicity or 
reduced absorption into materials. 
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Chapter 3 
Chapter 3: CONDUCTIVITY OF BLENDS OF 
CONDUCTING NANOPARTICLES 
AND HYDROGELS 
This chapter is based on the publication:  Katharina Schirmer, Cody Wright, Holly 
Warren, Brianna Thompson, Anita Quigley, Robert Kapsa and Gordon Wallace 
(2015). Can the Wet – State Conductivity of Hydrogels be Improved by 
Incorporation of Spherical Conducting Nanoparticles? MRS Proceedings, 1717, 
mrsf14-1717-a07-01 doi:10.1557/opl.2014.952. 
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3.1 Foreword 
In this chapter, the suitability of spherical nanometre sized particles as conducting 
fillers for the hydrogel alginate was analysed. The aim of this work was to 
introduce electrical conductivity into an ionically conducting hydrogel in a 
cytocompatible way to facilitate electrical stimulation of cells cultured within or in 
close proximity of the gel. A verbatim reproduction of the publication is given in 
Section 3.2. Section 3.3 provides additional information of the resistivity of 
alginate – nanoparticle blends measured via EIS as well as fabricated into fibres. 
Section 3.4 summarizes the results and provides an overall conclusion.  
3.2 Can the Wet – State Conductivity of Hydrogels be Improved 
by Incorporation of Spherical Conducting Nanoparticles? 
3.2.1 Abstract 
In nerve and muscle regeneration applications, the incorporation of conducting 
elements into biocompatible materials has gained interest over the last few years, 
as it has been shown that electrical stimulation of some regenerating cells has a 
positive effect on their development. A variety of different materials, ranging from 
graphene to conducting polymers, have been incorporated into hydrogels and 
increased conductivities have been reported. However, the majority of 
conductivity measurements are performed in a dry state, even though material 
blends are designed for applications in a wet state, in vivo environment. The focus 
of this work is to use polypyrrole nanoparticles to increase the wet–state 
conductivity of alginate to produce a conducting, easily processable, cell–
supporting composite material. Characterization and purification of the conducting 
polymer nanoparticle dispersions, as well as electrochemical measurements, have 
been performed to assess conductivity of the nanoparticles and hydrogel 
composites in the wet state, in order to determine whether filling an ionically 
conducting hydrogel with electrically conductive nanoparticles will enhance the 
conductivity. It was determined that the introduction of spherical nanoparticles 
into alginate gel does not increase, but rather slightly reduces conductivity of the 
hydrogel in the wet state. 
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3.2.2 Introduction 
In the last two decades, there has been recognition of the importance of electric 
fields in guiding and manipulating tissue patterning, development and function 
across many tissue types1-3, the implication being that the ability of biomaterials to 
conduct electricity has become more important4. One class of materials, which has 
been widely used for many applications as a biomaterial, is hydrogels5-7. Hydrogels 
can be tailored in their mechanical properties to suit specific tissue engineering 
applications as well as deliver growth factors and cells to the site of implantation8, 
9, however hydrogels are lacking inherent electrical conductivity. Some hydrogels, 
such as sodium alginate, are ionically conducting, as the ions in the gel act as 
charge carriers but, they are not considered to be sufficiently conductive for 
applications such as cell stimulation. 
To impart electrical conductivity into hydrogels most approaches focus on in situ 
polymerization of conducting polymers within the gels10, 11 or the incorporation of 
conducting polymers or other carbon based fillers in the shapes of small particles 
that are blended with the gel12, 13. Electrically conducting particles with high aspect 
ratios including rod shaped conducting polymers and carbon nanotubes have been 
successfully used as fillers to reduce the resistivity and improve mechanical 
properties of gels12, 13. Conductivities in the range of 10-3 – 10 S cm-1 were achieved 
using organic fillers of different shapes and in varying concentrations11, 13. The 
effects of filling conductors on cell behaviour within 3D hydrogels were rarely 
studied in detail, however a number of reports describe better biocompatibility of 
spherical particles compared to rod shaped particles or carbon nanotubes when in 
contact with cells 14-17.  
This work investigates the effect of incorporation of conducting polypyrrole 
nanoparticles (PPyNP) on the resistivity of alginate hydrogels. 5%(w/v) dried 
PPyNP were found to be the highest concentration that could be dispersed in 
2%(w/v) alginate gel. As a control inherently conducting silver nanoparticles 
(AgNP) were also incorporated into alginate. Here a maximum of 2%(w/v) AgNP 
could be achieved in 2%(w/v) alginate. The majority of conductivity 
measurements are performed in a dry state where the materials are dehydrated 
and compacted, potentially changing their percolation threshold and, therefore, 
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capacity to conduct electricity, even though materials are proposed for 
applications in a wet in vivo environment. Here the resistivities of the blends were 
analysed in the wet state to approximate physiological conditions, using an 
adapted electrochemical impedance spectroscopy setup.  
3.2.3 Theory and Experimental 
3.2.3.1 Polypyrrole Nanoparticle (PPyNP) Synthesis 
To synthesize polypyrrole nanoparticles, 0.5 wt% polyvinyl alcohol (PVA, MW 31 –
 50 kDa, Sigma-Aldrich) was added to MilliQ water at 80°C and stirred until fully 
dissolved. The solution was cooled to 4°C before 0.05 M of iron (III) p-
toluenesulfonate hexahydrate (FepTS, Sigma-Aldrich) was added and stirred until 
fully dissolved. The polymerization was initiated with the addition of 0.01 M 
pyrrole monomer solution (Merck Millipore, distilled) and continued for at least 8 
h at 4°C before the particle dispersion was dialysed against MilliQ water for at least 
48 h (with water changes every 12 h) using cellulose dialysis tubing with an 
average molecular weight cut off (MWCO) of 12 – 14 kDa (Sigma-Aldrich). To 
remove excess PVA, the dispersions were concentrated and then washed in MilliQ 
water using centrifugal filter units with a MWCO of 100 kDa (Amicon Ultra, Merck 
Millipore). Washed dispersions were removed from the filters and freeze dried. 
Filtered particles synthesised in this manner have a spherical shape and an 
average size of 63 ± 3 nm (n > 1000 particles) measured by scanning electron 
microscopy. 
3.2.3.2 Silver Nanoparticle (AgNP) Synthesis 
Citrate-decorated silver nanoparticles were synthesized based on an adapted 
method from Lee and Meisel18 with increased concentrations: 500 mL of a 2.1 mM 
solution of silver nitrate (Sigma) was brought to a boil, to which 20 mL of 1 wt% 
sodium citrate was added and mixed at room temperature until a colour change 
was observed. This reaction was repeated three times, before the overall volume of 
1.5 L was reduced to 12 mL via freeze-drying to achieve a particle concentration of 
2.5 wt% in water. Using dynamic light scattering analysis the average particle size 
was shown to be 58 ± 2 nm. 
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3.2.3.3 Electrochemical Impedance Spectroscopy (EIS) on Gels 
Freeze dried PPyNPs were mixed with 2%(w/v) sodium alginate gel (alginic acid 
sodium salt from brown algae, medium MW from Sigma Aldrich, dissolved in MilliQ 
water) at a concentration of 5%(w/v). Sodium alginate was added to the 2.5 wt% 
AgNP dispersion at a concentration of 2%(w/v). These solutions will be referred to 
as PPyAlg and AgAlg, respectively. Additionally to the solutions containing 
nanoparticles, pure sodium alginate gels at 2%(w/v) (2% Alg) and 4%(w/v) 
(4% Alg) in MilliQ water, as well as 2%(w/v) alginate containing the same 
concentration of sodium nitrate (AlgNaNO3) as the calculated excess in the AgNP 
solution (0.71 M), were analysed using a custom-made EIS setup. Moulds to hold 
the gels were fabricated in 4 different lengths (1, 2, 3 and 4 cm) from Acrylic 
sheets, allowing the exact positioning of the working-, reference- and counter 
electrodes in the 3-electrode cell. In this study the electrodes used were glassy 
carbon as the working, platinum mesh as the counter and silver/silver chloride 
(Ag|AgCl) as the reference, shown in Figure 3.1. 
 
Figure 3.1: Electrochemical cell setup consisting of different length molds and a standard 3-electrode 
setup. 
Using a CHI660D electrochemical workstation, EIS was performed from -0.5 V to 
0.5 V (vs. Ag|AgCl) in 0.1 V steps starting from 0 V with increasing potential 
magnitude applied, each between 0.1 Hz to 106 Hz with an amplitude of 0.01 V. 
Before and after each set of EIS measurements cyclic voltammetry was performed 
to ensure no electrode plating had occurred. This was repeated over at least three 
different lengths, for all materials. The Nyquist plots of all gels, applied potentials 
and lengths were fitted to the model shown in Figure 3.2. The model consists of a 
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resistor in series with two parallel circuits, the first being a resistor parallel with a 
standard RC-circuit, the second consisting of a capacitor and Warburg element. 
The overall resistance was calculated from the modelled R1 and R2 values, which 
were plotted over the different distances. 
 
Figure 3.2: Electric circuit used to model Nyquist plots, with total resistance of the gel taken as the 
sum of R1 and R2. 
3.2.3.4 Results and Discussion 
The set-up presented here was utilized to investigate the resistivity of hydrated 
hydrogels and hydrogel-particle. The onset and dip of the semi-circle of the 
Nyquist plots in Figure 3.3 and Figure 3.4 represent the relative resistance of the 
respective solutions. Shifting of the onset and dip of the semi circles towards the 
right (higher Z’) indicates a higher resistive component of the impedance of the 
solution. The relative capacitance can be estimated from the highest point of the 
semicircle: higher semicircle apex values on the y-axis indicate higher capacitance 
of the solution. As Figure 3.3A shows no significant difference in relative resistance 
was found between the corresponding positive and negative voltages applied for 
each gel. Representatively, Nyquist plots at 0.1 V,  -0.1 V, 0.3 V, -0.3 V, 0.5 V and -
0.5 V for 2% Alg gels are shown. As expected, a slight decrease in relative 
resistance and capacitance was observed with an increase in voltage magnitude 
applied. Figure 3.3B shows Nyquist plots of 2% Alg gel at 0.3 V over 1 cm (circle), 
2 cm (triangle), and 3 cm (square) distance. As expected, the resistance and 
capacitance of the solution increases with distance. 
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Figure 3.3: Representative Nyquist plots of 2% alginate gel at different applied positive and negative 
potentials applied (A) and over different distances (B). 
The combined resistance values, extracted from the fitting of the above model are 
summarized for all materials and distances in Table 3.1. Where no values are given 
the modelling of the data was unsatisfactory and data was excluded from the 
investigation.  As can be seen from the Nyquist plots shown in Figure 3.4, the 
resistance and capacitance of pure alginate decreases with an increase in the 
concentration from 2% Alg (circle) to 4% Alg (star), due to the increase of ions per 
unit volume associated with the increased concentration of alginate salt. With 
addition of 5% PPyNPs to 2% alginate gel (PPyAlg, square) the resistance and 
capacitance of the gel increases. 
Table 3.1: Summary of resistance values for all materials and all distances 
 
AgNPs blended with 2% alginate gel (AgAlg, triangle) results in a reduction of the 
resistance. This was determined to be due to the additional sodium and nitrate 
ions in the gel, which were added with the AgNPs as the change in resistance could 
Resistance 1cm 2cm 3cm 4cm 
2% Alg 551 ± 51 Ω 919 ± 69 Ω 1267 ± 91 Ω - 
4% Alg 447 ± 55 Ω 740 ± 97 Ω   803 ± 89 Ω - 
PPy Alg 713 ± 72 Ω 1358 ± 136 Ω   1912 ± 141 Ω - 
Ag Alg 151 ± 25 Ω 219 ± 30 Ω - 294 ± 24 Ω 
Alg NaNO3 117 ± 14 Ω 159 ± 17 Ω   189 ± 23 Ω 234 ± 22 Ω 
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be reproduced by the addition of the same concentration of NaNO3 to the alginate 
gel alone (Alg NaNO3, diamond).  
 
Figure 3.4: Nyquist plots of 2% alginate gel (circle) 4% alginate gel (star), 2% alginate gel containing 
5% polypyrrole nanoparticles (square), 2% alginate gel containing 2% silver nanoparticles (triangle) 
and 2% alginate gel containing additional NaNO3 (diamond), all over a distance of 2 cm with 0.3 V vs. 
Ag|AgCl applied. 
Again, it can be observed that the addition of conducting nanoparticles at   the   
given   concentrations,   into   an already   ionically conducting hydrogels only 
hinders the ionic conductivity and does not improve the overall conductivity of the 
material. The EIS data was modelled and the overall resistance determined for 
each material over different distances, allowing resistivity of each material to be 
determined (see Figure 3.5B). The slope of the graphs in Figure 3.5A represent the 
resistivity in ohms cm-1, with a steeper slope indicating a higher resistivity of the 
material. The conductivity of alginate gel increases proportionally to the 
concentration of the gel, and hence the amount of ions present.  
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Figure 3.5: The resistance of different materials over different distances was extracted from EIS data 
fitted to the model shown in Figure 3.2. The resistance values for each material at different distances 
are shown (B). The slope of the plotted graphs represents the resistivity of the materials in 
ohms cm-1. 
3.2.3.5 Conclusion 
Here an EIS based method has been developed and tested, allowing analysis of the 
conductivity of gels in wet-state, in vivo – like environments. It has been shown 
that the introduction of spherical PPyNPs at up to 5 wt% into alginate gel at 2% 
and 4% did not increase the electronic conductivity over the ionic conductivity of 
the gel itself. Instead the resistance is increased as the particles physically hinder 
ionic movement. This was proven by the addition of spherical, inherently highly-
conducting AgNPs, which again increase the resistivity compared to an alginate 
containing an equivalent concentration of ions, showing that spherical, inherently 
conducing nanoparticles could not increase the conductivity in ionically 
conducting alginate gel. 
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3.3 Additional Information 
3.3.1 Additional Explanation, Results and Discussion 
EIS measurements were performed on five alginate gels and blends, over at least 
three distances each, applying different voltages. The results that could not be 
presented as part of the publication in section 3.2 are presented here, giving 
further insight into the methods and validation of results.  
The electric circuit used to model the data is shown in Figure 3.2. This model has 
been optimized from the simplified Randles circuit, which is one of the most 
commonly used models for EIS data19-21. The Randles circuit takes the solution 
resistance, double layer capacitance and charge transfer resistance of a single-step, 
diffusion-accompanied charge transfer reaction into consideration by placing a 
resistor in series with the parallel combination of a capacitor and a resistor in 
series with the Warburg element (Figure 3.6)19. The fit of the Randles model to the 
Nyquist plots acquired as part of this study was not satisfactory. To achieve a 
better fit, another capacitor was added to the circuit and together with the 
Warburg element set in series to the RD-circuit. The addition of another capacitor 
placed in series to the first circuit indicates that the capacitive behaviour of the 
system is caused in two different places. It is hypothesized, that C1 represents the 
double layer capacitance between the alginate and the electrode, and C2 results 
from the interactions of the electrolyte (salty water) with the alginate chains. The 
apex of the semicircle is indicative of the overall capacitance of the system: the 
higher it is positioned the higher is the capacitance. The resistivity of each system 
at each length was calculated from the sum of the modelled R1 and R2 values, 
where R1 represents the solutions resistance and R2 the systems resistance 
resulting from charge transfer procedures. The model error was used to calculate 
the standard deviation of the resistance at each point. 
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Figure 3.6: Simple Randles circuit and representative Nyquist plot. Modified from Randviir et al. 19. 
To analyse whether the different materials and material blends show a voltage 
dependency of the current, all systems were analysed at three voltages. Figure 3.7 
compares the Nyquist plots of alginate gels and blends with measurements 
performed over a distance of 2 cm at 0.1 V, 0.3 V and 0.5 V against Ag|AgCl. As can 
be seen from the graphs all materials exhibit very little to no voltage dependency 
at high frequencies.  
Figure 3.8 compares the Nyquist plots of alginate gels and blends analysed at 0.3 V 
against Ag|AgCl over a range of distances. In all alginates and gel blends the 
resistance of the system increases with the distance between the electrodes. Based 
on this principle, all modelled materials resistances were plotted over the distance 
at which they were measured, to analyse the materials resistivity independently of 
the distance. Furthermore an increase in capacitance can be observed with an 
increase in measuring distance for all gels and gel blends. Figure 3.9 shows the 
resistances of materials measured at 0.1 V, 0.3 V and 0.5 V against Ag|AgCl 
respectively over all distances and Table 3.2 summarizes the corresponding 
calculated resistivities. As can be seen from the graphs and the data summarized in 
the table, the difference between the resulting resistivities ranges between 0% and 
17% when voltages between 0.1 V and 0.5 V against Ag|AgCl are applied.  
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Figure 3.7: Nyquist plots of EIS measurements performed over 2cm on 2% alginate (2%Alg), 4% 
alginate (4% Alg), 2% alginate blended with 5% polypyrrole nanoparticles (PPyAlg), 2% alginate 
blended with 2% silver nanoparticles (AgAlg) and alginate supplemented with amounts of NaNO3 
equivalent to NaNO3 present in the silver nanoparticle dispersion. Different voltages were applied.  
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Figure 3.8: Nyquist plots of EIS measurements performed at 0.3V over at least 3 distances on 2% 
alginate (2%Alg), 4% alginate (4% Alg), 2% alginate blended with 5% polypyrrole nanoparticles 
(PPyAlg), 2% alginate blended with 2% silver nanoparticles (AgAlg) and alginate supplemented with 
amounts of NaNO3 equivalent to NaNO3 present in the silver nanoparticle dispersion.  
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Figure 3.9: The resistance of alginate gels and blends was measured over different distances using 
EIS. Three different voltages were applied to the samples: 0.1 V (A), 0.3 V (B) and 0.5 V (C). The slope 
of the lines represents the resistivity in ohms cm-1. 
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Table 3.2: Summary of resistivity of gels and gel blends when measured at different voltages.  
 Resistivity at 0.1V 
in Ω cm-1 
Resistivity at 0.3V 
in Ω cm-1 
Resistivity at 0.5V 
in Ω cm-1 
Variation  
2% Alg 306 358 357 17% 
4% Alg 295 293 281 5% 
PPyAlg 560 599 649 16% 
AgAlg 46 46 52 13% 
Alg NaNO3 38 38 38 - 
 
Overall this additional data shows that the system works reliably for the analysis of 
the resistivity of hydrogels in a wet state. Furthermore, it confirms that the 
incorporation of inherently conducting, spherical nanoparticles at concentrations 
of 2% - 5% does not decrease the gels resistivity, in fact, a slight increase in 
resistivity is observed when nanoparticles are introduced into the ionically 
conducting alginate.  
3.3.2 Resistivity of Fibres Wet-Spun from Alginate Blends 
Fibres were wet-spun from 2% Alg, 4% Alg, PPyAlg and AgAlg by extruding the gel 
solutions into a 2% CaCl2 coagulation bath. Figure 3.10 shows representative 
images of all types of fibres hydrated in a calcium bath. While alginate fibres are 
almost transparent, PPyAlg fibres are black and AgAlg fibres show a grey 
coloration. All fibres could be wet-spun, however fibres containing silver or PPy 
nanoparticles were more brittle and harder to handle.  
 
Figure 3.10: Fibres wet-spun from 2% alginate (2%Alg), 4% alginate (4%Alg) and blends containing 
2% alginate and 5% polypyrrole nanoparticles (PPyAlg) or 2% silver nanoparticles (AgAlg), 
respectively.  
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To investigate the wet-state resistivity of crosslinked gels with and without the 
addition of conducting nanoparticles the setup shown in Figure 3.11 was 
developed and used. The setup consists of a 3D printed MED610 base and wiring 
that has been inserted into channels present in the base. The end of the wires in 
exposed through a hole in the base. To make a connection between the wires and 
the hydrated fibres, a drop of mercury is placed on top of the exposed part of the 
wire and the hydrated fibre is placed on top of that. A multimeter is attached to the 
wire on both sides and the resistance value taken.  
 
Figure 3.11: Setup to measure wet-state conductivity of hydrogel fibres. Connection between the 
wires and the fibres is made by mercury. 
All measurements were taken over a distance of 1cm using hydrated and 
dehydrated fibres. The results are summarized in Table 3.3.  
Table 3.3: Resistivity and diameter of hydrated and dehydrated hydrogel fibres produced from 
alginate and alginate blends containing conducting polypyrrole or silver nanoparticles respectively.  
 
Hydrated (2% CaCl
2
) Dehydrated 
Resistivity Diameter Resistivity Diameter 
2%Alg   0.22 ± 0.06 MΩ 425.0 ± 14 µm 46.8 ± 6 MΩ 184.4 ± 21 µm 
4%Alg 0.21 ± 0.5 MΩ 439.4 ± 35 µm 48.0 ± 3 MΩ 122.6 ± 16 µm 
PpyAlg   0.25 ± 0.07 MΩ 398.1 ± 61 µm    62.8 ± 11 MΩ 123.7 ± 21 µm 
AgAlg  0.16 ± 0.3 MΩ 325.9 ± 59 µm - 169.1 ± 30 µm 
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In dried fibres, the conducting particles are most likely in closer proximity to each 
other, however the resistivity increased drastically when the fibres are 
dehydrated, to the point where the resistivity was not measureable (AgAlg) The 
increase in resistivity, as well as the similar resistivity across all hydrated fibre 
types indicates that the measured resistivity in hydrated fibres is purely based on 
ionic conductivity, as a result of the calcium ions present. 
3.4 Chapter Summary 
Based on the results presented here, the incorporation of a conducting pathway 
into hydrated hydrogels cannot be achieved by the addition of conducting 
spherical nanoparticles at the given percentages (which are equal to, or exceeding 
the amount of hydrogel present in the blends). To achieve a continuous conducting 
pathway, the particles need to be touching each other in a randomized network in 
order to allow a continuous movement of electrons. This can be achieved easily 
when particles of long aspect ratios are utilised22-24. However as discussed before 
the biocompatibility of these particles was found to be impacted by the shape of 
the particles and a spherical appearance thought to be favourable for biological 
applications15, 16. In this study the addition of 2% silver and 5% PPy particles to 
alginate hydrogels does not reach the threshold required to form randomized 
networks, conclusively electrical conductivity was not achieved.  
Other more promising approaches are the polymerization or spray coating of 
conducting polymer films or coatings, either free standing or on other substrates10, 
11, 23, 25. The conductivity delivered from conducting polymer films is in the range of 
1 – 10-3 S cm-1 25-27, however the translation into 3D very difficult. To overcome 
this, the introduction of pre-formed conducting fibres into hydrogels is proposed. 
This would allow not only the introduction of sufficient conductivity into the gel to 
allow electrical stimulation of cells, but potentially also topological guidance, 
which is another critical factor in nerve regeneration.  
Chapter 4 describes the method used to purify the PPy nanoparticles used as part 
of this study, use of the PPy nanoparticles to produce free-standing conducting 
PPy-only fibres, and also investigates the effect of the PVA reduction in the 
dispersion on the properties of PPy fibres. 
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4.1 Foreword 
This chapter describes the development of a method to increase the conductivity of 
a PVA stabilized PPy nanodispersion, by reducing the amount of PVA pre- and post 
PPy synthesis, without compromising the dispersability or dispersion stability of 
the nanoparticles. Following optimization, fibres were produced from both 
optimized and original nanodispersions using a wet-extrusion approach. The fibres 
were produced only from the PPy nanodispersions, without the incorporation of 
other matrix materials. The aim of this work was to produce fibres which can be 
embedded into alginate hydrogels, in order to introduce electrical conductivity and 
facilitate electrical stimulation of the cells in close proximity to the fibres, or within 
the gel. The material and electoconductive properties of the two fibre types 
(containing high and low amounts of PVA) were analysed and compared. 
Section 4.3 contains supplementary information of the published article and more 
information on the coagulation of the fibres in different solvents, while section 4.4 
summarizes the findings and places them into the context of the thesis. 
4.2 From Nanoparticles to Fibres: Effect of dispersion 
composition on fibre properties 
4.2.1 Abstract 
A polyvinyl alcohol (PVA) stabilized polypyrrole nanodispersion has been 
optimised for conductivity and processability by decreasing the quantity of PVA 
before and after synthesis. A reduction of PVA before synthesis leads to formation 
of particles with a slight increase in dry particle diameter (51 ± 6 nm to 
63 ± 3 nm), and conversely a reduced hydrodynamic diameter. Conductivity of the 
dried nanoparticle films was not measureable after a reduction of PVA prior to 
synthesis. Using filtration of particles after synthesis, PVA content was sufficiently 
reduced to achieve dried thin film conductivity of 2 S cm-1 while the electroactivity 
of the dispersed particles remained unchanged. As-synthesised and PVA-reduced 
polypyrrole particles were successfully spun into all-nanoparticle fibres using a 
wet-extrusion approach without addition of any polymer or gel matrix. Using 
nanoparticles as a starting material is a novel approach, which allowed production 
of macro-scale fibres that consisted entirely of polypyrrole nanoparticles. Fibres 
made from PVA-reduced polypyrrole showed higher electroactivity compared to 
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fibres composed of the dispersion high in PVA. The mechanical properties of the 
fibres were also improved by reducing the amount of PVA present, resulting in a 
stronger, more ductile and less brittle fibre, which could find potential applications 
in various fields. 
4.2.2 Introduction 
Conducting polypyrrole (PPy) polymers have been comprehensively studied over 
several decades, since the discovery of the material in 19631. Due to the simplicity 
of PPy synthesis, its potentially high electrical conductivity and electrochemical 
activity, a broad variety of applications have been described and proposed for PPy, 
from conducting inks to regulated drug delivery 2-7 as well as various biomaterials, 
biomedical and tissue engineering applications 8-11. Proposed biomedical 
applications of PPy generally require conductivity and electroactivity of the 
polymer12.  
Chemical and electrochemical polymerizations of PPy result in insoluble coarse 
powders or brittle thin films respectively, which provide a challenge for fabrication 
into more complicated structures. From around 1990, an increasing number of 
publications reported synthesis of soluble PPy polymers, usually achieved by 
utilizing sulphonic acid derivatives as dopants, or by chemical modification of the 
monomer or conducting polymer chain13, 14. Solubility was typically achieved in 
organic solvents, while conductivities of dried films of soluble PPy were reported 
to be in the range of 10-3 – 100 S cm-1 15-21. Good dispersibility and stability of PPy 
in water was achieved by using a colloidal synthesis approach, in which large 
water-soluble polymers function as the site of polymerization and steric stabilizer 
once the synthesis is completed. The water soluble polymer (often polyvinyl 
alcohol (PVA), as described by Hong et al. 201022, amongst others) forms small 
reaction sites in solution where the oxidation and polymerization of the PPy takes 
place in the presence of an oxidant and dopant. The results are homogenous, nano-
dimensional, spherical conducting polymer particles, which are encapsulated in 
the water-soluble long chain polymer22, 23.  
The stabilizing layer of the long chain polymer on the outside of the conducting 
polymer can be disadvantageous as they are insulating and hence reduce or even 
disable the conductivity and electroactivity of the conducting polymer. 
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Conductivities of 2 S cm-1 have been reported for dried films or pelleted particles 
synthesized in this fashion22, 23. These values were achieved either with a wash 
step22 or without a wash step23, 24 in preparation of the particles. However, the 
electroactivity of the conducting polymer particles, the conductivity in a wet state, 
as well as the effect of the amount of stabilizing polymer present in the dispersions 
has not been investigated in these studies.  
PPy has been successfully used in biomedical applications in the form of films, 
particles, coatings or as part of a blend or composite3, 11, 12, 25, 26. The major reason 
for the focus on use of this particular conducting polymer, in addition to ease of 
synthesis, processability in aqueous solutions and high conductivity, is largely due 
to the cytocompatibility of PPy27-31 and its ability to promote cell adhesion32-35.  
In nerve and muscle regeneration applications, electrical conductivity and 
electroactivity of biomaterials have been found to play an important role as they 
allow electrical stimulation of cells and tissues 36, which has had positive effects on 
their regeneration, resulting in longer neurite outgrowth, better functionality and 
alignment 37-39. To mimic the natural structure of nerves and muscles best, fibrous 
structures in the macro, micro and nano domains have been used to provide 
scaffold support to regenerating tissues. The fibre structures have positive effects 
on the regeneration and growth of nerve and muscle cells, providing support and 
direction, either with or without electrical stimulation40-43.  
To address the desire for electrically conducting, electroactive fibrous structures 
for biomedical applications, we have investigated the processability of the 
optimized, PVA-reduced PPy nanodispersion. Using wet-spinning, PPy 
nanoparticles could be formed into fibres without further modification with non-
conducting polymers or gels. To the authors’ knowledge, this is the first report 
investigating the fabrication of PPy-only fibres from a nanodispersion, without 
addition of other polymers or gels.  
In this work we describe and evaluate various methods to reduce the amount of 
the stabilizing, insulating polymer (PVA) and the effects on the synthesis and 
particle characteristics including their conductivity in dried state and 
electroactivity in solution. As-synthesized particles and dispersions with reduced 
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PVA content were directly fabricated into macroscopic solid fibres. The effect of 
the stabilizing polymer on morphology, mechanical properties and electroactivity 
of the fibres was also investigated. PPy fibres produced from dispersions reduced 
in PVA show promising properties. 
 
4.2.3 Materials and Methods 
4.2.3.1 Particle Synthesis 
To synthesize PPy nanodispersions, PVA (Sigma, molecular weight 31–50 kDa) 
was stirred in MilliQ water at 80°C until fully dissolved. The initial PVA 
concentrations used were 1.2 wt%, 0.9wt% and 0.5 wt%, respectively. The 
solution was cooled to 4°C before 0.05 M of iron (III) para-toulenesulfate (FepTS, 
Sigma) was added to the PVA solution and stirred until dissolved. 0.1 M of pyrrole 
monomer (Merck, distilled) was slowly added to the cooled PVA solution under 
continuous stirring and left to polymerize and oxidize for 8 to 12 h before the 
solution was dialysed against deionized water using dialysis tubing (Sigma, 12 kDa 
molecular weight cut off). Dialysis was carried out for 48 h with three water 
changes. 
4.2.3.2 Post Synthesis Optimization 
To reduce the PVA content in the dispersion, centrifugation filters (MilliPore, 
regenerated cellulose membrane, 100 kDa molecular weight cut off) were used. 
12 ml of the dialysed dispersion was added into each filter and centrifuged for 30 
min at 5000 RCF. 12 ml of deionized water was added to each filter and again 
centrifuged at the same settings. These steps were repeated up to 10 times to 
increase the particle concentration before 10 centrifugation cycles were 
performed with the addition of deionized water only. On completion the particles 
were removed from the filters using bath sonication before freeze-drying the 
solutions. 
4.2.3.3 Particle Size Analysis 
The particle size and size distribution of the dispersions were analysed using 
dynamic light scattering (DLS, Malvern Zetasizer Nano – ZS, Zetasizer software 
6.01, UK). The hydrodynamic diameter (HDD) was compared to scanning electron 
microscopy images of dried particles. Images were taken with a JEOL JSM-7500-FA 
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cold field emission gun scanning electron microscope (FEGSEM, Jeol, Germany), at 
an acceleration voltage of 5 kV. 
4.2.3.4 Elemental Analysis 
To determine the chemical composition of the original and modified (filtered) 
dispersions, elemental analysis was carried out on unfiltered particles synthesised 
with 1.2 wt% and 0.5 wt% PVA, as well as modified dispersion originally 
containing 0.5 wt% PVA after filtration. The Microanalytical Unit at the Australian 
National University in Canberra performed elemental analysis, which included 
quantification of iron, hydrogen, nitrogen, sulphur and carbon. Hydrogen, carbon 
and nitrogen were analysed using the elemental analyser Carlo Erba 1106 
(accuracy ≥ 0.25%44). Flame Atomic Absorption Spectrophotometry 
(accuracy ≈ 0.5%) was used for the detection of iron and Dionex Ion 
Chromatography (accuracy ≈ 0.5%) was utilized for sulphur analysis. The results 
of each analysis were given as mass fraction of each element present in the 
samples was provided in percent. For calculations it was assumed that molecules 
present in the samples are limited to PPy ((C4 H2 NH)n), PVA ((C2 H4 O)n), p-
toulenesulfate (pTS) (CH3 C6 H4 SO3 H) and iron (Fe). In this case all nitrogen 
detected was assumed to be associated with PPy and all sulphur detected was 
attributed to pTS. Based on this, the mass fractions of carbon associated with PPy, 
PVA and pTS respectively were calculated. Respective amounts of each material 
are displayed as a weight percentage of the overall amount of PVA, PPy and pTS 
present. 
4.2.3.5 Film Conductivity 
Films of all dispersions were cast before and after purification using 1 ml of 
dispersion with a concentration of 10 mg ml-1 on an area of 15 x 15 mm. The films 
were heated at 60°C until fully dried. The film thickness was determined using a 
profilometer (Veeco Instruments, Dektak 150, Dektak 9.2.0.8, USA) before a linear 
four-point-probe (Jandel RM3, UK) was used to measure the resistance of the dried 
PPy films, from which the bulk conductivity was calculated. 
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4.2.3.6 Electrochemical Characterization of Particles 
Cyclic Voltammetry (CV) was used to determine the electroactivity of PPy 
dispersions containing different amounts of PVA. The particles were dispersed at 
5 wt% in 1 M sodium nitrate solution and in water and tested in a standard three-
electrode setup, using a 3 mm diameter glassy carbon electrode as the working 
electrode, a platinum mesh as the counter electrode and Ag|AgCl as the reference. 
After initial screening the potential was scanned between -0.5 and 0.5 V vs. 
Ag|AgCl as this window covered the redox reactions occurring in the samples. Scan 
rates between 10 and 100 mV sec-1 were applied.  
4.2.3.7 Fibre Spinning 
Spinning solutions were prepared by gradual addition of freeze-dried PPy particles 
to dichloroacetic acid (DCAA, Sigma-Aldrich, purity ≥ 99%). Solutions were 
allowed to mix for at least a day to ensure clump free, homogenous dispersion of 
the particles. The filtered 0.5 wt% PVA PPy (LPVAPPy) dispersion was dispersed 
at 12 wt% and 15 wt% in DCAA, the unfiltered 1.2 wt% PVA PPy (HPVAPPy) 
solutions were prepared at 15 wt% and 30 wt% dispersion in DCAA. Viscosity was 
measured using a rheometer (TA instruments, Model ARG2, cone: 992486: 50mm 
angle 2%). Shear rates from 1 to 100 s-1 were applied over a period of 5 min, to 
determine the most suitable viscosities for the spinning or printing process. The 
Envisiontec 3D-Bioplotter (Manufacturer Series) was used to extrude the fibres 
into a deionised water bath (18.2 MΩ cm-1) cooled to 10°C. The HPVAPPy 
dispersion (1.2 wt% PVA, unfiltered) was extruded using a 25-gauge extrusion tip 
and a 21-gauge tip was used for the LPVAPPy dispersion (0.5% PVA, filtered) as 
these needle sizes showed the best fibre formation. After extrusion, the fibres were 
left in the water bath (2 to 3 min for LPVAPPy fibres and 12 to 15 h for HPVAPPy 
fibres) until solidified. 
4.2.3.8 Mechanical Testing 
Tensile testing was performed using Shimadzu EZ-S. A minimum of 10 samples 
were tested per fibre, with a sample distance of 1 cm and a sample rate of 1 mm 
min-1 using a 10 N load cell. The elastic modulus was calculated from the linear 
elastic region in the stress – strain curve. The curves displayed below are 
representative for the test results of each fibre type. 
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4.2.3.9 Imaging Using SEM 
Fracture surfaces of the fibres after tensile testing were sputter coated with 15nm 
of gold before images were taken with a JEOL JSM-7500-FA cold field emission gun 
scanning electron microscope (FEGSEM, Jeol, Germany). 
 
4.2.4 Results and Discussion 
4.2.4.1 Effects of PVA Reduction on Particle Size 
The effect of reducing PVA content before and after synthesis of PPy particles was 
investigated with regards to the hydrodynamic diameter of the particles 
determined by DLS. With a reduction of PVA content prior to synthesis, the 
hydrodynamic diameter (HDD) determined by DLS slightly decreased from 
160 ± 1 nm (1.2 wt% PVA) to 156 ± 2 nm (0.9 wt% PVA) and 148 ± 1 nm 
(0.5 wt% PVA). The SEM images (Figure 4.1) show that synthesized and filtered 
dispersions, exclusively contain spherical particles that are homogenous in size. 
The lower the PVA concentration of the dispersion at synthesis, the more 
aggregated the particles appear when dried under SEM conditions, however the 
DLS data (see 4.3.1 Supplementary Information) shows that the particles are 
evenly distributed and uniformly dispersed before drying. The particle size of the 
dried particles, as measured by SEM (Figure 4.1), shows an increase in diameter 
from 51 ± 6 nm (1.2 wt% PVA) to 61 ± 5 nm (0.5 wt% PVA). The increase in dry 
particle size indicates that reduction of PVA content during particle synthesis 
changes the reaction dynamics, resulting in an increased particle size. This 
observation is in accordance with Hong et al.22. The decrease in HDD (by DLS) at 
lower PVA concentration, combined with the increase in dried particle size (by 
SEM) indicates reduction of the PVA shell around the particles. The filtered 
particles show no change in dried particle size by SEM compared to unfiltered 
particles, however a slight reduction in the HDD to 145 ± 2 nm was found, 
potentially as a result of further reducing the PVA shell. 
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Figure 4.1: Polypyrrole nanoparticle size and shape as a result of reduced PVA content during 
synthesis (a – c) and after synthesis (d). Dried particle diameter measured by scanning electron 
microscopy (SEM) and hydrodynamic diameter (HDD) measured by dynamic light scattering, are 
indicated. 
 
This is supported by elemental analysis of the dried dispersions (Figure 4.2), 
which showed that reducing the PVA content during synthesis from 1.2 wt% to 
0.5 wt% results in an increase of PPy weight fraction from 11 wt% in to 23 wt%, 
while the PVA content decreases from 82 wt% to 63 wt%. Filtration of the particles 
further increases the PPy content to 58 wt%. The increased mass fraction of 
conducting polymer is largely due to a 79% decrease in PVA content with filtering 
(in 0.5 wt% samples, PVA mass fraction decreases from 63 wt% to 13 wt% with 
filtration). The dispersions also contain pTS, which as a mobile dopant for PPy and 
present in ratios between 1:4 to 1:5. The water-soluble PVA chains are capable of 
binding metal cations through ion–dipole interactions and form a metal/polymer 
complex. The metal cations introduced into the aqueous solution disrupt the local 
structure of polymer chains and thus create new structures. The shape of the 
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PVA/iron cation complex would be also influenced by critical factors such as the 
molecular weight and concentration of PVA and the molar ratio of PVA to iron 
cation22. Considering this it is plausible that a change of the ratio pf PPy to dopant 
is caused by changes to the synthesis kinetics, however purification of the particles 
could also affect this ratio. Measurement errors can also not be excluded as 
potential cause of variations. pTS represents 29 wt%, 14 wt% and 7 wt% of the 
dried unfiltered (1.2 wt% and 0.5 wt% PVA) and filtered dispersions, respectively. 
A change in the ratio of PPy to pTS will have an effect on the conductivity of the 
particles, wherein a higher degree of doping should lead to a higher conductivity of 
the PPy. 
 
Figure 4.2: Contents of polypyrrole (PPy), polyvinyl alcohol (PVA) and p-toulenesulfate (pTS) in the 
different dried particle dispersion as calculated from elemental analysis data. 
 
Using a four-point-probe, electrical conductivity could not be measured in films 
cast from any of the unfiltered dispersions, even though according to the results 
from the elemental analysis, their level of doping is slightly higher compared to the 
filtered dispersion, suggesting that the PVA content was sufficiently high to form a 
complete insulating layer around the particles. For films cast from the filtered 
dispersions, a conductivity of 2  ± 0.5 S cm-1 (n = 14) was measured, indicating 
that the reduction of PVA was sufficient to allow the conducting PPy cores of the 
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particles to form a continuous conductive pathway across the film. This 
conductivity is consistent with previous reports 22, 23. 
Cyclic voltammetry (CV) was performed to investigate any differences in 
electroactivity of the wet-state PPy particles and electrochemical response of 
unfiltered dispersion synthesized with 1.2 wt% PVA (high in PVA PPy dispersion, 
HPVAPPy) and filtered dispersion synthesized with 0.5 wt% PVA (low in PVA PPy 
dispersion, LPVAPPy). The data displayed in Figure 4.3 shows CV performed on 
both the HPVAPPy and LPVAPPy dispersions at a concentration of 5 wt% in 1 M 
sodium nitrate, using a scan rate of 10 mV sec-1 respectively. Both graphs show 
broad reduction and oxidation responses typical of PPy, with the HPVAPPy having 
slightly more pronounced peaks compared to LPVAPPy. Oxidation () and 
reduction () peaks can be identified at 0.13 V and -0.11 V vs Ag|AgCl for 
HPVAPPy, and 0.09 V and -0.12 V vs Ag|AgCl for LPVAPPy, which indicates a slight 
overpotential of HPVAPPy compared to LPVAPPy. These results indicate that 
filtration of the particles and the resulting reduction in PVA has very little effect on 
the electroactivity of the dispersions in solution, even though cast films of the same 
dispersion show differences in electrical conductivity. 
 
Figure 4.3: Cyclic Voltammetry of PPy dispersions high in PVA (HPVAPPy) and dispersions low in 
PVA (LPVAPPy) using a glassy carbon working electrode at a scan rate of 10 mV s-1 against a Ag|AgCl 
reference electrode. Arrows pointing up () and down () indicate oxidation and reduction peaks, 
respectively. 
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4.2.4.2 Fibre Spinning 
Investigation of production of PPy-only structures from the HPVAPPy and 
LPVAPPy dispersions was undertaken using wet-extrusion to produce free-
standing fibres. Fibres were produced from the unfiltered dispersion synthesized 
using 1.2 wt% PVA (HPVAPPy) (Figure 4.4a) and from the filtered 0.5 wt% PVA 
dispersion (LPVAPPy) (Figure 4.4b). To produce fibres from the HPVAPPy and 
LPVAPPy dispersions, the freeze-dried particles were first dispersed in 
dichloroacetic acid (DCAA). The spinning solutions created from the dispersions 
were high in viscosity, which increased with the amount of dispersion introduced 
into solution (rheology data presented in 4.3.1 Supplementary Information, Figure 
4.9). The spinning solutions were found to coagulate in water or solutions 
containing water (including ethanol-water mixes, acetone-water mixes, acetic acid, 
and NaOH solution). The presence of other solvents, salt concentration and pH of 
coagulation solution were not found to significantly change the coagulation of the 
fibre, with the presence of water being the major determinant of coagulation. The 
LPVAPPy solution coagulated within 1-2 min, forming a semi-solid fibre. Once fully 
dried, the gel-like fibre became fully solidified and brittle. Longer exposure of the 
fibre to the coagulation solution resulted in more brittle fibres. The fibres spun 
from HPVAPPy took longer to coagulate, approximately 10 hrs in the coagulation 
solution were required for formation of a fibre that could be handled and drying of 
the fibres also resulted in solid, brittle fibres.  
The proposed mechanism for formation of the fibres is based on two separate 
processes: The first step is an esterification reaction of DCAA and PVA, forming 
polyvinyldichloro acetate (PVDCA). In the second step, the fibre extrusion and 
coagulation, the unreacted DCAA is washed out of the structure, while water-
insoluble PVDCA is coagulated into a macro-sized porous fibre. It is proposed that 
the soaking in coagulation solution is required to wash remaining DCAA out of the 
fibres, resulting in sufficient solidification for handling. The amount of PVDCA is a 
lot higher in the HPVAPPy spinning solution, resulting in a solid fibre with low 
porosity, possibly contributing to the increased coagulation time. 
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Figure 4.4: Dehydrated fibres produced from PPy nanodispersions containing high (HPVAPPy, A) and 
low (LPVAPPy, B) amounts of polyvinyl alcohol using 25 and 21 gauge extrusion heads, respectively. 
 
4.2.4.3 Tensile Strength 
Stress-Strain curves (Figure 4.5) demonstrated that the fibres spun from the 
HPVAPPy dispersion exhibit less strain at break compared to fibres made from 
LPVAPPy dispersions. Moreover the elastic modulus of HPVAPPV fibres was found 
to be twice as high as the elastic modulus of LPVAPPy fibres (1.09 ± 0.07 GPa for 
HPVAPPy fibres compared to 500 ± 200 MPa for LPVAPPy fibres). The ultimate 
stress was found to be very similar with 11 ± 3 MPa for HPVAPPy fibre and 
10 ± 7 MPa for the LPVAPPy fibre. Overall the fibre made from LPVAPPy had an 
elongation at break more than three times greater compared to the fibre high in 
PVDCA (4 ± 3 % and 1.1 ± 0.4 %, respectively). This is most likely a result of the 
different morphologies, especially porosity of the two types of fibres.  
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Figure 4.5: Representative tensile test of PPy fibres made from dispersions high in PVA (HPVAPPy) 
and dispersions reduced in PVA (LPVAPPy), showing increased mechanical properties for fibre made 
from the dispersion lower in PVA (LPVAPPy). 
 
4.2.4.4 Morphology 
Cross-sections of the fracture surfaces of HPVAPPy and LPVAPPy fibres show the 
different morphologies resulting from fatal tensile testing (Figure 4.6). The fibres 
made from HPVAPPy dispersions (Figure 4.6a1 – a5) are more homogeneous 
within the group of fibres. Large irregular pores can be seen on the outer radius of 
the cross section, while the fibre appears more solid towards the centre (Figure 
4.6a1). Higher magnifications show irregular granularity throughout the surface 
and some relatively smooth sections towards the centre, with little indication of 
the presence of nanoparticles (Figure 4.6a2 – a5). The PPy particles are most likely 
harder to identify as a result of the lower relative amount of PPy and the high 
amount of PVDCA present. As the HPVAPPy fibre was non-conductive beneath the 
gold coating, imaging at high magnification was difficult. Fibrous structures, which 
can be found in some of the larger pores (Figure 4.6a1) are most likely pure 
PVDCA. 
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The fibres made from the LPVAPPy dispersion were less homogenous within the 
group (Figure 4.6b1–b5). Areas of higher (Figure 4.6b2) and lower (Figure 4.6b3) 
PVDCA content can be found between and within fibres. These fibres were overall 
a lot more porous throughout. PPy particles are clearly visible at higher 
magnifications, which could be an indication of higher conductivity underneath the 
gold coating (Figure 4.6b4 & b5). 
 
Figure 4.6: SEM images showing the different morphologies of fibres produced from polypyrrole 
dispersion containing high (a) and low (b) amounts of PVA respectively 
Considering the comparably fast coagulation of the LPVAPPy fibre, the high degree 
of porosity is most likely a result of DCAA diffusing quickly out of the structure, 
while coagulating it. In the HPVAPPy fibre, the coagulation process is a lot slower. 
This indicates that the diffusion of DCAA out of the structure is reduced, due to the 
high amount of PVDCA present. Large pores are formed as the DCAA gets 
encapsulated and aggregates, before diffusion slowly out of the structure45. 
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4.2.4.5 Electrochemical properties of Fibres 
The electrochemical behaviour of the HPVAPPy and LPVYPPy fibres was 
investigated using cyclic voltammetry (CV). Multiple scan rates were taken using 
two different types of fibres as working electrodes in 1 M sodium nitrate solution 
(Figure 4.7 shows scans taken at 50 mV s-1 of HPVAPPy and LPVAPPy fibres). 
Fibres produced from LPVAPPy dispersion (2 x 10-4 g cm-1) exhibit a much more 
pronounced electrochemical response compared to the fibres made from HPVAPPy 
dispersion (1.5 x 10-3 g cm-1, Figure 4.7 insert). The voltage dependence of the 
current demonstrates that Faradaic processes (albeit ones with very slow kinetics) 
were occurring within LPVAPPy fibres, and the fibres also displayed a much 
greater capacitance (estimated at 0.03 F g-1 compared to 1.5 x 10-5 F gPPy-1). The 
HPVAPPy fibres showed a much more resistive response, with minimal 
capacitance and much less current flow. 
 
Figure 4.7: Cyclic voltammetry of polypyrrole fibres at a scan rate of 50 mV s-1 Ag|AgCl reference 
electrode. Insert shows enlarged graph of HPVAPPy. CVs have been normalized for scan rate and 
weight of polypyrrole. 
Differences in electrochemical response between dispersions (Figure 4.3) and 
fibres (Figure 4.7) are most likely a result of the soluble nature of PVA in water: 
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the CVs of particles were performed in water based electrolytes, allowing the 
particles to electrochemically respond similarly, despite the difference in PVA and 
PPy present in the dispersions. Once the dispersions are fabricated into fibres, or 
films, the PVA is most likely encapsulating the particles, impeding the formation of 
a conducting pathway and electroactivity of the PPy. This hypothesis is supported 
by the difference found in capacitance. After normalizing the current for voltage 
dependency and weight of polypyrrole in each of the fibres, the maximum 
capacitance for HPVAPPy fibres is 1.7 x 10-6 F gPPy-1, where the maximum 
capacitance for LPVAPPy is 0.05 F gPPy-1. The differences in reactivity could also be 
a result of the difference in active surface area. As shown in the SEM images 
(Figure 4.6), the LPVAPPy fibre is more porous compared to the HPVAPPy fibre, 
and will therefore have a larger reactive surface area per mass.  
4.2.5 Conclusion 
A well-characterized polypyrrole nanodispersion has been optimised to increase 
conductivity in dry state without adversely affecting particle size, stability of the 
dispersion, dispersability or electroactivity of the dispersion. This has been 
achieved by reducing the amount of polyvinyl alcohol before and after synthesis. 
Fibres of dispersions high and low in PVA content have been produced using a wet-
extrusion approach, resulting in fibres entirely made from PPy nanodispersions. 
The fibres made from reduced PVA dispersion showed lower resistivity compared 
to the fibres made from dispersions high in PVA content. The mechanical 
properties of the fibres were also improved by reducing the amount of PVA 
present in the dispersion, resulting in an elastic fibre with higher ultimate strain. 
Compared to neural tissue with maximum strain of 5 – 20% and moduli of 0.1 –
 1.4 MPa the fibres are less elastic and stiffer46. In comparison to other PPy fibres 
the fibres presented here are weaker and more brittle47. The surface area created 
here is increased compared to other PPy fibres48. The main difference is the 
fabrication from nanoparticles, which allows very accurate tuning of the fibres 
properties through the characteristics of the dispersion. Furthermore the potential 
of incorporation of drug loaded particles for controlled drug delivery should be 
investigated. Due to their electroactivity, these fibres could be used for 
applications in smart wearable textiles, energy storage, batteries or as drug 
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delivery devices, utilizing the high surface area of the fibre structure. Additionally 
they could find application in biomedical and tissue engineering applications, 
especially nerve and muscle regeneration where electroactive fibrous structures 
are thought to be most appropriate, however the mechanical properties would 
require further improvements to better match the tissues properties. Further 
investigations into improving the electrochemical behaviour, biocompatibility, as 
well as degradation behaviour under biological conditions warrant investigation in 
further studies. 
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4.3 Additional Information 
4.3.1 Supplementary Information 
DLS graphs of PPy dispersions synthesized using different concentration of PVA 
(Figure 4.8A) show no difference in particle size distribution, which can be 
identified by the shape of the curve. The HDD of the dispersion synthesized with 
1.2% PVA is slightly higher compared to dispersions synthesized using 0.9% or 
0.5% PVA. The dispersion synthesized with 0.5% PVA shows a reduced HDD after 
filtration (Figure 4.8B), even though the actual particle size, measured via SEM, is 
the same for filtered and unfiltered dispersions. Again, no change in particle size 
distribution can be observed. 
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Figure 4.8: Dynamic Light Scattering of Polypyrrole Nano-Dispersion using different amounts of PVA 
for synthesis as well as 0.5% PVA polypyrrole dispersion after filtration 
Figure 4.9 shows the shear rate depended viscosity of spinning solutions 
containing filtered (LPVAPPy) and unfiltered (HPVAPPy) dispersions at different 
weight ratios. An increase in viscosity is observed with an increased amount of 
dispersion added to DCAA.  
100 | From Polypyrrole Nanoparticles to Fibres 
 
 
Figure 4.9: Viscosity as a function of shear rate of different spinning solutions from dispersions in 
DCAA at different concentrations 
4.3.2 Coagulation and Extrusion of PPy Fibres 
To investigate the influence of coagulation mechanisms on fibre formation, the 
particles were dispersed in different solvents and manually extruded into different 
baths. The results are summarized in Table 4.1. Coagulation was only achieved 
when PPy particles were dispersed in DCAA and extruded into a bath containing 
mainly water. The coagulation was found to be largely independent of the pH and 
solvents present in the bath, as long as the bath contains mostly water.  
To better control the extrusion process and produce greater lengths and more 
consistent fibres, different approaches were tested. Initially fibres were injected 
horizontally into a rotational spinning setup, wherein the spinneret was stationary 
and submerged into a water bath rotating in extrusion direction at controllable 
speeds. Using this approach, fibres were produced in lengths of no more than 2 cm.  
As a next step, fibres were extruded from a spinneret orientated vertically in the 
same rotational setup. This approach improved the fibre formation and lengths of 
up to 8 cm were produced.  
As a final step, fibres were extruded using the 3D printer as described in section 
4.2.4.2, where the bath was kept stationary and the fibres were extruded through a 
tipless needle moving in a certain pattern. This approach allowed longer, 
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undisturbed coagulation of the fibres, resulting in fibres lengths of up to 30 cm, 
which was limited by the printing setup as opposed to the coagulation speed or 
manageability of the fibres. 
Table 4.1: Summary of coagulation of spinning solutions extruded into different baths.  indicates 
successful coagulation of the spinning solution, whereas X indicates no coagulation occurred. 
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Spinning solution 
10% PPy in Water X X X X X X X X X 
10% PPy in 1M AA X X X X X X X X X 
12% PPy in DCAA  X   X X X   
 
4.4 Chapter Summary 
A PVA stabilized PPy nanodispersion has been optimized in terms of its 
conductivity by reducing the amount of PVA present in the dispersion, without 
compromising the dispersability of the particles in solution. Films from purified 
particles show increased conductivity, however fibres produced from the particles 
display a highly resistive behaviour. The mechanical properties of the fibres were 
improved by reducing the amount of PVA present in the PPy dispersion, however 
the tensile properties of the fibres remained poor. In order to use these fibres in a 
biological environment, the cytocompatibility of the fibres needs to be assessed 
and, depending on the application, the mechanical properties need further 
improvement.  
To improve the mechanical and electrical properties of the fibres, PPy has been 
blended with graphene. Chapter 5 introduces and discusses the formation of these 
composite fibres and their material properties. Toxicity of the composite fibres, as 
well as the PPy fibres presented in this chapter are investigated as part of 
chapter 5. 
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Chapter 5 
Chapter 5: COMPOSITE FIBRES FROM 
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5.1 Foreword 
This chapter describes improvement of fibres produced from optimized 
polypyrrole nanodispersion (Chapter 4) in terms of their conductivity and 
mechanical properties by addition of reduced graphene oxide into the dispersion 
and fabrication of wet-spun composite fibres. The spinnability of different ratios of 
polypyrrole to reduced graphene oxide composite fibres was investigated before 
the mechanical and electrochemical properties were analysed. Furthermore the 
electrical conductivity and cytotoxicity of the composite fibres were investigated. 
The aim of this work was to produce electrically conducting fibres with good 
mechanical properties that can be used in a final 3D structure, along with alginate 
hydrogels, in order to introduce electrical conductivity and facilitate electrical 
stimulation of the cells in close proximity to or within the gel.  
5.2 Conductive Composite Fibres from Reduced Graphene 
Oxide and Polypyrrole Nanoparticles 
5.2.1 Abstract 
Continuous composite fibres composed of polypyrrole (PPy) nanoparticles and 
reduced graphene oxide (rGO) at different mass ratios were fabricated using a 
single step wet-spinning approach. The electrical conductivity of the composite 
fibres increased significantly with the addition of rGO. The mechanical properties 
of the composite fibres also improved by the addition of rGO sheets compared to 
fibres containing only PPy. The ultimate tensile strength of the fibres increased 
with the proportion of rGO mass present. The elongation at break was greatest for 
the composite fibre containing equal mass ratios of PPy nanoparticles and rGO 
sheets. L929 fibroblasts seeded onto fibres showed no reduction in cell viability. 
To further assess toxicity, cells were exposed to media that had been used to 
extract any aqueous-soluble leachates from developed fibre. Overall, these 
composite fibres show promising mechanical and electrical properties while not 
significantly impeding cell growth, opening up a wide range of potential 
applications including nerve and muscle regeneration studies. 
5.2.2 Introduction 
Over the last three decades, significant progress has been made in achieving 
regeneration of damaged peripheral nerve tissue1-3. Much of the progress can be 
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attributed to the improvement in biomaterials and scaffolds as well as the 
increased understanding of factors that support the natural ability of the nerve to 
regenerate4-9. Mechanical properties of materials for scaffold development need to 
be selected carefully to suit the application as well as enable fabrication into 
structures of the required size and shape. The materials should mimic the natural 
tissue, guide and stimulate cells using electrical10-12, chemical13-17 and physical7, 18-
20 cues  21, 22. Fibres and fibrous structures, ranging from nanoscale to microscale, 
have been increasingly used for nerve regenerative applications as they best mimic 
the natural structure of nerves, providing guidance to the regenerating axons, 
resulting in faster reconnection of the regenerating tissue23-26. Biomaterials with 
electrical conductivity allow electrical stimulation of cells and tissues, which is 
known to have positive effects on neural regeneration, resulting in longer neurite 
outgrowth and alignment13, 26, 27. 
Polypyrrole (PPy) has been used extensively for regenerative nerve applications28, 
29. The conducting nature, simplicity of synthesis and biocompatibility of PPy has 
led to its use in triggering controlled drug delivery as well as applying electrical 
stimulation to cells and tissues. 26-28, 30-35. PPy can be synthesized via chemical or 
electrochemical polymerization, resulting in generally insoluble powders or thin 
films36. Chemical polymerization in the presence of a stabiliser produces colloids in 
the size range 10 – 100 nm37. These PPy particles can be dispersed in a number of 
solvents and mixed with other materials and matrices to form composites. In our 
previous studies a colloidal synthesis approach was utilized to form conducting 
PPy particles, which were then fabricated into PPy fibres using a simple wet 
extrusion technique38. The resulting fibres exhibited poor mechanical properties, 
no measurable conductivity and low electroactivity due to a lack of interactions 
between nanoparticles38. To increase the mechanical and electrochemical 
properties of the fibres, we have undertaken fabrication of composite materials 
containing both PPy nanoparticles and graphene. Graphene is a two dimensional, 
atomic carbon lattice with extraordinary strength and the ability to conduct 
electricity. It has been commonly used in composites with conducting polymers to 
enhance their properties39-41. Composites containing both graphene and PPy have 
found application as capacitors42-47, sensors48-50 and electrodes51, 52  
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There are different types of graphite (multi-layer stacks) and graphene (single 
layer), which exhibit a range of mechanical and electrical properties53, 54. Graphite 
oxide is highly oxidized and has oxide functional groups within its structure, which 
not only increase the distance between the layers but also make it hydrophilic and 
more dispersible in water than non-functionalized graphite55. This property 
enables graphite oxide to be exfoliated in water ultimately producing single or few 
layer graphene oxide (GO)55-57. The dispersibility of GO in both aqueous and 
organic solvents is a desirable property for fabrication of composites, as mixing 
with other materials can easily be achieved58. The oxidation of graphene results in 
a disruption of its sp2 bonding networks, and accordingly GO is an electrical 
insulator. To achieve electrical conductivity, the sp2 bonds need to be restored, 
which requires reduction of the GO53, 55-57, 59, 60. GO can be reduced using thermal, 
chemical and electro-chemical reduction, leading to the removal of oxygen-
containing functional groups and restoring most of the sp2 bonds56, 60. Reduced GO 
(rGO) can conduct electricity61, but is more difficult to disperse and has a tendency 
to re-aggregate as a result of the removal of oxygen groups53, 62. 
Two approaches to form composite materials from GO and PPy have been 
primarily used in previous studies. In one of these approaches PPy is synthesized, 
forming films, nanowires or particles, prior to mixing with GO47, 48, 63, 64. The other 
approach requires mixing of pyrrole monomer and GO prior to the synthesis of 
PPy, which is then performed in situ65-71. 
Recent work by Ding et al.67 describes the fabrication of graphene/polypyrrole 
composite fibres, using an in situ spinning approach in which pyrrole and GO are 
mixed and extruded into baths containing ferric chloride and hydriodic acid. This 
method results in polymerization to polypyrrole allowing the formation of a 
continuous fibre and reduction of GO to rGO67. 
Here liquid crystal graphene oxide (LCGO) was chosen to enhance the properties 
of PPy nanoparticle fibres over other graphene formulation because of its good 
dispersability in aqueous systems and the already established wet-spinning 
protocols available for fabrication of rGO fibres from LCGO. Furthermore it was 
hypothesized that the interactions between LCGO and PPy particles are favourable 
due to the opposing charges of the components and resulting attracting forces.  
  
Composite Fibres from Graphene and Polypyrrole | 109  
 
In the present work, we demonstrate a simple, single step wet-spinning approach 
based on mixtures of LCGO and PPy nanoparticles to produce continuous, 
conducting fibres, which exhibit large internal surface areas resulting from the 
presence of PPy nanoparticles. Furthermore we investigate the electrical, 
electrochemical and mechanical properties of the fibres as well as the cytotoxicity 
of fibres and their leachates. 
5.2.3 Experimental 
5.2.3.1 Polypyrrole Nanoparticle and Fibre Synthesis 
To synthesize PPy nanoparticle dispersions, 0.5 wt% polyvinyl alcohol (PVA, 
Sigma, molecular weight 31–50kDa) was stirred in deionised water at 80°C until 
fully dissolved. The solution was cooled to 4°C before 0.05 M of iron (III) para-
toluenesulfonate (FepTS, Sigma) was added to the PVA solution and stirred until 
dissolved. 0.1 M of pyrrole monomer (Merck, distilled) was slowly added to the 
cooled PVA solution under continuous stirring and left to polymerize and oxidize 
for 8 to 12  h before the solution was dialysed against deionized water using 
dialysis tubing (Sigma, 12 kDa molecular weight cut off). Dialysis was carried out 
for 48 h with three water changes. The particles were purified after synthesis using 
cellulose membrane centrifugation tubes (Merck) with a molecular weight cut off 
of 100 kDa. 
Fabrication of PPy fibres was achieved using previously described methods38. 
Briefly, spinning solutions were prepared by gradual addition of 12 wt% freeze-
dried PPy nanoparticles to dichloroacetic acid (DCAA). A 3D-Bioplotter 
(Envisiontec, Manufacturer Series) with a 21-gauge tip was used to extrude the 
fibres into a deionised water bath (18.2 MΩ cm-1) cooled to 10°C (Figure 5.1A). 
After extrusion, the fibres were left in the water bath until solidified, before 
washing in a series of ethanol/water solutions, (100% ethanol, 75% ethanol in 
water, 50% ethanol in water, 25% ethanol in water, 10% ethanol in water and 
water only). Fibres remained in each ethanol bath for 4 h and the final water bath 
overnight. After the final washing step, fibres were dried under vacuum at 60°C. 
5.2.3.2 rGO – Polypyrrole Composite Fibre Synthesis 
Dry expandable graphite flakes (3772, Asbury Graphite Mills USA) were thermally 
treated (at 1050°C for 15 s) before being used as a precursor for GO synthesis 
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following a previously described method58, 72. Briefly, expanded graphite and 
sulphuric acid were mixed and stirred, before KMnO4 was added to the mixture 
slowly. The mixture was transferred into an ice bath, before deionised water and 
H2O2 were slowly added to the mixture, resulting in a colour change of the 
suspension to light brown. After stirring for another 30 min, the GO particles were 
washed and centrifuged in a HCl solution, before further centrifugation and 
washing with deionised water, until the solution pH reached 5. The resulting GO 
sheets were dispersed in deionized water by gentle shaking to form a liquid 
crystalline graphene oxide dispersion (LCGO)73, 74. 
LCGO (8.7 mg ml-1 in water) was stirred overnight with PPy nanoparticle 
dispersions (100 mg ml-1 in water) to achieve final mass ratios of GO:PPy of 80:20, 
50:50 and 30:70. Wet-spinning was carried out using a rotational wet-spinning 
apparatus in a mixture of ethanol and water (70%:30%), 5 wt% calcium chloride 
and 5 wt% hypophosphorous acid with an extrusion rate of 25 ml h-1 using a metal 
spinneret (20 gauge, Figure 5.1B). Fibres were kept in the coagulation bath at 90°C 
for 4 h, before collecting and washing with ethanol as described for PPy fibres. 
 
Figure 5.1: Schematic of extrusion method of polypyrrole fibres (A) and rotation wet spinning of 
fibres containing graphene (B). 
5.2.3.3 Composite Crystallinity 
Formation of liquid crystals of GO and its composites with PPy were evaluated 
using cross polarized optical microscopy (Leica, CTR6000 and corresponding 
software LAS version 4.4.0.). A drop of each mixture was placed on a microscope 
glass slide and observed under the polarized optical microscope, operated in 
transmission mode. Images were taken at 200x magnification with the analyzer 
and polarizer perpendicular to each other. 
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5.2.3.4 Fibre Characterization 
5.2.3.4.1 Tensile Testing 
Tensile testing was performed using a Shimadzu EZ-S. A minimum of 10 samples 
were tested for each fibre type, with a sample distance of 1 cm and a sample rate of 
1 mm min-1 using a 10 N load cell. The elastic modulus was calculated from the 
linear elastic region in the stress – strain curve. The curves presented are 
representative for the test results of each fibre type. 
5.2.3.4.2 Scanning Electron Microscopy 
After tensile testing, fracture surfaces of PPy fibres were sputter-coated with 
15 nm of gold before images were taken with a JEOL JSM-7500-FA cold field 
emission gun scanning electron microscope (FEGSEM, Jeol, Germany). Fracture 
surfaces of fibres containing rGO were imaged without further surface preparation. 
5.2.3.4.3 Electroactivity and Conductivity 
Voltammetry (CV) was used to determine the electroactivity and redox potential of 
the fibres. The fibres were used as the working electrode in a standard three-
electrode set-up, using platinum mesh as the counter electrode and an Ag|AgCl 
(saturated KCl) reference electrode. All CVs were performed on 1 cm length of 
fibre in water and 0.1 M phosphate buffered saline (PBS). The potential was 
scanned between -0.8 and 0.8 V vs. Ag|AgCl at scan rates between 10 and 
100 mV sec-1. The weight of each fibre was determined and all CVs were 
normalized for the mass of the fibre. Data below shows CVs recorded at 
25 mV sec-1 in PBS. Fibre conductivity was measured for at least 15 samples from 
different batches per group using a four point probe to which the fibres were 
attached using silver paint. To investigate the stability of the conductivity, a 
constant voltage of 25 mV was applied to a 1 cm fibre length for 1 minute before a 
drop (100 µl) of PBS was added to the middle of the fibre. Changes in current were 
recorded until the current remained constant. 
5.2.3.5 Fibre Toxicity Testing 
To investigate the cytocompatibility of the fibres with L929 fibroblasts, cells were 
seeded onto the fibres as well as cultured in different concentrations of fibre 
leachates. L929 fibroblasts were routinely cultured following standard protocols 
from the American Type Culture Collection (ATCC)75. 
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Washed and dried fibres were cut into 5 mm length and sterilized (autoclaved) 
before washing in Dulbecco's Modified Eagle's Medium (DMEM, Gibco, Life 
Technologies) twice for 24 h at 37°C to wet the fibres in the cell culture media. 
Three 5 mm lengths of fibres were placed into separate wells of a 96-well plate and 
left to settle in DMEM for 4 h before L929 fibroblasts were seeded on the fibres at a 
density of 12000 cells cm-2. L929 cells were left to proliferate for 72 h without 
media changes before staining to visualize viability using calcein AM (Life 
Technologies) and propidium iodide (PI, Life Technologies) and imaged using Axio 
Vert microscope and corresponding software.  
To investigate the possibility that the fibres could release toxic products 
(leachates) that affect cell viability, L929s were exposed to different 
concentrations of leachate collected from the different fibre types. Washed and 
dried fibres were weighed and sterilized (autoclaved) before 7 day incubation in 
DMEM at 37°C and 5% CO2 at a concentration of 100 mg mL-1. After 7 days, DMEM 
was removed from the vials and the pH of the conditioned DMEM was measured. If 
pH was below 7, it was adjusted using 0.1 M sodium hydroxide as the aim was to 
investigate the effects of leachates independent of changes in pH. Conditioned 
DMEM was then filter sterilized using 0.2 μm syringe filters, before addition of 
10% Foetal Bovine Serum (FBS, Invitrogen). Cells were seeded at 5000 cells cm-2 
and left to adhere overnight, before media was removed and replaced with 
different concentrations of conditioned media (undiluted at 100 mg ml-1 fibre, and 
conditioned media diluted with cell media (DMEM, 10% FBS to 80, 65, 50, 10 and 
1 mg ml-1). A positive media-only control and a negative control of media adjusted 
to pH 2, were used, and all conditions were performed in triplicate. After 24, 48 
and 72 h of culturing cells in conditioned media, the media was removed and cells 
stained to visualize viability as described above.  
For analysis of cell viability, live and dead cell numbers were estimated using the 
cell counter macro available in ImageJ. One-way ANOVA was performed to 
determine significant differences between treatment groups (alpha level 0.05) 
using Origin Pro 9.1.0. 
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5.2.4 Results and Discussion 
We have exploited the inherent self-assembly properties of LCGO to induce liquid 
crystallinity in PPy nanodispersions in order to improve the properties of PPy 
nanoparticle fibres. LCGO was introduced into PPy nanodispersions at different 
weight ratios (LCGO:PPy: 80:20, 50:50 and 30:70). Cross-polarized optical 
microscopy images (POM) were obtained and show anisotropic, birefringence 
properties typical for LCGO (Supplementary Information Figure 5.7), while the PPy 
dispersion displays isotropic behaviour. We suggest that the small size of the PPy 
nanoparticles (50-70 nm) allows them to fit in between the LC mesogens and 
minimise any disruption of the LC phase. This allows the formation of a LC phase 
even after the addition of more than double the amount of PPy nanoparticles by 
weight to the LCGO dispersion. Fibres were successfully produced from rGO, PPy, 
80:20 and 50:50 (rGO:PPy, Figure 5.2), following preliminary wet spinning 
experiments using a Ca2+ containing coagulation bath to spin fibres from LCGO73. 
Fibres were also formed from the spinning solution with a ratio of 30:70, however 
even after extended coagulation time, the fibres were not strong enough to be 
handled when removed from the coagulation bath. The coagulation of the fibres is 
based on ionic crosslinking between the negatively charged rGO sheets and Ca2+ 
ions. The greater physical distance between the rGO sheets induced by an 
increased PPy content would decrease the degree of cross linking. Fibres produced 
from rGO, 80:20, 50:50 and PPy are uniform in diameter and were easily produced 
in continuous lengths of at least 50 cm. Fibres containing graphene were extruded 
using a 20 gauge needle (600 µm internal diameter). Resulting diameters ranged 
from 41 ± 6 µm (rGO) to 55 ± 5 µm (80:20) and 61 ± 4 µm (50:50). With more 
PPy particles present in the fibres containing graphene, less shrinking of the fibres 
is observed, supporting the hypothesis that the particles increase the spacing 
between the graphene sheets resulting in less crosslinking points. Fibres 
fabricated from PPy were 146 ± 24 µm in diameter (extruded from a 21 gauge 
needle, 510 µm internal diameter). 
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Figure 5.2: Fibres made from reduced graphene oxide (rGO, A), polypyrrole nanoparticles (PPy, D) 
and their composites (rGO:PPy) 80:20 (B) and 50:50 (C). 
5.2.4.1 Electrical and Electrochemical Properties 
The conductivity of the fibres, measured using the four-point-probe method, 
increased with increasing rGO content. PPy fibres show no measurable 
conductivity due to the non-conducting PVA shell around the particles as 
previously described38. However, the lack of electrical conductivity was addressed 
by the addition of rGO sheets into the fibres. The conductivity of the composite 
fibres increased significantly after the addition of 50 wt% and 80 wt% rGO 
(18 ± 4 S cm-1 to 20 ± 3 S cm-1), respectively. The conductivity of these fibres is 
possibly generated through the interconnected pathways created by the rGO 
sheets. An increase in PPy particle content, likely increases the distance between 
the rGO sheets, which results in a reduction of the conductivity compared to fibres 
containing only rGO (30 ± 6 S cm-1). The conductivity values reported here are an 
order of magnitude higher than measured for previously reported rGO and PPy 
fibres (~ 1.4 S cm-1)67. This can be explained by the high alignment of rGO sheets 
within the fibres, resulting from the liquid crystalline phase of the spinning 
solution. The stability of the conductivity upon hydration was investigated by 
exposing dried 80:20 fibres to PBS while applying 25 mV and recording the 
resulting current. After a droplet of PBS came into contact with the dried fibre the 
current increased briefly before dropping and finally stabilizing at around 40% of 
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the original value (Supplementary Information Figure 5.8) indicating stable, albeit 
reduced, conductivity of the fibres within a media mimicking physiological 
conditions 
Cyclic Voltammetry (CV) was performed to determine the electrochemical 
behaviour of the fibres comprised of rGO, PPy and their composites (Figure 5.3). 
The electrochemical studies using a three-electrode configuration setup 
demonstrate a highly resistive response for fibre made entirely from PPy 
nanoparticles (Figure 5.3 insert), compared to fibres containing rGO. This 
behaviour is postulated to be a result of the non-conducting PVA around the 
nanoparticles38, which makes them electrochemically inaccessible. When mixed 
with rGO, electrical conductivity is introduced into the fibres, resulting in a 
pronounced capacitive electrochemical response, however typical PPy peaks 
cannot be identified in the CVs. 
 
Figure 5.3: Cyclic Voltammetry (CV) of reduced graphene oxide (rGO, solid black) fibres, polypyrrole 
(PPy, dotted red, enlarged in insert) nanoparticle fibres and their composite fibres (rGO:PPy) 80:20 
(dashed blue) and 50:50 (dash-dotted green). CVs were recorded in a standard 3 electrode setup, 
using the fibre as the working electrode, platinum mesh as the counter and Ag|AgCl as the reference 
electrode. CVs shown here are representative and were recorded at 25 mV sec-1 against Ag|AgCl in 
phosphate buffered saline (PBS). 
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A decrease in rGO content results in less capacitive fibres, with the greatest 
capacitance observed in the 50:50 composite fibres (as demonstrated by the 
increased charging current represented by the distance between the forwards and 
backwards scan), while the capacitance of rGO and 80:20 composite fibres is 
similar. All fibres exhibit a voltage dependency of the current, indicating that 
Faradaic processes are occurring. Since the overall porosity and morphology of the 
fibres is very similar, geometric and surface area effects on the electrochemical 
response are believed to be minimal. A similar electrochemical behaviour of 
rGO/PPy composite fibres has been reported by Ding et al.67. 
5.2.4.2 Mechanical Properties 
To evaluate the mechanical properties of the composite fibres, in comparison to 
the fibres containing only PPy or rGO, tensile testing was performed on all fibres. 
Representative Stress - Strain curves (Figure 5.4) demonstrate that all fibres 
initially display a linear elastic behaviour. The strength of the fibres increased with 
an increase in rGO content. Fibres made from PPy were the weakest, with an 
elastic modulus of 0.5 ± 0.2 GPa, while the 50:50 composite fibres showed the 
greatest strength and ductility (Table 5.1). There was no significant difference in 
ductility between rGO, 80:20 and PPy fibres (Table 5.1). There is no difference in 
the elastic modulus of the composite fibres 80:20 and 50:50, showing values of 
8 ± 4 GPa and 8 ± 3 GPa, respectively. The rGO fibres show the highest elastic 
modulus (13 ± 4 GPa) and ultimate stress (175 ± 8 MPa), but a lower elongation 
at break compared to 50:50 with a maximum strain of 6.9% ± 0.3% (Table 5.1). It 
is hypothesized that the higher elongation at break of the 50:50 composite is a 
result of the composition, which could allow sliding and aligning of graphene 
sheets with the PPy particles acting as a lubricant. 
Table 5.1: Summary of tensile properties of fibres containing reduced graphene oxide (rGO), 
polypyrrole (PPy) and their composites (rGO:PPy, 80:20 and 50:50) and their conductivity. 
 
Elastic Modulus 
[GPa] 
Max Stress 
[MPa] 
Max Strain 
[%] 
Conductivity 
[S cm
-1 
] 
rGO 13 ± 4 175 ± 8   2.2 ± 0.5    30 ± 6 
80:20   8 ± 4   110 ± 20   2.5 ± 0.7    20 ± 3 
50:50   8 ± 3     90 ± 30   6.9 ± 0.3 18 ± 4 
PPy 0.5 ± 0.2   10 ± 7   4 ± 3 - 
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Figure 5.4: Stress - Strain curves of fibres containing reduced graphene oxide (rGO), polypyrrole 
(PPy) and their composites (rGO:PPy, 80:20 and 50:50). 
The comparably high variation within the PPy fibre group is most likely caused by 
defects within the fibres which have significant impact on the failure behaviour 
during tensile testing. As the fibres contain a matrix (PVA) that makes up less than 
50% of the overall mass of the fibre, small irregularities like particle 
agglomerations will introduce significant defects into the fibres. Upon addition of 
rGO to the PPy fibres, the variation within the sample groups decreases drastically, 
as the increase in mechanical properties is a result of the interactions between rGO 
sheets, which are much less affected by defects in the structure.   
In comparison to previous work the fibres described here show similar or better 
mechanical properties compared to the graphene-polypyrrole fibres fabricated by 
Ding et al.67, indicating that the incorporation of PPy results in reduced mechanical 
strength, regardless of the morphology of the PPy components. 
5.2.4.3 SEM Imaging 
SEM images of the fracture surfaces after fatal tensile testing were obtained. Figure 
5.5 shows lower (insert) and higher magnification images of all fibre cross 
sections. These images demonstrate that the PPy particles are distributed 
homogeneously both on the surface of the rGO sheets and also between the sheets. 
Sheets of graphene and spherical polypyrrole particles can be clearly identified in 
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all fibres containing either or both components. All fibres appear to be solid, with 
low porosity and homogeneous in their internal structure and distribution. 
 
Figure 5.5: Scanning electron microscopy cross section images of fibres synthesized from reduced 
graphene oxide (A: rGO), polypyrrole nanoparticles (D: PPy) and their composites at rGO:PPy ratios 
of 80:20 (C) and 50:50 (D). Cross sections were analysed after tensile testing (PPy fibres were 
sputter coated with gold to facilitate imaging). Insets show lower magnifications and are shown at 
higher magnifications. 
 
5.2.4.4 Fibre Toxicity 
To examine the cytocompatibility of the fibres, L929 fibroblast cells were seeded 
directly onto the fibres, as well as cultured in media containing fibre leachates 
(Figure 5.6).  
L929 fibroblasts seeded directly on the fibres were allowed to grow for 3 days 
before cell viability was analysed (Figure 5.6A). Cell viability was found to range 
between 98 – 99% on all samples, with no differences found in number of live or 
dead cells between the samples. Most importantly, none of the samples showed a 
decrease in viability compared to cell media (cells grown on tissue culture plastic) 
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controls. Cells were found to adhere to all types of fibres as can be seen from 
representative images shown in Figure 5.6A. 
To investigate the effect of potential leachates at higher fibre concentrations, fibre 
compositions were incubated in DMEM at 37°C and 5% CO2 to generate media 
conditioned with leached products. The conditioned media was then used to 
culture L929 cells in order to evaluate the potential toxicity of leachates from the 
fibres. Cells were exposed to varied concentrations of the conditioned media over 
periods of 1, 2 and 3 days before an estimation of live and dead cells was 
determined for each treatment group. The graph in Figure 5.6B shows the number 
of live and dead cells, exposed to the equivalent of media conditioned with low 
(1 mg ml-1), medium (50 mg ml-1) and high (100 mg ml-1) concentrations of fibres 
after 48 h (see Supplementary Information Figure 5.9 for all time points and 
concentrations). Cells were also exposed to normal unconditioned media (positive 
control) as well as a media control adjusted to pH 2 (negative control). 
After incubation of media with the different fibres, the pH of the conditioned media 
was found to range between 7 and 7.4 for rGO, 80:20 and 50:50 fibres, which is a 
slight reduction in pH compared to unconditioned DMEM (pH 7.5). This is likely 
the result of leaching of some acidic reagent from the spinning bath, however 
differences were found to be minimal so pH was not adjusted before cell culture. 
DMEM incubated with PPy fibres showed a pH of 2. To adjust the pH to 7.5, 150 µL 
of 0.1 M NaOH was added. The low pH in the conditioned media was most likely 
caused by residual DCAA in the PPy fibre after synthesis and washing. 
After 48 h, no significant decrease in number of live L929 cells was found when 
exposed to conditioned media containing leachates from 1 mg ml-1 of any fibre 
type, compared to the media-only control. Furthermore, the number of live cells 
was not reduced significantly when cultured in the conditioned media containing 
leachates from 50 mg ml-1 of composite fibres 80:20 and 50:50. 
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Figure 5.6: A: Live (green) and dead (red) cell numbers of L929 cells after 3 days of culturing on 
fibres and representative images of stained cells attached to fibres. White dotted lines mark the fibre 
outlines. B: Live (green) and dead (red) cell numbers of L929 cells after 2 days of culturing in media 
conditioned with 1 mg ml-1, 50 mg ml-1 and 100 mg ml-1 reduced graphene oxide (rGO) fibres, 
polypyrrole (PPy) fibres and composites (rGO:PPy) 80:20 and 50:50. Error bars indicate the standard 
deviation. Selected relevant significant differences are indicated (* = p<0.05, ** = p<0.01, 
*** = p<0.001) Bottom: To top graph corresponding representative images of live (green) and dead 
(red) stained cells cultured in conditioned media containing the equivalent of 1 mg ml-1 (1) and 100 
mg ml-1 (100) of each fibre type respectively. Scale represents 100 µm. 
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The number of live cells was significantly reduced when cells were cultured in 
conditioned media containing leachates from 50 mg ml-1 and 100 mg ml-1 of rGO or 
PPy fibre, or leachates from 100 mg ml-1 of composite fibres 80:20 or 50:50. 
For cells cultured in media conditioned with 1 mg ml-1 or 50 mg ml-1 of fibres 
containing rGO (rGO, 80:20 and 50:50), the number of live cells was significantly 
higher compared to cells cultured in leachates produced from 100 mg ml-1 of these 
fibres. Cells cultured in media containing leachates derived from either 50 mg ml-1 
or 100 mg ml-1 PPy fibres, showed significantly reduced viability compared to cells 
cultured in media conditioned with 1 mg ml-1 of PPy fibres. This strongly suggests 
that pure PPy fibres show significantly increased toxicity at lower doses (50 mg 
ml-1) compared to fibres containing rGO. 
It is important to note that the ratio of dead cells was very low for all samples and 
treatment groups (0.3 – 1.2% of live cells), except for cells exposed to leachates 
derived from PPy, even though the number of live cells was reduced significantly 
between and across the treatment groups. The consistently low number of dead 
cells could be caused by cells being washed off during the staining procedure. This 
effect would also be amplified by a decreased rate of cell proliferation. 
Cells cultured in conditioned media containing the leachates from 50 mg ml-1 or 
100 mg ml-1 of PPy showed 8 % and 100% dead cells, respectively. By adjusting the 
pH of the conditioned media to pH 7.5, the osmolarity of the media was changed, 
which could be a contributing factor to the high amount of dead cells. The same 
applies for the negative pH 2 control, which exposed the cells to not only a pH of 2, 
but also changes in osmolarity.  
Overall the media conditioned with composite fibres 80:20 and 50:50 seem to be 
tolerated best by L929 cells. The fibres showed no sign of degradation after being 
incubated at 37°C in media for 7 days, the media was clear and no aggregates were 
visible. The slight decrease in pH can contribute to the changes in cell proliferation 
and cell number, however it is possible that vital nutrition components, such as 
essential amino acids or vitamins and inorganic salts adhered to the fibres during 
incubation and were as a result, reduced or missing in the conditioned media. 
Furthermore, non-acidic fibre components could have leached out of the fibres and 
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affected cell metabolism. Overall the cells tolerated media incubated with more 
than 1.5 m of the fibres per ml, which exceeds the lengths usually utilized in in vivo 
applications. Nonetheless, further investigation needs to be carried out to 
determine the biocompatibility of rGO/PPy composite fibres, particularly the 
investigation of application-specific cell-type compatibility and effects on cells 
directly in contact with the fibres in vivo. 
5.2.5 Conclusions 
Composite fibres made from reduced graphene oxide (rGO) and polypyrrole (PPy) 
nanoparticles have been produced using a simple one step wet-spinning approach. 
The fibres show superior conductivities and mechanical properties compared to 
similar composite fibres reported in the literature. While fibres containing both 
rGO and PPy showed great improvements in mechanical and electrical properties 
compared to PPy fibres, composite fibres were generally inferior to rGO fibres. The 
toxicity of fibres and fibre leachates was also investigated. L929 fibroblasts 
cultured on fibres showed no significant change in cell viability or number, while 
cell viability and number was affected when cultured in high concentrations of 
fibre leachates, with the composite fibres showing the least toxicity. The high-level 
conductivity, mechanical properties as well as cytotolerance make these composite 
fibres suitable for a wide range of applications including as cell scaffolding 
components in implantable devices that involve electrical stimulation. Fibres can 
be used in the form of freestanding 3D structures that can simultaneously act as a 
scaffold and conductor for electrical stimulation.  
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5.2.7 Supplementary Information 
To investigate the crystallinity of the particle-composite solutions polarized optical 
microscopy images were taken (Figure 5.7). Anisotropic, birefringent properties 
were introduced into the solution mixtures of LCGO and PPy particles, resulting 
from the liquid crystal phase in the GO dispersion. The birefringence was present 
in all dispersions, regardless of how much PPy was present. As expected PPy 
particle dispersion showed isotropic behaviour. 
 
Figure 5.7: Polarized optical Microscope (POM) images of spinning solution of LCGO, PPy and their 
composites (8.7 mg ml-1 LCGO:PPy) in water. 
 
The stability of the fibre conductivity was analysed for the 80:20 composite fibre. A 
constant voltage of 25 mV was applied to 1 cm of dried fibre and the resulting 
current recorded. After one minute a droplet (100 µl) PBS was placed in the 
middle of the fibre without touching either of the contacts. The resulting change in 
current is shown in Figure 5.8. Before PBS was added on top of the fibre, the 
current was stable at ≈1.6 x 10-4 A. After adding the PBS the current increased to a 
maximum of 2.3 x 10-4 A within one minute and then decreased before stabilizing 
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at 0.7 x 10-4 A 30 min after addition of PBS to the fibre. To avoid evaporation of the 
droplet water was regularly (every 30 min) added to the droplet of PBS. The sharp 
increase in current is most likely resulting from the addition of a large number of 
ions which stabilizes over time. Overall a 40% decrease in current was observed, 
most likely resulting from swelling of the fibre. A decrease in current indicates a 
decrease in conductivity, which stabilizes 30 min after initial exposure to PBS. 
 
Figure 5.8: Change in current over time upon application of 25 mV along a dry 1 cm length of 80:20 
composite fibre. After the addition of 100 µl of PBS at 1 minute the current increased briefly, before 
stabilizing at 40% of the original current, indicating a decrease in conductivity upon hydration that 
stabilised after 20 min.  
Section 5.2.4.4 of this chapter discussed the effect of three different concentrations 
of leachates from rGO, PPy and their composite fibres on the cell numbers and 
viability of L929 cells at one time point (48 hrs), as well as the viability of cells in 
direct contact with the fibres.  
L929 cells were exposed to six different concentrations of fibre leachates (1 – 
100 mg ml-1) and the cell viability and number was evaluated at three time points 
(24, 24, 72 hrs). Figure 5.9 shows the results for all time points and 
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concentrations. The trends and observations discussed in detail in section 5.2.4.4 
are supported by the additional results presented here.  
 
Figure 5.9: Live (green)/dead (read) cell counts of L929 cells after being exposed to conditioned 
media at different concentrations over 1 (A), 2 (B) or 3(C) days 
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5.3 Chapter Summary 
PPy nanoparticles fibres presented in Chapter 4 have successfully been optimized 
with regards to their mechanical properties, electroactivity and electrical 
conductivity by addition of reduced graphene oxide. The toxicity of the fibres has 
been investigated and found to be minimal at low levels of exposure. The improved 
properties of the fibres and the acceptable cytotoxicity make these fibres well 
suited for incorporation into hydrogels to facilitate electrical stimulation. Here the 
toxicity was investigated using L929 fibroblasts. For the use as a conductor in 
hydrogels to facilitate electrical stimulation of cells, the toxicity of relevant 
concentrations need to be re-evaluated using neuronal cells, preferably primary-
derived cells that match the final application (e.g. sensory neurons derived from 
the dorsal root ganglion or motor neurons). 
Chapter 6 introduces the development of a new technique to facilitate the 
incorporation of filaments into three dimensional hydrogels. Building on this work, 
the 80:20 composite fibres are incorporated into 3D hydrogels and effects of fibres 
within hydrogels on cell viability assessed, as presented in Chapter 7. 
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6.1 Foreword 
After conducting fibres were fabricated as part of chapter 5, this chapter presents 
development of a new fabrication method that allows the incorporation of fibres or 
filaments into three dimensional hydrogel structures. The setup of the system is 
explained and its performance systematically analysed using a multitude of types 
of filaments. Versatility of the system and suitability for the fabrication of 
structures for nerve regenerating purposes were investigated and discussed. The 
aim of this work was to develop a simple approach to fabricate hydrogels 
containing filaments in order to deliver electrical stimulation to incorporated 
living cells. 
6.2 Cell Compatible Encapsulation of Filaments into 3D 
Hydrogels 
6.2.1 Abstract 
Tissue engineering scaffolds for nerve regeneration, or artificial nerve conduits, 
are particularly challenging due to the high level of complexity the structure of the 
nerve presents. The list of requirements for artificial nerve conduits is long and 
includes the ability to physically guide nerve growth using physical and chemical 
cues as well as electrical stimulation. Combining these characteristics into a 
conduit, while maintaining biocompatibility and biodegradability, has not been 
satisfactorily achieved by currently employed fabrication techniques. Here we 
present a method combining pultrusion and wet-spinning techniques facilitating 
incorporation of pre-formed filaments into ionically crosslinkable hydrogels. This 
new biofabrication technique allows the incorporation of conducting or drug-laden 
filaments, controlled guidance channels and living cells into hydrogels, creating 
new improved conduit designs. 
6.2.2 Introduction 
Manufacturing complex scaffolds which truly mimic natural tissue is one of the greatest 
ongoing challenges for biofabrication
1
. Critically, these structures must match the 
intrinsic geometry and functionality of the body’s environment to develop treatments 
for conditions where artificial tissues or structures are essential
1, 2
. Engineering 
scaffolds for regenerative peripheral nerve applications is particularly difficult as many 
biological, physical, and chemical requirements need to be fulfilled
3
. This challenge has 
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been outlined in a number of reviews which detail required characteristics to build an 
ideal conduit and facilitate nerve regeneration (Figure 6.1)4-6.  The ideal conduit that 
has been proposed needs to be biocompatible, biodegradable, and have appropriate 
porosity to allow exchange of fluids, gasses and nutrients, while preventing unwanted 
cells from penetrating into the structure
7
. Strategies for these conduits also include 
controlled drug and growth factor release to provide chemical cues to the regenerating 
nerve contributing to the ideal environment for regrowth
8
. Integrating conductivity 
within the conduit has additionally been suggested as a way to facilitate electrical 
stimulation of nerve cells, which has been shown to have positive effects on the 
regeneration process
9
. Further, to structurally mimic the nerve and provide guidance to 
the regenerating cells small channels or lumens need to be incorporated into the 
design
10
. Finally, inclusion of supportive cells like Schwann cells can further provide 
guidance and chemical stimulation by releasing growth factors and hence improve the 
regeneration of the nerve
8
. 
 
Figure 6.1: Characteristics of an “ideal” nerve conduit. Modified from de Ruiter et al.6. 
Efforts to address these requirements have often focused on developing material 
systems to meet one or two characteristics of the ideal conduit at a time and 
assembling them into a final structure. For instance, by electrospinning drug-
loaded silk mats and manually rolling them into a tube, Dinis et al.11 fabricated a 
slow release, multi-luminal, but non-degradable nerve conduit that closely 
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mimicked the mechanical properties and morphological structure of nerves. 
Abidian et al.12 manufactured a partially-degradable, conducting, single lumen 3D 
hydrogel conduit in a multi-step approach utilizing sputter coating, dip coating and 
electro-polymerization, as well as chemical treatments to dissolve parts of the 
construct, creating the inner lumen. A conducting pattern was created by manually 
covering parts of the structure with masking tape before electrically polymerizing 
a conducting polymer onto the surface. Lee et al.13 implanted a non-degradable, 
porous, collagen coated electrode-conduit system into a rat model and delivered 
electrical stimulation to the regenerating nerve. Using a multi-step approach our 
group has previously fabricated a conduit combining biodegradability, precise 
pore sizes, internal guidance and (uncontrolled) growth factor delivery (Quigley et 
al.14). This conduit was produced using sequential fabrication and assembly 
processes, including wet spinning, electrospinning, knitting and drop-casting of 
multiple components before manual assembly.  
The fabrication of the examples above required multiple production steps and 
manufacturing technologies and significant manual assembly. So far the design and 
manufacture of a universal platform able to integrate the ideal features into a 
single structure has been limited by currently employed fabrication techniques. A 
less complicated approach would be desirable to increase quality and repeatability 
in production of the conduits and reduce the complexity and costs of fabrication 
without compromising on the conduits performance.  
Reduced to their most basic morphological features, nerves and nerve guides or 
conduits are tubular structures and several leading fabrication approaches have 
been used to create scaffolds that conform to this general form15-17. Wet-spinning 
is a well-established, versatile fabrication technique that has been used to produce 
long homogenous bio-fibres with diameters ranging from nanometres to 
millimetres18-21. During wet-spinning, the spinning solution is passed through a 
nozzle or spinneret and into a bath that contains the material’s specific coagulation 
agent. Fibres either remain in the bath to coagulate, or more commonly are 
gathered on a collector drum after coagulation. The drum can also be used to draw 
the fibres during the spinning process, resulting in smaller fibre diameters and 
increased mechanical properties in some materials22. The cross-sectional shape 
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and size of the fibre are mainly dictated by dimensions of the extrusion nozzle, the 
extrusion rates used and the post-spinning treatment applied to the fibre.  
Commonly used materials for wet spinning bio-fibres are ionically crosslinkable 
hydrogels like sodium alginate or gellan gum. These materials can easily be wet-spun 
into fibres using calcium containing coagulation baths. Fibres produced in this way 
show biocompatibility with a range of cell types which are in contact with or 
encapsulated into the fibres. Alginate in particular, has been used frequently to 
produce viable-cell laden fibres due in part to the mild conditions under which 
fibres can be produced (aqueous systems, neutral pH, no harsh solvents or high 
temperatures)23, 24. However, these hydrogels alone cannot achieve all the features 
needed for an ideal nerve guide, as they lack inherent controllable drug or growth factor 
release as well as the presence of electrical conductivity in the bulk material for 
stimulation. As such, alginates are often combined with other materials such as 
polylactic acid and organic electrically conducting materials like conducting polymers 
or graphenes, which show excellent drug delivery profiles and electrical conductivity
25-
29
. These secondary components are easily produced in different shapes, including 
films, particles and fibres.   
In order to address the lack of inherent electrical conductivity and ability to deliver 
drugs in a controlled fashion, a novel technique has been developed, which 
combines the processability of ionically crosslinked hydrogels with the desired 
properties of secondary material components by controllably embedding pre–
formed filaments into hydrogels. This method allows not only the encapsulation of 
reliably conducting or drug releasing elements, but also enables encapsulation of 
living cells into the 3D system. Here we present the design, testing and optimization of 
the system and also showcase its flexibility by producing fibrous 3D hydrogels 
containing filaments of different materials, morphologies and geometries, placed 
controllably into a range of positions and configurations throughout the 3D hydrogel. 
Furthermore, we investigate the production of homogenous channels in the hydrogels 
by mechanically removing the encapsulated filaments as well as backfilling these 
channels with other liquids. The cytocompatibility of the fabrication method and the 
resulting 3D structures were also investigated by extruding living cells directly into the 
3D structure and analysing their viability at different time points after production. 
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6.2.3 Experimental 
6.2.3.1 Materials 
Medium viscosity alginate (AlgM, Sigma-Aldrich, Australia) and ultrapure, low 
viscosity alginate (AlgL, Pronova, USA) were used to encapsulate filaments into fibrous 
3D structures. Alginate stock solutions were prepared by dissolving the respective 
alginate powder in water at 20 mg ml
-1
. Stock solutions were kept at 4°C and used 
within 8 weeks of preparation. Spinning solutions containing less than 20 mg ml
-1
 
alginate were prepared by diluting from stock solutions. 90 mM calcium chloride 
(CaCl2, ChemSupply, Australia) was used as the coagulation solution for all 
experiments. 
The filaments used are summarized in Table 6.1 and filament specific dimensions, 
shapes, properties (roughness, hydrophobicity) and manufacturers are detailed. To 
assist the reader abbreviations for the filaments referenced throughout the article 
are also outlined. 
Table 6.1: Summary of abbreviations, materials, diameters and manufacturers of filaments used as 
part of this study. 
Abb. Material Diameter Properties Manufacturer 
SS50 316 stainless steel 50 µm circular, very smooth, hydrophilic Goodfellow, UK 
SS150 316 stainless steel 150 µm circular, very smooth, hydrophilic Goodfellow, UK 
Fe65 iron 65 µm circular, smooth, hydrophilic, degradable Goodfellow, UK 
PLA100 poly lactic acid  115 µm mostly circular, smooth, hydrophilic, degradable made in-house 
PLA+ poly lactic acid 100 µm star shaped, smooth, hydrophobic, degradable made in-house 
rGO-PPy 80% graphene  
20% polypyrrole  
150 µm mostly circular, rough, very hydrophobic made in-house 
CFT carbon fibre tow - bundle, rough, hydrophobic SGL group, Germany 
Nylon nylon fishing line 280 µm circular, very smooth, very hydrophobic Jarvis Walker, Australia 
 
Commercially available filaments were used as received, with exception of CFT 
which was manually pulled into small bundles containing 20 – 50 fibres. PLA and 
rGO-PPy composite fibres were produced in-house using either melt or wet-
spinning methods respectively. PLA fibres were produced by means of a counter 
rotating micro twin-screw extruder (Burrell Scientific, USA). The extruded 
filaments were drawn at ambient temperature to a diameter of 100 - 150 µm and 
collected on a winder.  
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rGO-PPy composite fibres were produced by using a rotational wet-spinning 
approach as described in Schirmer et al.30. The spinning solutions were prepared 
by adding PPy nanoparticles to graphene oxide dispersed in water at a weight ratio 
of 80% graphene and 20% PPy particles. Fibres were extruded through a 19 gauge 
single lumen metal spinneret at a rate of 25 ml h-1. A coagulation bath was used to 
form the fibres which contained a mixture of ethanol, acidic reducing agent and 
calcium chloride. Fibres remained in the coagulation bath at 80°C for 12 h; then 
were washed, collected and dried in air. 
6.2.3.2 Fabrication Method 
The setup for the customized wet-spinning based pultrusion method is illustrated in 
Figure 6.2A. Purpose-built, custom spinnerets with continuous through-channels to 
feed and encapsulate filaments are core to the method. A transverse section of an 
example of a spinneret accommodating four filaments is shown in Figure 6.2B. 
Filaments are passed straight through the spinnerets, while a hydrogel is fed into the 
main barrel through a separate port, resulting in the encapsulation of the filaments. A 
dual syringe pump (Gemini 88, KD Scientific) was installed vertically to extrude the 
spinning solutions at precisely controlled rates through the spinneret into the 
coagulation bath. To allow formation of the 3D structure, the coagulation bath was 
secured on a motorised linear stage to move the bath in a fixed plane relative to the 
spinneret at variable controllable speeds. Operation of the 24 V linear stage (Cool 
Muscle RCM1) was managed through proprietary control software (Cool Works Lite 
4.1.4) that provides an interface to define parameters including, position, acceleration, 
and velocity. 
Before the extrusion process was initiated, filaments were threaded through the 
spinneret, aligned, and secured within the coagulation bath using custom 3D printed 
titanium holders. The spinneret was then connected to the syringe containing the 
hydrogel solution and placed in the first position in the syringe pump. If an additional 
spinning solution was required, it was placed into the second position in the syringe 
pump and connected to the spinneret via a piece of tubing, as shown in Figure 6.2C and 
Figure 6.2D, respectively. 
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Once these steps were completed the filament was put under tension and the coagulation 
solution was filled into the bath until the horizontal barrel of the spinneret was fully 
submerged. 
 
Figure 6.2: Schematic setup of filament encapsulating extrusion system (A). B: Exemplary transverse 
section of spinneret. Insets show the respective setup for formation of gel structures containing one 
(C) or two (D) gel materials. 
The pultrusion process is illustrated in Figure 6.3. The procedure was initiated by 
starting the syringe pump and pumping the hydrogel solution from the syringe through 
the spinneret and into the coagulation bath (Figure 6.3A1-3). Once the hydrogel was 
observed to exit the spinneret, the stage was set into motion, starting with the end of the 
coagulation bath close to the front tip of the spinneret and moving to the opposite side. 
As the coagulation bath is moved away from the spinneret, the gel was continually 
extruded, surrounding the installed filament/s, forming a structure which encapsulates 
the filament/s (Figure 6.3B1-2). The extrusion and stage movement continued until the 
back end of the spinneret has reached the end of the coagulation bath, or when the 
desired length of extrusion has been reached. The extruded structure was then removed 
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from the set-up by severing at the attached end and in front of the spinneret (Figure 
6.3C1-3). 
 
Figure 6.3: Illustration of the extrusion process. A: The spinning solution is pushed through the 
spinneret and into the coagulation bath. B: While the extrusion of the spinning solution continues, the 
bath starts moving away from the spinneret, resulting in the hydrogel to be extruded around the 
filament. C: When the extrusion is completed, both stage and syringe pump are stopped and the 
extruded structure removed from the bath. 
A critical part of the assembly was the exact positioning of the filaments, which 
need to be reliably aligned with the spinneret and held under tension throughout 
the pultrusion process to ensure even encapsulation. This was achieved by 
designing a custom filament holder as shown in Figure 6.4: an array of fine holes 
(Ø 400 µm) allow filament positioning in different configurations to enable the use 
of the holder with a range of commercial and custom spinnerets. Larger holes were 
incorporated into the design to allow unimpeded fluid flow through the holder and 
prevent any baffling effect during the extrusion process. The holder rested on the 
side wall of the coagulation bath anywhere along its length and was secured in 
place by M4 screws. The filament holders were 3D printed (titanium 6-4, powder 
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of spherical particles 20-60 µm distribution in 25 µm layers) using a SLM-50 metal 
additive fabrication system (Realizer, Germany). Post-treatment of the printed 
parts to achieve a smoothened surface finish involved the removal of support 
material, bead blasting (20 µm glass beads) and bath sonication in water to 
remove loose material. 
 
Figure 6.4: Rendered view (A) and technical drawing (B) of filament holder including enlarged detail 
view of positioning of holes which hold the filaments in place. All measurements are in mm. 
The coagulation bath was folded and welded from stainless steel sheets to a length 
of 750 mm, with a width and depth of 25 mm. The length of the bath was chosen to 
use the entire moving range of the linear stage in order to maximize the length of 
filament that could be encapsulated in one extrusion event (65 cm). The width and 
depth were kept to a minimum to reduce the amount of coagulant required to fill 
the bath, in order to reduce the weight that has to be moved.  
6.2.3.3 Controllability, Reproducibility and Versatility 
Controllability and reproducibility of the system were analysed by the production of 
fibres from AlgM extruded around Fe65 at different combinations of extrusion rates and 
stage speeds. The resulting fibre diameters extruded under the same conditions were 
compared within batches as a measure of reproducibility and between fabrication runs 
to assess the instruments limitations and flexibility with respect to the hardware. 
To analyse the response of the system to changing stage speeds and extrusion rates 
different thickness gradients were produced. Gradual diameter gradients along the gel 
structure were produced by extrusion around Fe65 while manually varying the extrusion 
rates between 0.1 – 0.8 ml min
-1
 with a constant stage speed (4.8 mm sec
-1
). Abrupt 
changes in diameter were produced by varying the stage speeds during the extrusion 
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process between 3.6 – 24.1 mm sec
-1
, while keeping the extrusion rate constant 
0.3 ml min
-1
. 
To investigate the versatility of the method, a variety of spinneret designs were utilized 
to fabricate structures with different filament layouts using a range of filament sizes (50 
– 290 µm diameter), shapes and materials.  
6.2.3.4 Incorporation of Living Cells 
To incorporate cells into the conduits, the setup was sterilized and moved into a Class II 
biosafety cabinet. Instrumentation not suitable for autoclaving (syringe pump, power 
supply, stage, tubing) was sprayed with 70% ethanol. All other parts (coagulation bath, 
spinneret, holders, SS wires) were autoclaved at 121°C for 20 minutes. 90 mM calcium 
chloride coagulation solution and AlgL spinning solution diluted to 1% were filter 
sterilized using 0.2 µm sterile cellulose filters (Merck Millipore, Australia).  
The extrusion process was performed at room temperature. To decrease the period of 
time cells were exposed to ambient temperatures and maintain high viability, cells were 
suspended in gels warmed to 37°C shortly before pultrusion and transferred into media 
warmed to 37°C immediately after finishing the extrusion process. 
A PC12 cell line used in the work, was cultured by splitting routinely every two to three 
days when semi-confluent using 0.05% Trypsin (Life Technologies, Australia) 
following the protocols from the American Type Culture Collection (ATCC). Cells 
were maintained in proliferation medium containing Dulbecco’s Modified Eagle’s 
Medium (DMEM, Invitrogen, Australia), 10% horse serum (Sigma), 5% fetal bovine 
serum (FBS, Bovogen) and 2 mM Glutamine (Life Technologies).  
For incorporation in the extrusion process, PC12 cells were counted and resuspended in 
1% AlgL at a density of 5 x 10
5
 cells ml
-1
. Cell-laden gel was pipetted up and down 
several times to ensure that the cells were well dispersed within the gel, before it was 
transferred into a sterile syringe. 
For viability studies cell-laden fibres were extruded using a four lumen spinneret and 
four SS50 filaments with the stage speed set to 4.8 mm sec
-1
 and an extrusion rate of 
0.5 ml min
-1
. Cells in fibres were stained for live and dead cells (described in Section 
6.2.3.5) at 3 h, 24 h and 4 days after extrusion. 
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For fabrication of 3D gel fibres containing cells in a middle lumen and four SS50 
filaments, cells were suspended in a gellan gum microgel, which was prepared based on 
a modified bio-ink protocol31. Briefly, 0.5 ml of 1% filter sterilized gellan gum (Gelzan 
CM, Sigma-Aldrich) solution and 9.5 ml DMEM were heated separately to 80°C before 
being mixed together in a 50 ml centrifugation tube and vortexed until cooled to room 
temperature. The resulting gellan gum microspheres keep cells homogenously 
suspended in solution, which overcomes cell settling issues during the extrusion 
process. Cells were suspended in gellan gum microgel at a density of 1.5 x 10
6
 cells ml
-1
 
and extruded through the innermost needle at a rate of 0.05 ml min
-1
. A 1% AlgL 
solution was fed into the outer needle of the spinneret at a rate of 0.8 ml min
-1
, with the 
stage speed set to 4.8 mm sec
-1
. A lower alginate concentration was chosen for 
hydrogels containing cells to allow for better diffusion through the gels. 
For fabrication of triaxial fibres, cells dispersed in 2% AlgL were extruded in the middle 
lumen around one filament of SS50 at a rate of 0.05 ml min
-1
, while 2% AlgL without 
cells was extruded through the outer needle at a rate of 0.4 ml min
-1
. The stage speed 
was set to 4.8 mm sec
-1
. Alginate concentrations of 2% were used for both gels with and 
without cells to avoid different shrinkage of the gels during the crosslinking process.  
6.2.3.5 Cell Staining and Imaging 
Calcein acetoxymethyl ester (Calcein AM, Life Technologies, stock concentration: 
1 mg ml-1) and propidium iodide (PI, Life Technologies, stock concentration: 
1 mg ml-1) were used to fluorescently label live and dead cells respectively. 
Staining solutions were prepared separately by diluting Calcein AM 1:500 and PI 
1:1000 in DPBS (Dulbecco’s phosphate buffered saline, Life Technologies). Cells 
were incubated with Calcein AM staining solution for 15 minutes at 37°C, followed 
by addition of PI staining solution and 5 minutes further incubation at room 
temperature, before the Leica TSC SP5 II confocal microscope and LAS AF version 
2.6.3.8173 software were used to obtain z-slices and stacks of fluorescently 
labelled cells cultured in 3D gels. Numbers of live and dead cells were counted 
using the cell counting plugin of ImageJ software. 
6.2.3.6 Imaging and Microscopy 
Brightfield microscope images were taken using a Leica DM IL LED (Germany) 
with LAS software version 4.0. A confocal microscope (Leica TSC SP5 II) was used 
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to image cells and obtain digital micrographs. Scanning electron microscopy 
images of gel cross-sections were obtained after freezing and sectioning the 
samples in liquid nitrogen. Imaging was performed using a low-vacuum JEOL JSM 
6490LV. 
6.2.4 Results and Discussion 
6.2.4.1 Controllability, Reproducibility and Flexibility 
To evaluate the controllability and reproducibility of gel fibre diameters resulting 
from the extrusion process, AlgM was extruded around a single Fe65 filament using 
the coaxial spinneret. The extrusion rate was set to 0.3, 0.5 or 0.7 ml min-1 
respectively with stage speeds varying between 2.4 – 21.6 mm sec-1. Four stage 
speeds were used per extrusion event over the length of 65 cm, with each speed 
held for a distance of around 15 cm. To distinguish between stage speeds a small 
low speed phase (stage speed 1.2 mm sec-1 over 1 cm) was introduced between 
each speed section (Figure 6.5A).  
The order in which stage speeds were used along the length of each extrusion 
event was selected randomly to eliminate the potential influence of previous 
speeds on the resulting gel diameter. All combinations of stage speeds and 
extrusion rates were repeated three times in varying combinations of speeds per 
extrusion event. Once the extrusion was completed, the extruded gel was 
separated into one piece per speed section that was cut into five pieces each. 
Images were taken using the Leica M205A microscope with LAS 4.0 software. On 
each section, the diameter was measured in three locations (towards each end and 
in the middle) using ImageJ. The data of all sections produced using the same 
parameters were pooled together and analysed. 
As expected, the fibre diameter decreases with a reduction in extrusion rate and an 
increase in stage speed, as shown in Figure 6.5D. The diameters of gels extruded at 
the same extrusion rates follow a power function. At lower stage speeds an 
increase therefore results in a significant reduction of the extruded gel diameter. 
At higher stage speeds, an increase of the speed still results in a reduction of fibre 
diameter, albeit a much smaller one.  
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As can be seen from the small errors, the variation in gel diameter was minimal, 
averaging 3 ± 0.9% of the measured diameter. For fibres extruded at a rate of 
0.3 ml min-1 the deviation of diameters was the largest, averaging 3.8 ± 0.7%, 
while diameters of gels extruded at 0.5 ml min-1 and 0.7 ml min-1 showed a 
deviation of 2.6 ± 0.9% and 2.9 ± 0.5% respectively. The difference in consistency 
of the fibres could be a result of better or poorer match of extrusion rates for the 
spinneret. If the extrusion rates are well matched to the flow area of the spinneret, 
the gel can form evenly around the fibre, without causing disruptions or 
disturbance at the exit of the spinneret, resulting in a more homogenous gel 
encapsulated fibre. Images B – D in Figure 6.5 show examples of the fibre 
diameters that can be achieved with the same spinneret, by varying the extrusion 
rate and stage speed. Without sacrificing precision and uniformity, a wide range of 
desired gel diameters can be produced. 
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Figure 6.5: Speed over distance diagram illustrating the method (A) used to produce fibres of 
different diameters within one extrusion event, using four different speeds (S1 – S4 (A)) while 
applying a constant gel extrusion rate. The short low speed sections between the constant speeds are 
implemented to distinguish between the applied speeds in the finished extrusion as illustrated in B. 
C: Representative images of the resulting gel sections produced in one extrusion event. Gel 
encapsulated fibre diameter as a function of the stage speed (D) at three extrusion rates (0.3, 05 or 
0.7 ml min-1). 
 
By keeping either the extrusion rate or the stage speed constant and varying the 
other, gel structures with thickness gradients like those shown in Figure 6.6 can be 
created. Keeping the stage speed constant and applying a variety of extrusion rates 
throughout the extrusion event will lead to the formation of gentle gradients in the 
overall diameter of the gel fibre. To create more abrupt changes in diameter the 
extrusion rate is kept constant, while the stage speed is varied. As shown in Figure 
6.6B the average distance over which the diameter change can be created is 
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around 3 mm with an extrusion rate of 0.3 ml min-1. Over this distance the fibre 
diameter can be halved or doubled by applying stage speeds with a difference of 
15 – 18 mm sec-1. The distance over which the fibre diameter changes can be 
tailored by changing the extrusion rate (lower rates will lead to a shorter 
distance). The difference in fibre diameter is controlled by the difference between 
the stage speed settings (larger differences will lead to a larger change in 
diameter). 
 
Figure 6.6: Thickness gradients of gel around a 50 µm stainless steel wire resulting from A: varying 
extrusion rates (0.3 – 0.7 ml min-1, distance between measurements 11 mm) used throughout the 
extrusion process with a constant stage speed (speed 4.8 mm sec-1) and B: through a constant 
extrusion rate (0.3 ml min-1) and varying stage speeds (2.4 – 21.6 mm sec-1). 
 
By using one spinneret and one type of filament, a large variety of fibrous 3D 
structures can be produced in a very controlled fashion. Gel diameters from 0.4 - 
2 mm can be fabricated readily, in single or multiple extrusion events, creating 
consistent and gradually or rapidly increasing or decreasing sizes. 
6.2.4.2 Versatility 
To further expand and explore the versatility of the system a range of spinnerets were 
studied. All spinnerets were custom fabricated (Rame Hart Instrument, USA). Fibre 
images in Table 6.2 show that high complexity of the hydrogel structures can be 
achieved by changing the spinneret design, allowing for positioning of filaments 
virtually anywhere within the gel. The number of encapsulated filaments can be 
varied, however limitations apply eventually, as the spacing between the filament 
carrying needles needs to be sufficient to allow unimpeded flow of gel around each 
filament. If gels of lower viscosity are used this spacing can be smaller, compared 
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to application where a high viscosity spinning solution is required. The ideal 
design needs to be evaluated on an individual basis taking into consideration the 
range of viscosities of spinning solutions, desired overall diameter of the structure 
as well as coagulation speed of the spinning solution. 
Table 6.2 summarises each spinneret’s dimensions and resulting gel structure layouts. 
The overall gel diameters that can be achieved depend on the spinneret dimensions, the 
extrusion rate at which the gel is passed through it and the speed at which the stage is 
moved. 
The incorporation of different materials in a controlled fashion was of particular 
interest when developing the system for the fabrication of improved artificial 
conduits. As a result of this, spinnerets with up to three different inlet ports have 
been custom built, allowing the incorporation of fibres and two different gel or 
liquid compositions. Using this approach, cells can be placed into a separate part of 
the structure, which allows the creation of a better suited environment using softer 
and more porous gels, while the other part of the structure, made of a stronger gel, 
holds the filaments and maintains structural integrity.  
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Table 6.2: Overview of spinneret designs, dimensions (OD: outer diameter, ID: inner diameter), 
examples of resulting conduit structures, parameters for fabrication and spinneret limitations. 
Extrusion conditions are given in stage speed (mm sec-1) and extrusion rate (ml min-1). 
Spinneret 
Needle Gauge 
(OD/ID mm) 
Structure 
Layout 
Example of 3D 
structure 
Materials and 
Extrusion conditions 
Possible Layout and Size 
Spectrum 
 
17 
(1.47/1.07) 
24 
(0.57/0.31)  
 
2% AlgM 
SS50 
11.9/0.5 
1 filament, centered 
100 µm – 2 mm 
 
14 
(2.11/1.60) 
27 
(0.41/0.21)  
 
2% AlgM 
2 PLA115 
2 SS50 
4.8/0.8 
1 - 4 filaments, off centre 
1 – 3 mm 
 
12 
(2.77/2.16) 
27 
(0.41/0.21)  
 
2% AlgM 
5 Fe65 
4.8/1.2 
1 – 5 filaments, off centre 
1.5 – 4 mm 
 
13 
(2.4/1.8) 
27 
(0.41/0.21)  
 
1% AlgL 
4 SS50 
4.8/0.8 
Gellan Gum Microgel 
with PC12 cells 
4.8/0.05 
up to 2 gels 
1 filament, centered 
1 – 4 filaments, off centre 
1.5 – 3.5 mm 
 
17 
(1.5/1.1) 
21 
(0.82/0.51) 
28 
(0.36/0.18) 
 
 
2% AlgL 
4.8/0.4 
0.5% GG + PC12s 
4.8/0.05 
SS50 
 
up to 2 gels 
1 filament, centered 
200 µm – 2 mm 
 
Filaments made of different materials with a variety of sizes and surface finishes 
have been incorporated into coaxial gel fibres to investigate the versatility as well 
as limitations of the system with regards to the filaments that can be encapsulated. 
Figure 6.7 shows a selection of filaments which were successfully embedded into 
alginate. The lumen diameter of the inner needle of the coaxial spinneret has a size 
of 310 µm, allowing filament of a size of up to 300 µm to be fed through. Single or 
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multiple filaments in a size range of 50 – 150 µm, of hydrophobic or hydrophilic 
materials with smooth and rough surfaces were embedded into homogenous gel 
layers. This included SS50 (Figure 6.7A-B), SS150, PLA150 (Figure 6.7C-D), rGO-PPy 
(Figure 6.7E-F) and multi filament CFT (Figure 6.7G-H). The encapsulation of 
280 µm Nylon was not successful. During the extrusion process a continuous 
fibrous gel of alginate was formed, however it was not attached to the filament, nor 
encapsulating it. As encapsulation of other hydrophobic filaments was achieved, 
the large diameter in relation to the needle size or a combination of the large 
diameter and the hydrophobic behaviour of the filament are most likely to have 
prevented the encapsulation with gel. This could be addressed by applying a 
surface treatment to the filaments to increase their hydrophilicity or by 
roughening the surface. Overall a broad range of filaments was successfully 
encapsulated into alginate, including rough, weak filaments (rGO-PPy), smooth, 
elastic filaments (PLA115) and bundles of very fine filaments (CFT), which, 
depending on the filament, introduce properties such as electroactivity, 
conductivity and controlled drug release into the 3D hydrogel. 
 
Figure 6.7: Filaments of different size, materials and surface structure that have been encapsulated 
into alginate gel. A&B: SS50, 11.9 mm sec-1/0.5 ml min-1; C&D: PLA150, 4.8 mm sec-1/0.5 ml min-1; E&F: 
rGO-PPy, 4.8 mm sec-1/0.5 ml min-1, G&H: CFT, 4.8 mm sec-1/0.5 ml min-1. 
 
The method also allows for a range of filament shapes to be incorporated. Not only 
filaments with a circular cross section and homogenous axial diameter can be 
encapsulated into gel, but also filaments with an irregular axial diameter as well as 
fibres with cross sections different from circular shape. To demonstrate this capability, 
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three SS50 filaments were manually braided before being fed through the coaxial 
spinneret. 1% AlgM was extruded around the braided filaments at an extrusion rate of 
0.5 ml min
-1
 and stage speed set to 4.8 mm sec
-1
 (Figure 6.8A-B). Incorporation of a 
hydrophobic filament will lead to the formation of a hollow lumen around the filament, 
resulting from a lack of interaction between the hydrogel and the filament. As shown in 
Figure 6.8C-D a hydrophobic star-shaped PLA filament was embedded into the 
hydrogel creating a lumen around the filament. The same result was observed for PLA 
filaments with a circular cross section. In contrast no hollow lumen was observed when 
hydrophobic CFT or rGO-PPy were encapsulated, which is most likely a result of the 
rough and uneven surface topography of these filaments. Furthermore intermolecular 
forces will determine whether a hollow lumen is formed around a filament or alginate 
gel coagulation is achieved at the surface of the filament.  
To further increase the versatility and areas of application of the extruded structures, 
filaments were encapsulated into alginate and removed following the extrusion process, 
leaving empty or backfilled channels of controlled size and shape (Figure 6.8D-H). To 
backfill the gel channels the encapsulated filament was removed while the structure was 
submerged into a dispersion of spherical 50 nm sized polypyrrole particles (Figure 
6.8G), or a suspension of PC12 cells in cell culture media (Figure 6.8H). The 
maximum length that was backfilled as part of this work was 50 cm. 
The diameter of the channels is dictated by the size of the filament encapsulated. 
Removal of filaments is uncomplicated as long as the hydrogel does not adhere to the 
surface of the filament. SS filaments with a diameter of 50 – 150 µm were successfully 
removed from extruded alginate fibres. Channels formed by 50 µm filaments show 
smooth and evenly spaced walls, with the diameter within 2µm of the filament diameter. 
When removing the 150 µm filament the resulting channel had rougher walls, which 
were up to 25 µm larger than the filament. As a result of their thickness, the 150 µm 
filaments are stiffer compared to the 50 µm filaments. In the case of the 150 µm SS 
filaments the structure of the gel was dictated by the shape of the filaments as opposed 
to the shape of a gel, i.e. a filament that is not absolutely straight, but instead slightly 
curved as a result of being stored on a spool, will cause the gel to follow the same curve 
as the filament if the filament is stronger than the extruded hydrogel. That is the case 
when the SS150 filaments are embedded in the hydrogel. When removing these filaments 
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from the gel the channels become distorted as the filament does not bend with the gel 
during removal. This also causes the rougher surface on the inside of the channels, as 
the relatively sharp end of the filament scratches along the walls, leaving them with a 
rough texture.  
When backfilling the channels while removing the SS150 filament, these effects were 
observed to be less pronounced. This could be a result of the added lubrication from the 
liquid that is drawn into the channel. Channels produced using SS150 filaments were 
uncomplicated to backfill with aqueous based solutions containing nanoparticles 
(50 nm) or PC12 cells (10 – 20 µm).  
 
Figure 6.8: Structural versatility of extruded hydrogels containing filaments. A&B: 3 manually braided 
SS50 filaments embedded into 2% AlgM (4.8 mm sec-1/0.4 ml min-1). C&D: PLA+ filament embedded 
into 2% AlgM (4.8 mm sec-1/0.5 ml min-1). E&F: 2 SS50 and 2 SS150 encapsulated into 2% AlgL and 
removed after extrusion. White arrows indicate the 4 resulting channels. G&H: Backfilling of 2% AlgL 
extruded gels by removing the SS150 filament as the structure was submerged into either a dispersion 
of spherical 50 nm sized polypyrrole particles (G) or a suspension of PC12 cells in cell culture media 
(H). 
 
The ability to backfill size-controlled channels within the fibrous 3D hydrogel 
structure opens up a different level of versatility. On one hand this method has the 
benefit of creating very homogenously sized channels, as well as much smaller 
channels than those that can usually be achieved in traditional coaxial wet-
spinning approaches. These utilise lower concentration of coagulant or plain water 
to inject into the spinning process creating coagulant or water filled channels 
within the gel. Additionally this new technique creates the possibility of backfilling 
the channels with materials or cells that cannot be incorporated into the wet-
spinning process due to incompatibility with the coagulant or the un-crosslinked 
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spinning solution. Furthermore, it allows more versatile use of one spinneret 
configuration as no sealed syringe attachment ports are required to inject the 
solution during the spinning process.  
6.2.4.3 Cell compatibility of Filament Encapsulation 
PC12 cells were encapsulated into alginate gel which had been extruded around 
four SS50 filaments. The viability of the cells was analysed at three time points after 
the extrusion by selectively staining live and dead cells. As can be seen from the 
graph in Figure 6.9A, the viability of the cells was above 90% for all time points. 
The low percentage of dead cells at 3 h (5 ± 2%) after the extrusion indicates that 
the extrusion process itself is cell compatible and does not induce cell death due to 
unfavourable conditions. After culturing the cell-filled construct for 4 days, the 
viability was still observed to be in a normal range (94 ± 3%), indicating that the 
cells are sufficiently supplied with nutrients over the period tested. As can be 
observed from the average live cell numbers at each time point, proliferation of the 
cells is limited, with no increase in cell number observed between 24 h and 4 days 
of culturing post fabrication. This is a phenomenon that has previously been 
observed with cells encapsulated in alginate32.  
 
Figure 6.9: Alginate encapsulating PC12 cells and four 50 µm stainless steel wires. A: Number of live 
(green, diagonal lines) and dead (red, vertical lines) cells, with the percentage of dead cells. B: 
alginate encapsulating cells (round dots) and filaments (black lines). 
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The lack of cell binding motifs and the dense encapsulation lead to inert cell 
behaviour where cells are viable and metabolically active, without showing any 
signs of adhesion, proliferation or differentiation. The lack of attachment to 
encapsulating gels can be mitigated by chemically modifying the alginate gel with 
cell adhesion-promoting peptides, utilizing a different material composition or 
encapsulating the cells in a different part of the structure using a softer, more 
porous hydrogel. 
6.2.5 Conclusions 
Here we have presented a reliable semi-automated method to create a variety of 
3D fibrous structures that are based on filaments encapsulated within hydrogels. A 
wide range of filaments (size, shape, material) can be embedded controllably into 
positions throughout the hydrogel. The positioning, number of filament elements 
and overall size of the structure are mostly dependent on the spinneret design, 
however diameters can be varied greatly by adjusting the extrusion rate of the gel 
as well as the speed at which the stage translates, allowing high controllability 
while offering versatility within one setup. Further potential applications are 
opened up by removing filaments from the gel, creating precisely sized channels 
which can be left empty or backfilled with other solutions including those 
containing living cells or particles. When used with alginate and a calcium bath as 
the coagulant, this method shows great cytocompatibility with cells extruded 
straight into the structure. 
The method introduced here can address the difficulties of bringing all desired 
properties for the “ideal” nerve conduit together in one structure (Figure 6.10). 
The overall size of the extruded gel is within the range required for use as a 
conduit and can be varied on demand. The porosity of the structure can be tailored 
by choosing the right material configuration and supported by the incorporation of 
hollow channels within the gel, controlled drug release can be achieved by 
incorporating drug laden fibres or spheres, electrical conductivity and 
electroactivity can be introduced using fibres from organic conducing materials or 
other inherently conducting materials. Physical guidance for regrowing nerve 
fibres can be provided by small encapsulated filaments or channels that are 
created by the removal of filaments. The incorporation of living cells can either be 
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achieved by introducing the cells into the gel during the extrusion process, or 
backfilling them into channels by removing the filaments. 
 
Figure 6.10: Schematic of nerve conduit deigns achieved through use of the developed technique. 
 
Overall, if a lower level of controllability is sufficient for the desired application, 
this setup can be simplified and built up in an inexpensive manner using less 
sophisticated hardware with respect to the stage and syringe pump. 
Miniaturization of the system is again possible if a more portable build is desired. 
Furthermore we envision that this technique can be of use to other fields outside of 
peripheral nerve regeneration where fibrous hydrogels with controlled features 
and properties are required, including actuation in the field or artificial muscles, 
general microfluidics applications and the broader field of regenerative tissue 
engineering.  
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6.3 Chapter Summary 
This chapter introduces the development of a new technique to facilitate the 
incorporation of filaments into three dimensional hydrogels. The system was 
designed, built, tested and optimized to use live cells in the process. Different fibre 
designs and layouts were explored with a focus on fulfilling the structural and 
material requirements to facilitate nerve regeneration. The viability of cells 
incorporated into the hydrogels was found to be high, however not proliferating. 
The work described here builds the foundation of further studies into the 
stimulation of cells within the construct.  
In Chapter 7, structures were designed using the method introduced here and 
analysed for thier ability to allow cell differentiation and a setup to allow electrical 
stimulation of cells within the hydrogels containing filaments is developed and 
tested.  
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Chapter 7 
Chapter 7: DELIVERING ELECTRICAL 
STIMULATION TO CELLS IN 3D  
7.1 Foreword 
In this chapter the method described in Chapter 6 was analysed for its suitability 
to produce 3D hydrogels containing live cells and conducting elements for 
electrical stimulation of cells. The aim was to optimize the 3D structure to support 
cell differentiation before developing a method to address the conductors within 
the gels. Sections 7.2 and 7.3 present an introduction to the topic and the 
experimental details. Sections 7.4.1 and 7.4.2 concern the analysis and 
optimization of cell differentiation within the 3D hydrogel. In Section 7.4.3 the 
electrical and magnetic fields resulting from stimulation through the conducting 
filaments were modelled. The facilitation of electrical stimulation within the 
hydrogels and a proof of concept are presented in Section 7.4.4. Overall 
conclusions are presented in Section 7.5. 
7.2 Introduction 
Electrical fields, currents and potentials naturally occur within the body and are 
known to be responsible for influencing a variety of functions and signalling 
processes1, 2. Electricity plays a vital role in the central and peripheral nervous 
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system, especially in signal transmission and communication between cells, tissues 
and organs3. Electrical fluxes within and around nerve cells, called action 
potentials, accompany activities in axons. The effects of electrical stimulation on 
cells and peripheral nerve show a great deal of variation in the literature, with no 
consensus on how exposure to electrical stimulation affects tissues. It is 
challenging to compare research results as stimulation parameters, cell types and 
sources, electrode materials and stimulation set ups are not standardized and vary 
greatly within and between research groups (an overview of studies performed 
between 2010 and 2015 can be found in Table 1.2 in Chapter 1). Despite this, many 
reviews have included the presence of electrical activity as a desirable feature 
alongside the right material and mechanical properties, porosity, structural 
features, topographical cues, supportive cells and growth factors when designing 
an “ideal” artificial nerve conduit3-8.  
Even though in situ nerve regeneration occurs in three dimensions (3D), very few 
in vitro electrical stimulation studies have been performed on nervous tissues or 
nerve cells in 3D9. Stimulation in vivo occurs naturally in 3D, however control of 
the environment is very difficult. As a result of this and the varying experimental 
set ups, comparison of results between studies is rarely possible. Studies 
performed in vivo apply electrical stimulation either before or for short periods 
after the nerve reconstruction or placement of a conduit structure5, 6, 10-12. 
Stimulation is routinely applied to the damaged nerve directly, rather than through 
the conduit, which is potentially a more invasive approach and limits the 
application of electrical stimulation to the time of surgery, as it requires (mostly 
metallic) electrodes to be inserted into or in direct contact with the tissue. Some 
conduits manufactured from conducting materials have shown improved 
outcomes after sciatic nerve damage in vivo without the application of electrical 
stimulation13.  
The discrepancy between in vitro and in vivo investigations calls for development 
of conducting 3D conduits suitable for use both in vitro and in vivo in order to 
further analyse and validate the necessity for conducting elements and electrical 
stimulation in nerve regenerative applications. 
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Various materials have been used as electrodes to deliver electrical stimulation to 
nerves and nerve cells in vitro and in vivo, including tungsten14, stainless steel15-17 
and platinum18 as well as different conducting polymers6. Since biocompatibility 
and biodegradability are critical requirements of artificial nerve conduits, 
conductors need to be selected carefully. Organic conductors like polypyrrole 
(PPy) have been studied intensively for delivery of electrical stimulation to cells in 
vitro19-22 and used for fabrication of conducting conduits for in vivo studies23. 
Apart from being conducting PPy also shows some antioxidant properties, which 
makes it an attractive substrate as it could scavenge free radicals at the site of 
injury and minimize scar formation24. If synthesised as a co-polymer with 
degradable polymers PPy can be produced in such a way that it is biodegradable19, 
25. Electrically conductive fibres can be fabricated readily from PPy and graphene 
as well as composites of both, making them good candidates for the incorporation 
into 3D hydrogels.  
The fabrication method introduced in Chapter 6 facilitates the production of 
hydrogel based filament and cell laden 3D fibrous structures. It allows 
incorporation of conducting filaments to facilitate electrical stimulation of 
encapsulated or nearby cells. The cells used for this body of work are PC12 cells. 
This cell line was selected as the effects of electrical stimulation on the extension of 
neurites has been explored thoroughly and there is common understanding in 
literature that PC12 cells electrically stimulated in 2D will show increased 
sprouting21, 26. Furthermore several studies on 3D cell encapsulation have been 
performed on PC12 cells, showing high viability of the cells27, 28. 
The goal of this chapter is to utilize the method described in Chapter 6 to fabricate 
3D structures containing conducting filaments as well as living cells, and to 
facilitate electrical stimulation of these cells within the 3D hydrogel. More 
specifically the pultrusion method introduced in chapter 6 will be tested and 
modified to support neural cell differentiation within the 3D structure. The 
suitability of the graphene-polypyrrole filaments produced in Chapter 5 for 
incorporation into the 3D hydrogel was evaluated. The electrical and 
electromagnetic fields resulting from different stimulation modes were analysed 
and discussed. A setup was designed and manufactured to allow electrical 
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addressing of the conducting filaments within the gel before electrical stimulation 
of 3D structures containing cells was performed as a proof of concept.  
7.3 Experimental 
7.3.1 General Cell Culture, Dissection Procedures and Staining Protocols 
PC12 cells were cultured and split routinely as described in Section 2.4.1.1. To 
induce differentiation, cells were exposed to differentiation media containing 
Nerve Growth Factor (NGF). 
7.3.1.1 Dorsal Root Ganglia Dissection 
All animal work was approved and performed in accordance with the Animal 
Ethics Committee (AEC, #13/04), University of Wollongong. Primary cells were 
harvested from BALB/cArcAusb mouse (Australian BioResources, NSW) pups at 
postnatal days 3 or 4. The pups were removed from their mother, transferred to a 
laminar flow hood, where they were sprayed with 70% ethanol prior to 
decapitation. Sterile instruments were used to decapitate pups and bodies were 
placed in a petri dish containing cold Leibovitz's L-15 media (L-15, Life 
Technologies) on an ice block. Each body was moved to a new petri dish containing 
cold L-15 media under a stereomicroscope, and dorsal root ganglion (DRG) 
explants were dissected from the spinal cavity. Dissected DRGs were then placed in 
a third petri dish containing cold L-15 media. DRG explants were trimmed of 
excess nerve and then either used whole or dissociated. For dissociated DRGs, 
explants were collected into 2 ml warm L-15 media, then collagenase (Sigma-
Aldrich) was added and the solution incubated at 37°C for 30 min. Once the DRGs 
began to dissociate, they were triturated with a glass pipette prior to the addition 
of 2 ml of fetal bovine serum (Gibco). This solution was then centrifuged at 800 x g, 
the supernatant discarded, and the cell pellet resuspended in Neurobasal media 
(Gibco) supplemented with 2v/v% B27 neural supplement (Gibco), 1v/v% 
Glutamax and 1v/v% penicillin/streptomycin (Gibco). Cells were then counted and 
used as required. Media was changed every two to three days as required.  
7.3.1.2 Cell Staining  
To assess viability, cells were stained with Calcein AM (Calcein acetoxymethyl 
ester) and PI (propidium iodide) as described in Section 2.4.2.1. 
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Immunofluorescence staining was performed to visualize differentiation of cells 
using βIIIT (beta-III-tubulin), GAP43 (Growth Associated Protein 43) and DAPI 
(4′,6-Diamidin-2-phenylindol). The cells cultured in 3D hydrogels were fixed, 
permeabilized and blocked as described in Section 2.4.2.2. All washing steps and 
storage were performed in DPBS to avoid decrosslinking of the hydrogels. The 
incubation times used for cells analysed within 3D gels were increased to allow 
extra time for diffusion through the hydrogels. The primary antibodies were 
incubated for 12 hours and the secondary antibodies were left to incubate for 6 - 8 
hours. DAPI staining was performed over 60 minutes.  
7.3.2 Production of Hydrogel Structures  
3D hydrogel Fibres were produced by utilizing either a single lumen or coaxial 
wet-spinning approach, or the method described in Chapter 6 with gels containing 
1 or 4 conductive filaments. Table 7.1 summarizes all spinnerets, gels and 
filaments used and their respective abbreviations used from here on, as well as 
illustrations of 3D hydrogel structures fabricated using each spinneret. 
Table 7.1: Summary of spinnerets, hydrogels and filaments used for formation of four different 3D 
hydrogel structures. 
Spinnerets 
   
3D Gels solid coaxial single filament four filaments four filaments 
+ cell channel 
 
     
Hydrogels Abbreviation Manufacturer 
Ultrapure Alginate AlgL Pronova, USA 
Alginate with RGD peptide  AlgRGD Novatech, USA 
Gellan Gum GG Gelzan CM, Sigma-Aldrich 
GG micro-dispersion / ink GGink made in house: Chapter 2 
developed by Ferris, et al. 29 
GGink with 40 µg ml-1 laminin GGLam made in house: this chapter 
Filaments Abbreviation Manufacturer 
50 µm stainless steel SS50 Good Fellow, UK 
80% graphene – 20% polypyrrole  rGO-PPy made in house: Chapter 5 
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Production of Solid and Coaxial Fibres and 3D Gels Containing a Single Filament 
For extrusion of solid fibres, cells were suspended in AlgL or AlgRGD and extruded 
only through the outer needle of the coaxial spinneret using a flow rate of 
0.3 ml min-1. To form a coaxial fibre with cells in the central lumen only the cell 
suspension (in DMEM, GGink, or GGLam) was extruded through the inner needle of 
the coaxial spinneret, while a sheath of AlgL was created on the outside with flow 
rates set to 0.3 ml min-1 on the outside and 0.08 ml min-1 on the inside. To produce 
a solid fibre around a single conductive filament extrusion was performed around 
(rGO:PPy) with cells suspended in AlgL. The stage speed was set to 4.8 cm sec-1 and 
a flow rate of 0.3 ml min-1 was used. The initial cell density used was 
3 x 106 cells ml-1, which was optimized to 1.8 x 106 cells ml-1 throughout the course 
of this study.  
 
Production of 3D Gels Containing 4 Filaments 
Alginate structures containing four SS50 filaments and cells throughout were 
produced by suspending the cells in AlgL and extrusion around the four filaments 
with the stage speed set to 4.8 mm sec-1 and the extrusion rate set to 0.6 ml min-1 
using a 4-lumen spinneret. 
 
Production of 3D Gels Containing 4 Filaments and a Cell Channel 
Alginate structures containing four SS50 filaments embedded into alginate with a 
core of cells suspended in GGink or GGLam were produced by using the 5x-lumen 
spinneret with an inner extrusion rate of 0.05 ml min-1 and an outer rate of 
0.9 ml min-1, with the stage speed set to 4.8 mm sec-1. 
Initially all hydrogel structures were transferred straight into cell culture media 
after production. This has been found to leave granular looking residue within the 
channels containing GGink or GGLam as well as in the culture wells. To address this 
issue, hydrogels were briefly passed through a bath of sterile water to remove 
excess coagulant before being transferred into culture media.  
7.3.3 Design and Fabrication of Cell Well Plate and Stimulation Device 
A mould to accommodate and electrically address the gel structures and their 
embedded filaments was developed, tested and optimized. Parts were 3D printed 
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from MED610, titanium or RGD5160-DM and post-treated as described in 
Section 2.5.5.1. Silicone (PDMS, Sylgard 184, Dow Corning) gaskets and seals were 
produced by casting films of the desired thickness into moulds with a ratio of 
material to hardener of 6:1. The material and hardener were mixed thoroughly, 
before being degassed under vacuum and then poured into the mould. PDMS filled 
moulds were then placed under vacuum again until all bubbles were removed, 
then films were heated up to 70°C and allowed to cure. The PDMS films were then 
laser cut into desired layouts using a laser cutter (described in section 2.5.5.2, 
settings: Power: 40%, Speed: 12%).  
The performance of different mould designs was tested with respect to the moulds 
ability to seal and contain fluids, chemical inertness, hydrophobicity, ease and 
feasibility of assembly (containing hydrogel-filament-cell constructs under sterile 
conditions) and their ability to be sterilized and lastly their durability. Once fully 
assembled, the stimulation setup was analysed for reliably in electrically 
addressing the filaments, electrical isolation between the wells as well as ease of 
disassembly and separation from the well plate in order to facilitate unimpeded 
optical microscopy without disruption of the gel structures.  
7.3.4 Modelling of Electric and Electromagnetic Fields 
The electric and electromagnetic fields resulting from stimulation of the filaments 
were modelled using the software COMSOL (version 4.3) with its AC/DC module. A 
hydrogel structure containing a channel of cells in the centre, surrounded by four 
conducting filaments (each 50 µm in diameter) was modelled to represent the 
structure of the 3D hydrogel as shown in Figure 7.1. The modelled structure has a 
length of 20 mm with an overall diameter of 2 mm and is surrounded by a volume 
representing the cell media with a size of 8 x 8 x 20 mm, which is equivalent to the 
dimensions of the wells which are used to stimulate the cells. 
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Figure 7.1: Representative hydrogel structure (A) and corresponding model for modelling of electric 
and electromagnetic fields (B). Dimensions are in millimetre.  
The outside borders of the volume body were defined as insulators. The wire 
material was defined as stainless steel 316 (from materials library with relative 
permittivity 1 and relative magnetic permeability 850) and all other bodies were 
defined as DMEM (based on water from materials library with electrical 
conductivity 1.4 S m-1, relative permittivity 80 and relative magnetic 
permeability 130). Hydrogels were not defined separately as DMEM was assumed 
to dominate the gels electrical and magnetic properties.  
Magnetic and electric fields were analysed using the same-named physics. A 
magnetic insulator was added to the physics containing Electric Insulation, Ground 
and Electric Potential. All boundaries not acting as a ground or receiving electric 
potential were set as electric insulators (all outside faces). Wire faces were 
selected as grounds or receiving electrical potential. All possible symmetric 
patterns (two of four wires active) and configurations of grounds/applied 
electrical potentials were modelled as part of this study. 50 mV was applied as the 
electric potential, based on real voltage readouts when 10 mA are applied to the 
system. All modelling was performed set to an overall temperature of 37°C. 
The resulting electrical and electromagnetic fields were visualized using colour 
gradients (electric potential, magnetic field), streamlines and arrows (magnetic 
flux density). Two dimensional slices are given for the middle cross sections as 
well as the longitudinal section of the model. 
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7.3.5 Proof of Concept: Electrical Stimulation of Cells in 3D 
PC12 cells were collected from culture flasks, counted and dispersed at 
1.8 x 106 cells ml-1 in GGLam. Cell solution was extruded into alginate fibres 
containing four SS50 wires and fitted into the electrical stimulation setup described 
in section 7.4.4.1. 
Electrical stimulation of cells in 3D structures containing wires was performed 
using a DS8000 stimulator and DLS100 isolators (World Precision Instruments, 
USA). The waveform and stimulation parameters of the electrical stimulation 
applied are illustrated in Figure 7.2.  
 
Figure 7.2: Schematic illustration of electrical stimulation parameters applied at two separate current 
amplitudes of 10 mA (A) and 1 mA (B).  
Briefly, a monophasic square waveform was applied for 1 s, with a break of 1ms 
between stimulations. The amplitude applied was either 1 or 10 mA. Cells were 
electrically stimulated starting from 24 h after seeding. Stimulation was applied for 
8 h, followed by 16 h with no stimulation. This pattern was repeated for 3 days. 
Cells were fixed 16 to 24 h after the last stimulation was stopped. An eDAQ 
e‑corder 401 and corresponding software eDAQ chart 5.5.11 were used to monitor 
and recorded the stimulation applied to the cells. 
7.4 Results and Discussion 
7.4.1 3D Hydrogels Containing Cells 
7.4.1.1 Cell Viability in 3D Alginate Gels Containing Conducting Filaments 
As shown in Chapter 6, Section 6.2.4.3 the viability of cells extruded into the 
hydrogel structures is unaffected by the procedure and viability remains high after 
several days of culturing the cells in the gels with SS50 filaments.  
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The cells were encapsulated in 1% AlgL with rGO:PPy composite fibres to analyse 
the suitability of the fibres for 3D cell stimulation, as well as the effect of the 
filaments on PC12 cell viability. As investigated and discussed in Chapter 5, high 
concentrations of rGO:PPy fibres have an impact on L929 fibroblast cell number 
and viability, while low concentration of fibres, even when in contact with the cells 
do not affect L929 cell viability. In this study, 80:20 composite filaments were 
encapsulated into alginate hydrogel together with neural-like PC12 cells. As a 
control, cells encapsulated into the gel were manually extruded into droplets or 
fibres by inserting the spinning solution into the coagulation bath without the 
incorporation of a filament. 
rGO-PPy fibres were successfully encapsulated into a coaxial alginate hydrogel 
containing living PC12 cells. The fibres are mechanically strong enough to support 
the gel structure, however the process of setting up the fabrication, which includes 
manually threading the filaments through the spinneret, is challenging as fibres are 
brittle and break easily when bent. Further improvement of the mechanical 
properties of the filaments is desirable in order to simplify the process. 
The viability of PC12s encapsulated in the fibres containing rGO-PPy filaments was 
found to be 92% or higher at all time points (Figure 7.3).  No significant difference 
was found for live or dead cell numbers between each time point and the 
respective control (cells encapsulated in gel without filament). No significant 
change in number of cells was found over the culturing period of 7 days (p ≥ 0.05).  
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Figure 7.3: Viability assessment of PC12 cells encapsulated in alginate gels containing one rGO-PPy 
fibre at different time points (A). Representative images of PC12s stained with calcein AM and PI for 
live (green) and dead (red) cells at 2hrs, 24 hrs, 48 hrs, 7 days, respectively.  Scale bar represents 
200 µm. 
These results confirm that the utilized method to fabricate fibres containing 
filaments and cells is compatible with the cells and does not result in significantly 
increased number of dead cells to live cells. Furthermore it shows that low 
concentrations of rGO-PPy composite fibres have no significant effect on PC12 cell 
viability, which adds to the results presented in Chapter 5. 
7.4.1.2 Cell Distribution and Differentiation in 3D Alginate Gels 
For the proposed application as part of a nerve conduit, the ability of a gel to 
support cell differentiation is essential. To investigate the cells’ ability to 
differentiate within the gels, differentiation was induced and analysed. Figure 7.4 
shows PC12 cells in 2(w/v)% AlgL immediately after the extrusion process (A & B) 
and after four days of culture in differentiation media (C & D). As can be seen from 
the images no sprouting of neurites or differentiation of the cells has occurred 
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after four days. Images E and F in Figure 7.4 show PC12 cells on tissue culture 
plastic after 3 days of exposure to differentiation conditions.  
 
Figure 7.4: PC12 cells encapsulated in 2% AlgL together with 4 SS50 filaments straight after 
production (A & B) and after four days of culturing in differentiation media (C & D). PC12 cells 
differentiated on tissue culture plastic after 3 days, clearly showing neurite extensions (Arrows, E & 
F). 
As the material clearly supports cell viability but not differentiation it was decided 
to investigate if the material density prevents cell differentiation. The same 
experiment was repeated with the alginate concentrations lowered to 1, 0.5 and 
0.25 % respectively. The experiments showed the same result with no 
differentiation observed after extended periods of culturing under differentiation 
conditions (Figure 7.5). All experiments were performed with cells from the same 
batch seeded onto tissue culture plastic as controls, showing a high degree of 
differentiation, with neurite sprouting being observed as early as 24 h after 
seeding.  
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Figure 7.5: PC12 cells encapsulated in 0.5% AlgL (A), 1% AlgL (B) and 1.5% AlgL (C) together with 4 
SS50 filaments after four days of culturing in differentiation media. 
Whole DRG explants were encapsulated into 1% AlgL fibres to investigate their 
ability to sprout neurites and differentiate within the gel. DRG explants contain a 
number of different cell types including those supportive of neuronal survival and 
function such as satellite glial cells. Figure 7.6 shows DRG explants after five days 
of culturing. When encapsulated in AlgL no neurite sprouting or cell migration can 
be observed even though cell viability, assessed by Calcein AM and PI staining, 
remained high (Figure 7.6A). Explants cultured on tissue culture plastic showed a 
high degree of neurite sprouting (Figure 7.6B).  
 
Figure 7.6: Whole DRGs encapsulated in 1% alginate (A, Calcein AM and PI stained for live (green) 
and dead (read) cells) and on tissue culture plastic (B) after 5 days of culturing. Arrow indicates 
neurite extension. 
The absence of interaction points for cells in unmodified alginate could be 
contributing to the lack of cell differentiation. To test this hypothesis, dissociated 
DRGs were encapsulated in 1% AlgL as well as 1% AlgRGD, which has been 
previously shown to increase cell adhesion to the hydrogel31, 32.  Solid fibres from 
both gels were produced without the addition of other filaments. Figure 7.7 shows 
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dissociated DRGs encapsulated in AlgL (A), AlgRGD (B) and on tissue culture plastic 
(C). Even though DRGs adhere to the RGD peptide sequence and readily 
differentiate in 3D33, 34 no neurite outgrowth was observed after six days of culture 
in alginate gels. The control cells showed extensive neurite outgrowth after the 
same time.  
 
Figure 7.7: Dissociated DRGs in alginate (A) and alginate RGD (B) fibres and on tissue culture plastic 
(C) after 6 days of culture. Arrow indicates neurite extension. 
To ensure that the extrusion process itself or incompatibility with the materials 
were not causing the lack of differentiation, drops of AlgL and AlgDRG were inserted 
into well-plates and crosslinked using 90 mM CaCl2 solution before whole DRGs 
were placed on top and cultured. As can be seen in Figure 7.8 DRGs show cell 
migration and neurite outgrowth on all substrates (AlgL (A), AlgRGD (B) and tissue 
culture plastic (C)), indicating that the alginates are not inherently preventing cell 
differentiation. This finding however indicates that differentiation is inhibited 
when cells are encapsulated. 
 
Figure 7.8: DRGs seeded on alginate (A), Alginate RGD (B) and tissue culture plastic (C) after 5 days 
of culturing. Arrows indicate neurite extension. 
To overcome this limitation the cells ability to differentiate in a hollow fibre was 
investigated. PC12 cells suspended in DMEM (5 x 105 cells ml-1) were extruded 
into a coaxial fibre with a sheath of 2% AlgL. Figure 7.9 shows images of fibres from 
the start of the fibre (A), the middle of the fibres (B) and the end of the fibre (C). 
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The cell distribution was found to be uneven throughout the DMEM filled channel, 
even though the channel itself was formed homogenously. Cell settlement and 
agglomeration occurred in the downwards oriented syringe, leading to uneven cell 
distribution in the core of the fibre and ultimately clogging of the inner outlet of 
the spinneret.  
 
Figure 7.9: PC12 cells in inner lumen of alginate RGD fibre, suspended in DMEM at the beginning (A), 
middle (B) and the end (C) of the fibre. 
To improve cell distribution and avoid cell settlement during the extrusion 
process, cell required stabilization without being encapsulated within a material 
hindering differentiation. A previously developed gellan gum based microparticle 
dispersion (GGink) has shown to prevent cell settlement during extrusion processes 
while supporting PC12 cell differentiation29. Upon exposure to Ca2+ crosslinking of 
the weakly crosslinked GGink increases, leading to the formation of a very soft gel, 
unlikely to support the permanent incorporation of conductive filaments. Instead 
PC12s were suspended in the GGink and the GGink-cell dispersion was wet-spun into 
the centre of a coaxial alginate fibre. Figure 7.10 shows that PC12s were well 
dispersed within the gel structures as well as within the GGink. The inner channel 
was formed homogenously within the alginate sheath. Early neurite outgrowth 
was observed after two days of culturing cells under differentiation conditions. 
After five and eight days of culture, the degree of differentiation was high and a 
large number of cells showed significant neurite outgrowth. Cells aggregation was 
observed over time within the fibre, which indicates that cells are not firmly 
encapsulated and are able to migrate. Cell morphology remains rounded instead of 
spread out, while cells were structurally supported to enable differentiation.  
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Figure 7.10: PC12 cells encapsulated in GGink and 1% AlgL in a coaxial fibre after 2 days (A - B), 5 days 
(C - D) and 8 days (E - F) of culture in differentiation media. Arrows indicate neurite extension. 
The ability of whole and dissociated DRGS to differentiate within the GGink was 
investigated by suspending cells or whole explants in GGink and extruding them 
into coaxial fibres with 1% AlgL as the sheath. Figure 7.11 shows cells immediately 
after and 24 hours after spinning. It can clearly be seen that cells are migrating out 
of the DRGs (Figure 7.11F) and neurite outgrowth can be observed clearly in both 
whole DRGs and was less pronounced in dissociated DRGs. The higher rate of 
differentiation was observed in whole DRGs, resulting from the supporting cell 
cluster. 
 
Figure 7.11: Dissociated (A – D) and whole (E & F) Dorsal Root Ganglia in GGink encapsulated in 
1% AlgL after fibre spinning (A, C, E) and 24 hours later (B, D, F). Arrows indicate neurite extension. 
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7.4.2 Design, Optimization and Testing of Alginate-Wire-Cell Complex   
Based on the findings presented in Section 7.3.1 the spinneret design was adapted 
from accommodating four filaments in a solid body of gel, to accommodating four 
filaments as well as a separate central lumen for cells suspended in GGink, all 
surrounded by a body of gel (Figure 7.12).  
 
Figure 7.12: Schematic of cross section of 5x-lumen spinneret and the structure of the resulting gel. 
The extrusion settings used for this spinneret were adjusted to create a structure 
with an overall diameter between 1.7 – 2 mm, with the diameter of the inner cell 
laden lumen measuring 0.5 – 0.8 mm. Structures of these dimensions were 
produced with a flowrate of the inner lumen set to 0.05 ml min-1 and an outer rate 
of 0.9 ml min-1. The stage speed was set to 4.8 mm sec-1.  
Within this gel configuration, early neurite sprouting was observed after 2 – 3 days 
of culturing in differentiation conditions (Figure 7.13A&B). To further enhance 
differentiation GGink was supplemented with 40 µg ml-1 laminin. Figure 7.13C&D 
show PC12 cells suspended in laminin supplemented GGink after 2 and 3 days of 
differentiation in the inner lumen of an AlgL sheath containing four SS50 filaments. 
The majority of cells showed neurite sprouting after 48 h of culture, with extensive 
neurite outgrowth being observed after 72 h of exposure to media containing NGF.  
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Figure 7.13: PC12 cells suspended in GGink (A – B) and GGink with the addition of laminin (C – D) after 
48 h (A & C) and 72 h (B & D) of differentiation.  
 
7.4.3 Electric and Electromagnetic Fields in 3D Hydrogel Structures 
The electrical and electromagnetic fields resulting from electrical stimulation of 
the filaments within the gel structure were modelled. The results of five different 
stimulation configurations are summarized in Figure 7.14. Depending on the 
configurations in which wires are electrically addressed, the resulting electrical 
potentials and magnetic fields vary. The strength as well as the directionality of the 
fields can be tailored, allowing the analysis of cell behaviour in different 
stimulation scenarios, ultimately contributing to the understanding of the effects 
and benefits of electrical stimulation on neuronal cells.  
In the first regime, stimulation of 50 mV is applied to all wires at one end, while all 
wires were grounded at the opposing end. The resulting electric field shows a 
potential gradient along the gel structure ranging from 0 V to 0.05 V. The magnetic 
field is orientated perpendicular to the electric field with a maximum strength of 5 
A m-1 in close proximity to the filaments.  
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In the second regime the potential was applied to two opposite filaments on each 
side, while the end of each was set as the ground. In this configuration an opposing 
potential gradient is generated in close proximity to the filaments receiving a 
current, while the overall potential of the gel was found to be around 0.025 V. The 
magnetic fields are circulating clockwise or anticlockwise around the filaments 
with its strongest amplitude at 5 A m-1 around the filaments. 
Applying the current to two filaments situated next to each other with the ends 
grounded will create the electrical and magnetic fields shown in the third 
stimulation regime. Similarly to the second regime, the overall potential was 
0.025 V, with the highest and lowest voltages found in close proximity to the 
filaments. For this stimulation setup the increased or reduced voltages were found 
to be present in larger radii around the filaments. The magnetic field was found to 
be highly aligned in the centre of the cross-sectional plain of the structure with a 
maximum strength of 4 – 5 A m-1 between the filaments where the cells are 
positioned.  
In the fourth and fifth analysed regime the current was applied to both ends of the 
addressed wires, forcing the electrons to travel between the active and grounded 
filaments. In the fourth regime the active filaments are situated next to each other, 
creating an even potential across the structure with its maximums and minimums 
situated at the active and grounded filaments. The magnetic field has a maximum 
strength of 0.0025 A m-1 orientated perpendicular to the longitudinal cross section 
of the structure.  
An even smaller maximum strength of the magnetic field of 0.005 A m-1 was 
observed for the fifth stimulation regime, with the active and grounded filaments 
positioned next to each other. However the largest degree of directionality of the 
magnetic field was observed for this configuration, with the field aligned with the 
longitudinal axis of the structure. The potential within the structure was divided 
along the longitudinal plane in the middle of the structure, with the highest 
potential being observed around the grounded wires.  
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Figure 7.14: COMSOL models of electric fields and magnetic fields within the 3D hydrogel resulting 
from applying 50 mV potential to the conducting wires (+) in five configurations.  
 
In the following stimulation experiment the first regime was applied for mainly 
two reasons: (1) it produces the highest variation in electrical potential along the 
whole structure and (2) the simplicity of connection of filaments to the 
stimulators.  
 
7.4.4 Facilitating Electrical Stimulation of Cells in 3D Gels 
7.4.4.1 Design and Assembly of Stimulation Mould 
In house designed stimulation moulds were fabricated and tested in order to meet 
a range of different requirements, ranging from biocompatibility to ease of 
assembly. Parts were printed from biologically compatible MED610 polymer (see 
  
Delivering Electrical Stimulation to Cells in 3D | 179  
 
details in Chapter 2, Section 2.5.5.1), which is not only compatible with cells, but 
also chemically stable to withstand sterilization procedures. The design focussed 
on: 
 Containment: Fluids and cells need to be contained within each well of the 
moulds, without leaking out or between wells 
 Efficiency: The mould shall accommodate at least 6 separate wells, each for 
one single hydrogel structure in which the cells can be cultured for 
extended periods of time, allowing for microscopy observations and media 
changes. 
 Operability: The hydrogel structures need to be placed in the mould and the 
filaments separately outside of it to allow electrically addressing of the 
filaments. Threading of the filaments through holes was tested and found to 
be too inaccurate with low rates of success, while being labour-intensive 
and time consuming. 
 Ease of analysis: The mould needs to allow staining and imaging of cells 
within the gels, while remaining in a sterile environment without disruption 
of the gels or embedded cells. 
The final design of the mould resembled a multi-layer setup (Figure 7.15) and 
consisted of 3D printed parts, cover slips and PDMS gaskets.  
One of the key features of the well-plate is the bottom frame (Figure 7.15B), as it 
builds the foundation of the mould. Six windows are incorporated to accommodate 
six gel structures separated from each other. A to the bottom frame glued cover 
slips allows for unimpeded confocal microscopy. To facilitate easy, clean and 
accurate gluing of the cover slip, grooves were incorporated into the bottom of the 
bottom frame as can be seen from the detail B in Figure 7.15B.  
A perfectly fitted 0.3 mm thick PMDS gasket is placed on top on the bottom frame. 
The gel structures are placed on top of this gasket. Grooves in the bottom frame 
allow aligning of the gel structure and its filaments. A second, slightly thicker 
gasket (0.5 mm) is placed on top. The wells are then placed on top and pressed 
into place. The structure is sealed, no liquid moves between or out of the wells. 
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Figure 7.15: Schematic of well-plate design for culturing and electrical stimulation of 3D hydrogel 
structures containing filaments and cells. A: Exploded view of all components of the multi-layered 
setup. B: Technical drawing of Bottom Frame. C: Assembled setup.  
 
To cover the wells and maintain sterility, while not impeding the ability to image 
through the wells, a lid consisting of a grooved frame to which a cover slip is glued 
is placed on top of the structure. 0.5 mm spacers are located at the bottom of the 
lid, to facilitate gas exchange. 
In order to place the cell laden 3D gel into the well-plates, the gel structure is cut in 
5 cm long pieces. At both ends of the fibre, 1.5 cm of the gel is removed using a 
spatula and tweezers, as shown in Figure 7.16. The spatula is pressed into the gel 
where the gel should be removed. Using tweezers, the gel is carefully removed 
from the structure to expose the end of the conducting filaments (Figure 7.16B). 
Pegs, spaced approximately 3 cm apart, were used to clamp the gel structures at 
the exposed wires and to hold them in place on the bottom frame and gasket 
(Figure 7.16D). This step was implemented as keeping the filaments in place 
before securing with the well-plate was found to be difficult.  
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Figure 7.16: Preparation of hydrogel structures for placement into the custom made well-plate (A-C) 
and placement of the gels on top of the bottom frame using a peg-frame (D). 
 
Once the well-plate is fully assembled it is placed into the stimulation-plate shown 
in Figure 7.17 and connected to facilitate stimulation. The stimulation-plate 
consists of a sturdy frame, press fitted to the well-plate. Two connector elements 
printed from titanium facilitate electrical connection. The bottom connector 
(Figure 7.17C) is permanently glued to the frame. Once the assembled well-plate 
has been inserted, the top part of the connector is screwed to the bottom using an 
M2 screw, firmly securing the filaments in place and establishing electrical 
connection. Before stimulation, the connection between the corresponding 
connectors was tested using a multimeter. If electrical connection was confirmed 
the setup was transferred into a cell culture incubator and connected to the 
stimulator as shown in Figure 7.17D-E.  
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Figure 7.17: Stimulation-plate assembly (A) containing the assembled well-plate and two-part 
electronic adapters (B – C). The filaments are secured between the adaptors and electrical connection 
can be established (D – E). 
 
7.4.4.2 Electrical Stimulation: Proof of Concept 
To monitor the stimulation applied, as well as the connections between the 
stimulators and the filaments, the potential output at the stimulators was 
monitored at the beginning and end of each stimulation cycle. Figure 7.18 shows a 
representative potential over time output, acquired during stimulation with 10 mA 
(red) and 1 mA (black). As can be seen from the graph, the potential reaches 
around 0.05 V when a current of 10 mA is applied and around 0.008 V for 
stimulation at 1 mA. The potential drops to 0 V in correspondence to the 1 ms 
break where no current is applied to the system, after 1 sec of stimulation at the 
respective current. This break was implemented to ensure that charge was not 
building up in the system and causing damage to the cells or gels. As the potential 
immediately returns to 0 V in response to the pause in application of the current it 
can be seen that no charge is building up in the system.  
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Figure 7.18: Potential outputs over time of electrical stimulation with applied currents of 1 mA 
(black) and 10 mA (red). 
 
Electrical stimulation was applied to the cell laden hydrogel structures over three 
days, with stimulation for 8 hrs per day. One control group (minimum 3 gels) 
remained unstimulated while one group was stimulated with 1 mA and one with 
10 mA (minimum 3 gels each). Gels containing cells were imaged every 24 hrs 
before stimulation was applied and fixed within 36 hrs after the last stimulation 
period was completed. Immunofluorescent stained cells were imaged and the cell 
differentiation and orientation compared qualitatively. 
Cell differentiation was observed in all sample groups (unstimulated, stimulation 
at 1 or 10 mA) independent of electrical stimulation or stimulation applied, 
indicating that the cells remain alive and functional (Figure 7.19). Based on 
qualitative analysis similar numbers of neurites per cells, numbers of cells with 
neurites, length of neurites, sprouting, and directionality of neurite growth were 
observed in all groups. Figure 7.19 shows representative maximum projection 
images (z-stacks), acquired by confocal microscopy, of unstimulated samples and 
those stimulated at 10 mA. Long neurite outgrowth was observed for all groups. In 
comparison to PC12 cell differentiation in 2D (Figure 7.4 E & F), cells show a more 
rounded and less spread out morphology. This may be a result of weak adhesion to 
the substrate or could be due to the lack of a flat 2D surface. 
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 These results demonstrate a proof of concept for this novel stimulation setup as 
well as the unique 3D gel structure produced, which enabled electrical stimulation 
of the cells in 3D. Furthermore, the system allows systematic investigation of the 
effects of electrical stimulation on nerve cells in a 3D environment, which much 
better mimics the in vivo situation.  
 
Figure 7.19: Maximum projection of confocal z-stacks of electrically stimulated (B) and unstimulated 
(A) immunofluorescent stained PC12 cells (βIIIT, DAPI) in 3D hydrogels exposed to differentiation 
conditions for 5 days. Dotted arrows in top left corner of each image indicate direction of stainless 
steel filaments. Arrowheads indicate neurite extension. 
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7.5 Conclusions 
The creation and use of a hydrogel based “electrical cell” for the study of the effects 
of electrical stimulation on cell behaviour in 3D was investigated in the current 
chapter. To reach this objective, a complex spinneret design for the fabrication of 
hydrogel fibres containing conductive wires as well as living cells was designed 
and fabricated, this system was introduced in Chapter 6.  In the work outlined in 
the current chapter, this spinneret was used to encapsulate neural cells (PC12) 
suspended in gellan gum ink (in a central channel) within an alginate fibre 
containing four conducting filaments, in order to study the effects of electrical 
stimulation on PC12 behaviour.  
A multi-component well-plate in combination with a stimulation-plate setup was 
also designed and fabricated to allow electrical addressing of filaments in the 
hydrogel to facilitate electrical stimulation of cells in 3D. The methods developed 
here allow the systematic investigation of the effects of different electric and 
magnetic fields and type of conductors on cell differentiation. In a proof of concept 
study, electrical stimulation was successfully applied to PC12 cells with the 3D 
hydrogel system. Qualitative analysis showed that the cells remained viable and 
differentiated under the electrical stimulation regimes tested. Designed as a proof 
concept of stimulation of nerve cells in 3D, the number of samples analysed was 
small and further analysis and verification is required for quantitative analysis. 
Techniques enabling quantification of differentiation are still being optimized for 
the quantification of cell stimulation in 3D and are beyond the scope of the current 
thesis. Overall the tools and methods developed in this chapter allow the 
systematic application of different stimulation parameters to cells in a controlled 
3D environment which much more closely mimics the natural in vivo environment 
in which electrical stimulation is believed to be beneficial. 
In conclusion, the material selection, device design and test apparatus design was 
explored for the development of a system to allow systematic testing and analysis 
of cell stimulation in 3D. 
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Chapter 8 
Chapter 8: CONCLUSIONS AND 
FUTURE WORK  
The work presented in this thesis has been conducted with the aim of developing a 
three dimensional (3D) conducting structure to facilitate electrical stimulation in 
peripheral nerve regenerative applications. To this end, two different approaches 
for the incorporation of conducting materials into hydrogels were developed and 
tested, namely 1) blending conducting particles with hydrogels and 2) embedding 
pre-formed conducting fibres. Organic conducting materials were therefore 
fabricated and optimized for incorporation into hydrogels as conducting particles 
or fibres. Lastly, 3D structures were designed, fabricated and optimized to support 
nerve cell differentiation while allowing application of electrical stimulation. 
As part of the first approach, spherical conducting polypyrrole (PPy) nanoparticles 
were blended with alginate (Alg) hydrogel in an attempt to introduce electrical 
conductivity into the gel as described in Chapter 3. Electrochemical Impedance 
Spectroscopy (EIS) on hydrated gel-particle blends showed that the incorporation 
of up to 5 w/v% PPy into 2 w/v% Alg did not reduce, but rather increased the 
resistivity of Alg. Incorporation of silver nanoparticles, similar in size to the PPy 
particles resulted in the same observations, proving that the incorporation of up to 
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5 % of spherical conducting particles did not decrease the resistivity of Alg but 
instead reduced the ionic conductivity inherent to the hydrogels by physically 
hindering ion movement within the gel. To achieve electrical conductivity in Alg 
(i.e. reach the percolation threshold) a concentration of over 80 w/v% of spherical 
conducting particles need to be added to the hydrogel, creating an environment 
unsuitable for cells. This work presents the first comprehensive report on the 
effect of conducting spherical particles on the conductivity of hydrogels in their 
hydrated state. In a second approach, free-standing pre-formed conducting fibres 
were incorporated into Alg to facilitate electrical stimulation of cells within the gel.  
Chapter 4 describes the optimization of the PPy nanodispersion with respect to its 
electrical conductivity and their use in fabrication into conducting fibres without 
use of a supporting matrix. Fibres were produced using a wet-extrusion approach, 
which created brittle electroactive fibres. Reduction of stabilizing polymer in the 
PPy nanodispersion allowed the formation of fibres with improved mechanical and 
electrochemical properties compared to fibres produced from the original PPy 
dispersion. Despite the improvements the developed fibres were found to be too 
brittle and not sufficiently conductive for the desired application. 
To further improve the mechanical and conduction properties of the fibres, 
composite fibres from PPy nanoparticles and reduced graphene oxide (rGO) were 
fabricated and characterized as presented in Chapter 5. Incorporation of rGO into 
the fibres significantly improved their mechanical and electrical properties 
compared to fibres made from only the PPy nanodispersions. Toxicity of the fibres 
was assessed by growing cells in direct contact with fibres, and also by exposing 
cultured cells to leachates of the fibres. Results showed that cell viability was not 
compromised by contact with the fibres whilst in contrast, exposure to high 
concentration (50 – 100 mg ml-1 depending on composite ratio) of leachates from 
the fibres affected cell proliferation and viability. Overall the fibres were thought to 
be suitable to deliver electrical conductivity to cells in 3D hydrogels. A better 
understanding of the interactions between the materials would be desirable to 
potentially further increase or tailor mechanical properties for specific 
applications.  
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Chapter 6 investigates the development of a fabrication technique in which pre-
formed conductive filaments were incorporated into Alg using a modified wet-
spinning approach. In this approach, Alg hydrogel is extruded around a pre-formed 
fibre, resulting in a 3D gel structure containing filaments with desired properties 
including electrical conductivity. The new technique was tested for its reliability, 
versatility and limitations. Hydrogel fibres with different filament layouts were 
produced using a range of filament sizes and materials.  
The cytocompatibility of the fabrication method was of the highest priority in its 
development, with primary focus paid to biocompatibility, and maintenance of a 
sterile and biocompatible gelation mechanism for hydrogel fabrication. This 
resulted in the facilitation of living cells being incorporated into 3D hydrogels 
during fabrication. Viability of cells embedded into 3D hydrogels using this 
technique was found to be unaffected by the fabrication process (Chapter 6). 
In addition, this method showed potential for applications beyond the 
incorporation of filaments for electrical conducting purposes. Depending on the 
choice of embedded filaments and their properties, the ability to facilitate 
controlled drug delivery, mechanical reinforcement or controlled guidance 
channels can be achieved. In this context, fabrication of small consistent channels 
within 3D hydrogels resulting from removal of the embedded filaments could find 
application for improved vascularization, cell guidance or actuation in hydrogels.  
The method described in Chapter 6 allows construction of 3D hydrogels containing 
mammalian cells and electrical conductors encased in alginate hydrogel. In 
Chapter 7 the ability of the encased cells to differentiate within the 3D hydrogel 
structure was analysed and improved by accommodating a separate channel 
within the 3D structure for cells suspended in a gellan gum ink (GGink). The GGink 
ensured even cell dispersion within the channel of the Alg gel while allowing 
differentiation of the cells, which had been impeded when cells were fully 
encapsulated in Alg. Four conducting filaments arranged around the cell-filled 
channel were incorporated to deliver electrical stimulation to the cells.  
The electric fields and electromagnetic fields resulting from the stimulation of the 
embedded filaments in the described arrangement were simulated using finite 
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element analysis. Depending on the pattern in which they were addressed a range 
of complex electric and electromagnetic fields could be generated. To allow 
addressing of the filaments within the cell laden 3D structure a well plate and 
electrical contact plate were designed and fabricated using additive manufacturing 
approaches. The guiding principle in design was again to allow maximum ease of 
assembly and handling of the 3D gels to ensure that sterility was maintained and 
cell culturing enabled while electrical stimulation was applied. A proof of concept 
of the electrical stimulation was performed to test the developed system. Electrical 
stimulation was applied to differentiating nerve cells in 3D using the developed 
protocols (Chapter 6-7). Qualitative analysis showed that the cells remained viable 
and differentiated under the electrical stimulation regimes tested, however no 
conclusions regarding the effects of electrical stimulation applied to the cells were 
determined as part of this study. 
The work presented here describes development of a fabrication method and 
protocols that could provide fundamental tools for investigation of the effects of 
electrical stimulation on cells in a 3D environment. Furthermore the developed 
protocols are translatable between in vitro and in vivo investigations. This means 
that more tissue-relevant in vitro nerve modelling studies are possible that yield 
more physiologically relevant data to define the critical parameters by which nerve 
regeneration in vivo may be enhanced by electrical stimulation. This will lead to 
improvements in the end-stage performance of implantable regenerative 
structures such as synthetic nerve conduits.  
The versatility of the system developed here permits investigation of stimulation 
delivered from different materials using various configurations, enabling effects of 
both electrode composition and spatial arrangement of electrodes to be 
considered. Furthermore, supportive cells (such as Schwann cells), or growth 
factors can be incorporated into the construct in order to closer mimic the nerve’s 
natural environment. It is conceivable to introduce gradients of materials, growth 
factors or cells into the structure, as well as physical guidance cues such as 
channels and other topographical features using the fabrication method described 
in this work.  
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A greater focus on the conducting material used for in vivo stimulation of cells is 
required, especially for in vivo applications, where use of mechanically hard metals 
is not viable in many parts of the body that require softer, more flexible or even 
biodegradable electrode materials. In this study, electrical stimulation was 
delivered to the cells using surgical stainless steel filaments to eliminate potential 
side-effects of the filaments on the cells resulting from electrical or electrochemical 
processes occurring in the composite filaments. Stainless steel was found to be a 
good material for the proof of concept, however lacking biodegradability it is not 
an ideal candidate for implantation. In this work composite fibres from graphene 
and polypyrrole were fabricated and tested for their mechanical and 
electrochemical properties as well as their toxicity to cells in vitro, and these 
turned out to be good candidates for electrical stimulation in the 3D structure 
developed. Future work should involve the use of the developed composite fibres 
in cell stimulation experiments.  
Many challenges remain in the fabrication of the ideal synthetic nerve conduit. The 
work presented here focussed on the manufacturing of 3D cell-laden hydrogel 
structures that allow electrical stimulation of cells, enabling the future 
investigation of effects of stimulation in vitro as a precursor model that accurately 
defines in-context in vivo performance expectations. Electrically conducting 
materials were successfully incorporated into cell-containing hydrogels without 
compromising cell viability. The ability of the cells to differentiate was improved 
by addition of a non-structural hydrogel modified with peptide motifs for cell 
adhesion, which allowed cells to be held within the structure while avoiding full 
encapsulation, ultimately resulting in a complex 3D structure supporting nerve cell 
differentiation and facilitating electrical stimulation. Cell differentiation under the 
influence of electrical signals needs to be evaluated to determine whether 
stimulation of cells in a 3D environment can yield the same results as stimulation 
in 2D.  
